New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/nzpocs | Version: 0.1.0 | |||
| Active as of 2024-07-29 | Computable Name: NZPOCS | |||
A LOINC FHIR ValueSet of NZPOCS Observation Code Set
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet nzpocs
version: versionId: id (PrimitiveType/ValueSet.meta.versionId): native = id -> 1; Last updated: 2024-07-25 17:31:18+1200
This value set includes codes based on the following rules:
http://loinc.org version 2.77| Code | Display | https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use#ConsumerName | English (New Zeland) (English (New Zeland), en) |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | AHG (indirect, complement) | AHG (indirect, complement) |
| 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | Monkeypox DNA NAA+probe Ql (Specimen) | Monkeypox DNA NAA+probe Ql (Specimen) |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | AHG (direct, complement) | AHG (direct, complement) |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | AHG (indirect, IgG) | AHG (indirect, IgG) |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | AHG (direct, polyspecific) | AHG (direct, polyspecific) |
| 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefoperazone suscep (MIC) | Cefoperazone suscep (MIC) |
| 1008-2 | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma | AHG (indirect, polyspecific) | AHG (indirect, polyspecific) |
| 10331-7 | Rh [Type] in Blood | Rh phenotype | Rh phenotype |
| 10333-3 | Appearance of Cerebral spinal fluid | Appearance CSF | Appearance CSF |
| 10334-1 | Cancer Ag 125 [Units/?volume] in Serum or Plasma | CA 125 | CA 125 |
| 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceforanide suscep (MIC) | Ceforanide suscep (MIC) |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma | LH | LH |
| 10574-2 | Fructose [Moles/?volume] in Semen | Fructose seminal fluid | Fructose seminal fluid |
| 10579-1 | Leukocytes [#/volume] in Semen | Leucocytes semen | Leucocytes semen |
| 10580-9 | Liquefaction [Time] in Semen | Liquefaction semen | Liquefaction semen |
| 10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen | Abnormal forms (head) semen | Abnormal forms (head) semen |
| 10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | Abnormal forms (midpiece) semen | Abnormal forms (midpiece) semen |
| 10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | Abnormal forms (tail) semen | Abnormal forms (tail) semen |
| 10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen | Agglutination semen | Agglutination semen |
| 10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen | Non-motile semen | Non-motile semen |
| 10613-8 | Spermatozoa Viable/100 spermatozoa in Semen | Vitality semen | Vitality semen |
| 10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen | Non-progressive semen | Non-progressive semen |
| 10622-9 | Spermatozoa Normal/100 spermatozoa in Semen | Normal forms semen | Normal forms semen |
| 10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen | Rapid progressive semen | Rapid progressive semen |
| 10626-0 | Spermatozoa Slow/100 spermatozoa in Semen | Slow progressive semen | Slow progressive semen |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture | Amoebae culture | Amoebae culture |
| 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Clotrimazole suscep (MIC) | Clotrimazole suscep (MIC) |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nystatin suscep (MIC) | Nystatin suscep (MIC) |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy | Schistosoma urine | Schistosoma urine |
| 10718-5 | Strongyloides sp Ab [Units/?volume] in Serum by Immunoassay | Strongyloides Ab | Strongyloides Ab |
| 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | Terbinafine suscep (MIC) | Terbinafine suscep (MIC) |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture | Trichomonas culture | Trichomonas culture |
| 10739-1 | Virus identified in Unspecified specimen by Electron microscopy | Viruses (EM) | Viruses (EM) |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | Fat faeces (stain) | Fat faeces (stain) |
| 108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefotaxime suscep (MIC) | Cefotaxime suscep (MIC) |
| 10835-7 | Lipoprotein a [Mass/?volume] in Serum or Plasma | Lipoprotein (a) - mass/volume | Lipoprotein (a) - mass/volume |
| 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma | Troponin I | Troponin I |
| 10840-7 | Atropine [Mass/?volume] in Urine | Atropine | Atropine |
| 10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture | Varicella zoster (culture) | Varicella zoster (culture) |
| 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma | PSA (free) | PSA (free) |
| 10998-3 | Oxycodone [Presence] in Urine | Oxycodone, urine | Oxycodone, urine |
| 11011-4 | Hepatitis C virus RNA [Units/?volume] (viral load) in Serum or Plasma by Probe and target amplification method | Hepatitis C Viral Load (IU/mL) | Hepatitis C Viral Load (IU/mL) |
| 11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain | Peroxidase stain | Peroxidase stain |
| 11060-1 | Reducing substances [Presence] in Stool | Reducing substances faeces | Reducing substances faeces |
| 11067-6 | Bleeding time | Bleeding time | Bleeding time |
| 11084-1 | Reagin Ab [Titer] in Serum | Reagin Ab (titre) | Reagin Ab (titre) |
| 11085-8 | Schistosoma sp identified in Stool by Concentration | Schistosome faeces | Schistosome faeces |
| 11135-1 | Appearance of Spun Cerebral spinal fluid | Supernatant CSF | Supernatant CSF |
| 11227-6 | Pyruvate kinase [Presence] in Blood | Pyruvate kinase (screen) | Pyruvate kinase (screen) |
| 112-3 | Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefotetan suscep (MIC) | Cefotetan suscep (MIC) |
| 11257-3 | Haemophilus influenzae B IgG Ab [Mass/?volume] in Serum by Immunoassay | H Influenza Type2 Ab | H Influenza Type2 Ab |
| 11266-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen | Grp B Strep Ag | Grp B Strep Ag |
| 11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection | Varicella zoster (NAAT) | Varicella zoster (NAAT) |
| 11545-1 | Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain | Microscopy (acid fast stain) | Microscopy (acid fast stain) |
| 11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain | Microscopy (other stain) | Microscopy (other stain) |
| 11555-0 | Base excess in Blood by calculation | Base excess blood | Base excess blood |
| 11556-8 | Oxygen [Partial pressure] in Blood | PO2 blood | PO2 blood |
| 11557-6 | Carbon dioxide [Partial pressure] in Blood | PCO2 blood | PCO2 blood |
| 11558-4 | pH of Blood | pH blood | pH blood |
| 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma | Rheumatoid factor | Rheumatoid factor |
| 11573-3 | Rheumatoid factor IgM [Units/volume] in Serum | Rheumatoid factor IgM | Rheumatoid factor IgM |
| 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L | TSH DL <= 0.05 mIU/L Qn | TSH DL <= 0.05 mIU/L Qn |
| 11580-8 | Thyrotropin [Units/?volume] in Serum or Plasma by Detection limit <= 0.005 mIU/?L | TSH - by Detection limit <= 0.005 mIU/?L | TSH - by Detection limit <= 0.005 mIU/?L |
| 116-4 | Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefoxitin suscep (MIC) | Cefoxitin suscep (MIC) |
| 120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefpodoxime suscep (MIC) | Cefpodoxime suscep (MIC) |
| 12176-4 | Amino acids [Moles/?volume] in Serum or Plasma | Amino Acids | Amino Acids |
| 12195-4 | Creatinine renal clearance/1.73 sq M in 24 hour | Creat clearance (1.73 body SA) | Creat clearance (1.73 body SA) |
| 12241-6 | Osmotic fragility of Red Blood Cells by Diluted RBC | Osmotic fragility | Osmotic fragility |
| 12254-9 | Volume of Body fluid | Volume body fluid | Volume body fluid |
| 12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy | Semen (post vasectomy) | Semen (post vasectomy) |
| 12293-7 | Cotinine [Presence] in Urine | Cotinine urine | Cotinine urine |
| 12308-3 | Hydrocodone [Presence] in Urine | Hydrocodone, urine | Hydrocodone, urine |
| 12319-0 | Thioridazine [Presence] in Urine | Thioridazine | Thioridazine |
| 12327-3 | Ketamine [Presence] in Urine | Ketamine urine | Ketamine urine |
| 12389-3 | Olanzapine [Mass/?volume] in Serum or Plasma | Olanzapine | Olanzapine |
| 12467-7 | Amino acids [Identifier] in Urine | Amino Acids urine (ident) | Amino Acids urine (ident) |
| 124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefprozil suscep (MIC) | Cefprozil suscep (MIC) |
| 12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Amikacin suscep (MIC) | Amikacin suscep (MIC) |
| 12708-4 | Tin [Mass/?volume] in Urine | Tin urine | Tin urine |
| 12841-3 | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma | PSA (free/total) | PSA (free/total) |
| 12851-2 | Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis | Protein (electrophoresis) | Protein (electrophoresis) |
| 128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefsulodin suscep (MIC) | Cefsulodin suscep (MIC) |
| 12916-3 | Porphobilinogen synthase [Enzymatic activity/?volume] in Blood | Ala Dehydratase blood | Ala Dehydratase blood |
| 12998-1 | Methylene chloride [Mass/?volume] in Blood | Methylene chloride blood | Methylene chloride blood |
| 13000-5 | Mandelate [Mass/?volume] in Urine | Mandelic acid urine | Mandelic acid urine |
| 1304-5 | D Ab [Titer] in Serum or Plasma | Rh D Ab (titre) | Rh D Ab (titre) |
| 13046-8 | Variant lLymphocytes/100 leukocytes in Blood | Lymphocytes (atypical) (%) | Lymphocytes (atypical) (%) |
| 13087-2 | Complement alternate pathway AH50 [Units/?volume] in Serum or Plasma | Alternative pathway activity / AH50 | Alternative pathway activity / AH50 |
| 13238-1 | Epstein Barr virus Ab [Units/volume] in Serum | EBV Ab | EBV Ab |
| 13304-1 | HLA-DR [Type] | HLA-DR typing | HLA-DR typing |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells | Duffy Phenotype | Duffy Phenotype |
| 13310-8 | Kell group Ag [Type] on Red Blood Cells | Kell Phenotype | Kell Phenotype |
| 13311-6 | MNS group Ag [Type] on Red Blood Cells | MNS Phenotype | MNS Phenotype |
| 13316-5 | Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture | VRE (culture) | VRE (culture) |
| 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture | MRSA (culture) | MRSA (culture) |
| 13359-5 | Character of Semen | Appearance semen | Appearance semen |
| 133-9 | Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftazidime suscep (MIC) | Ceftazidime suscep (MIC) |
| 13438-7 | Protein Fractions [interpretation] in Urine by Electrophoresis | Protein urine (elph) | Protein urine (elph) |
| 13488-2 | aPTT in Control Platelet poor plasma by Coagulation assay | APTT (control) | APTT (control) |
| 13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain | Iron stain | Iron stain |
| 13514-5 | Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative | Hb electrophoresis - alkaline | Hb electrophoresis - alkaline |
| 13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative | Xanthochromia CSF | Xanthochromia CSF |
| 13533-5 | Acid hemolysis [Presence] of Blood | Ham's test | Ham's test |
| 13539-2 | Phosphate [Moles/?volume] in Urine | Phosphate urine | Phosphate urine |
| 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay | APCR | APCR |
| 137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftizoxime suscep (MIC) | Ceftizoxime suscep (MIC) |
| 13956-8 | Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection | Mycobacterium tuberculosis DNA (NAAT) | Mycobacterium tuberculosis DNA (NAAT) |
| 13964-2 | Methylmalonate [Moles/?volume] in Serum or Plasma | Methylmalonic Acid - in serum or plasma | Methylmalonic Acid - in serum or plasma |
| 13965-9 | Homocysteine [Moles/?volume] in Serum or Plasma | Homocysteine | Homocysteine |
| 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma | SHBG | SHBG |
| 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma | CKMB (mass) | CKMB (mass) |
| 13996-4 | Hydroxyproline/?Creatinine [Molar ratio] in 24 hour Urine | Hydroxyproline/creat urine 24h | Hydroxyproline/creat urine 24h |
| 14116-8 | IgG synthesis rate [Mass/?time] in Serum and CSF by calculation | IgG Synthesis | IgG Synthesis |
| 14117-6 | IgG clearance/Albumin clearance [ratio] in Serum and CSF | IgG Index serum/CSF | IgG Index serum/CSF |
| 141-2 | Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftriaxone suscep (MIC) | Ceftriaxone suscep (MIC) |
| 14122-6 | Pyruvate [Moles/?volume] in Cerebral spinal fluid | CSF Lactate & Pyruvate | CSF Lactate & Pyruvate |
| 14135-8 | CD3+?CD8+? (T8 suppressor cells) cells [#/?volume] in Blood | lymphocyte markers - Cells.CD3+CD8+ | lymphocyte markers - Cells.CD3+CD8+ |
| 14136-6 | CD34 cells [#/?volume] in Blood | CD34 Assay, blood | CD34 Assay, blood |
| 14196-0 | Reticulocytes [#/volume] in Blood | Reticulocytes | Reticulocytes |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum | Strep DNAse B Ab (titre) | Strep DNAse B Ab (titre) |
| 14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence | Giardia Ag faeces (IF) | Giardia Ag faeces (IF) |
| 14236-4 | Mitochondria Ab [Presence] in Serum | Mitochondria Antibody | Mitochondria Antibody |
| 14252-1 | Smooth muscle Ab [Presence] in Serum | Smooth muscle Antibody | Smooth muscle Antibody |
| 14272-9 | Liver kidney microsomal Ab [Presence] in Serum | Liver/Kidney Ab - Presence | Liver/Kidney Ab - Presence |
| 14286-9 | Carnitine free (C0) [Moles/?volume] in Serum or Plasma | Carnitine (free) | Carnitine (free) |
| 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method | Benzoylecgonine urine by Screen Method | Benzoylecgonine urine by Screen Method |
| 14316-4 | Benzodiazepines [Presence] in Urine by Screen method | Benzodiazepine urine by Screen method | Benzodiazepine urine by Screen method |
| 14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) | P-aminosalicylate suscep (MIC) | P-aminosalicylate suscep (MIC) |
| 14334-7 | Lithium [Moles/volume] in Serum or Plasma | Lithium | Lithium |
| 14398-2 | Creatinine [Mass/?volume] in Cerebral spinal fluid | Creatinine CSF | Creatinine CSF |
| 14503-7 | Human papilloma virus 16+?18 Ag [Presence] in Cervix | HPV Screen | HPV Screen |
| 14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence | Pneumocystis jiroveci Ag | Pneumocystis jiroveci Ag |
| 145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefuroxime inject suscep (MIC) | Cefuroxime inject suscep (MIC) |
| 14567-2 | 11-Deoxycortisol [Moles/?volume] in Serum or Plasma | 11Deoxycortisol | 11Deoxycortisol |
| 14569-8 | 17-Hydroxyprogesterone [Moles/?volume] in Serum or Plasma | 17-Hydroxy progesterone | 17-Hydroxy progesterone |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine | 5HIAA urine 24h | 5HIAA urine 24h |
| 14575-5 | Blood group antibody investigation [interpretation] in Plasma or RBC | Blood Group Ab (interpretation) | Blood Group Ab (interpretation) |
| 14581-3 | Acetaminophen [Moles/?volume] in Serum or Plasma | Paracetamol | Paracetamol |
| 14586-2 | Aldosterone [Moles/?volume] in Serum or Plasma | Aldosterone | Aldosterone |
| 14593-8 | Aluminum [Moles/?volume] in Serum or Plasma | Aluminium | Aluminium |
| 14597-9 | Amitriptyline [Moles/?volume] in Serum or Plasma | Amitriptyline - moles/volume | Amitriptyline - moles/volume |
| 14603-5 | Androstenedione [Moles/?volume] in Serum or Plasma | Androstenedione | Androstenedione |
| 14611-8 | Nuclear Ab pattern [interpretation] in Serum | Antinuclear Ab (pattern) | Antinuclear Ab (pattern) |
| 14622-5 | Ascorbate [Moles/?volume] in Serum or Plasma | Ascorbate | Ascorbate |
| 14628-2 | Bile acid [Moles/volume] in Serum or Plasma | Bile Salts | Bile Salts |
| 14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma | Bilirubin (conj) | Bilirubin (conj) |
| 14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma | Bilirubin (unconj) | Bilirubin (unconj) |
| 14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma | Bilirubin | Bilirubin |
| 14635-7 | Calcidiol [Moles/?volume] in Serum or Plasma | Vitamin D | Vitamin D |
| 14637-3 | Calcium [Moles/time] in 24 hour Urine | Calcium urine 24h | Calcium urine 24h |
| 14638-1 | Calculus analysis [interpretation] in Stone | Calculus analysis | Calculus analysis |
| 14639-9 | Carbamazepine [Moles/volume] in Serum or Plasma | Carbamazepine | Carbamazepine |
| 14642-3 | Carotene [Moles/?volume] in Serum | Beta Carotene | Beta Carotene |
| 14645-6 | Chlorpromazine [Moles/?volume] in Serum or Plasma | Chlorpromazine | Chlorpromazine |
| 14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma | Cholesterol (HDL) | Cholesterol (HDL) |
| 14647-2 | Cholesterol [Moles/volume] in Serum or Plasma | Cholesterol | Cholesterol |
| 14650-6 | Citrate [Moles/?time] in 24 hour Urine | Citrate urine | Citrate urine |
| 14651-4 | Clobazam [Moles/?volume] in Serum or Plasma | Clobazam | Clobazam |
| 14652-2 | Clomipramine [Moles/?volume] in Serum or Plasma | Clomipramine - moles/volume | Clomipramine - moles/volume |
| 14654-8 | Clomipramine+?Norclomipramine [Moles/?volume] in Serum or Plasma | Clomipramine+Norclomipramine�- moles/volume | Clomipramine+Norclomipramine�- moles/volume |
| 14655-5 | Clonazepam [Moles/?volume] in Serum or Plasma | Clonazepam | Clonazepam |
| 14656-3 | Clozapine [Moles/?volume] in Serum or Plasma | Clozapine | Clozapine |
| 14665-4 | Copper [Moles/?volume] in Serum or Plasma | Copper | Copper |
| 14666-2 | Copper [Moles/?time] in 24 hour Urine | Copper urine 24hr | Copper urine 24hr |
| 14674-6 | Corticotropin [Moles/?volume] in Plasma | Adrenocorticotropic hormone | Adrenocorticotropic hormone |
| 14675-3 | Cortisol [Moles/volume] in Serum or Plasma | Cortisol | Cortisol |
| 14676-1 | Cortisol Free [Moles/time] in 24 hour Urine | Cortisol (free) urine 24h | Cortisol (free) urine 24h |
| 14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen | Cortisol (PM) | Cortisol (PM) |
| 14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen | Cortisol (AM) | Cortisol (AM) |
| 14682-9 | Creatinine [Moles/volume] in Serum or Plasma | Creatinine | Creatinine |
| 14683-7 | Creatinine [Moles/volume] in Urine | Creatinine urine | Creatinine urine |
| 14684-5 | Creatinine [Moles/time] in 24 hour Urine | Creatinine urine 24h | Creatinine urine 24h |
| 14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma | Vitamin B12 | Vitamin B12 |
| 14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/?volume] in Serum or Plasma | Dehydroepiandrosterone Sulphate | Dehydroepiandrosterone Sulphate |
| 14691-0 | Desipramine [Moles/?volume] in Serum or Plasma | Desipramine - moles/volume | Desipramine - moles/volume |
| 14695-1 | Nordoxepin [Moles/?volume] in Serum or Plasma | Nordoxepin - moles/volume | Nordoxepin - moles/volume |
| 14698-5 | Digoxin [Moles/volume] in Serum or Plasma | Digoxin | Digoxin |
| 14702-5 | Disopyramide [Moles/?volume] in Serum or Plasma | Disopyramide | Disopyramide |
| 14703-3 | Dopamine [Moles/?volume] in Serum or Plasma | Dopamine | Dopamine |
| 14705-8 | Doxepin [Moles/?volume] in Serum or Plasma | Doxepin - moles/volume | Doxepin - moles/volume |
| 14711-6 | Epinephrine [Moles/?volume] in Plasma | Adrenaline | Adrenaline |
| 14712-4 | Epinephrine [Moles/time] in 24 hour Urine | Adrenaline urine 24h | Adrenaline urine 24h |
| 14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma | Oestradiol | Oestradiol |
| 14719-9 | Ethanol [Moles/volume] in Serum or Plasma | Ethanol | Ethanol |
| 14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma | Ethosuximide | Ethosuximide |
| 14722-3 | Extractable nuclear Ab [Presence] in Serum | ENA screen | ENA screen |
| 14726-4 | Fluoride [Moles/?volume] in Serum or Plasma | Fluoride | Fluoride |
| 14731-4 | Folate [Moles/volume] in Red Blood Cells | Folate RBC | Folate RBC |
| 14732-2 | Folate [Moles/volume] in Serum or Plasma | Folate | Folate |
| 14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid | Glucose CSF | Glucose CSF |
| 14745-4 | Glucose [Moles/volume] in Body fluid | Glucose body fluid | Glucose body fluid |
| 14749-6 | Glucose [Moles/volume] in Serum or Plasma | Glucose | Glucose |
| 14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO | Glucose (1h post 50g glucose) | Glucose (1h post 50g glucose) |
| 14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal | Glucose (2h post meal) | Glucose (2h post meal) |
| 14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer | Glucose (fasting) blood | Glucose (fasting) blood |
| 14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma | Glucose (fasting) | Glucose (fasting) |
| 14782-7 | Homovanillate [Moles/volume] in Urine | Homovanillate urine | Homovanillate urine |
| 14783-5 | Homovanillate [Moles/time] in 24 hour Urine | Homovanillate urine 24h | Homovanillate urine 24h |
| 14785-0 | Hydroxyproline [Moles/?time] in 24 hour Urine | Hydroxyproline urine 24h | Hydroxyproline urine 24h |
| 14796-7 | Insulin [Moles/?volume] in Serum or Plasma | Insulin (total) | Insulin (total) |
| 14798-3 | Iron [Moles/volume] in Serum or Plasma | Iron | Iron |
| 14799-1 | Iron [Moles/?time] in 24 hour Urine | Iron urine 24h | Iron urine 24h |
| 14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma | Iron binding capacity | Iron binding capacity |
| 14801-5 | Iron saturation [Molar fraction] in Serum or Plasma | Transferrin saturation - molar fraction | Transferrin saturation - molar fraction |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction | LDH fluid by Lactate to pyruvate reaction | LDH fluid by Lactate to pyruvate reaction |
| 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction | LDH by Lactate to pyruvate reaction | LDH by Lactate to pyruvate reaction |
| 14805-6 | Lactate dehydrogenase [Enzymatic activity/?volume] in Serum or Plasma by Pyruvate to lactate reaction | LDH by Pyruvate to lactate reaction | LDH by Pyruvate to lactate reaction |
| 14807-2 | Lead [Moles/?volume] in Blood | Lead blood | Lead blood |
| 14809-8 | Lead [Moles/?time] in 24 hour Urine | Lead urine 24hr | Lead urine 24hr |
| 14812-2 | Lidocaine [Moles/?volume] in Serum or Plasma | Lignocaine | Lignocaine |
| 14833-8 | Metanephrines [Moles/?time] in 24 hour Urine | Metanephrines urine 24h | Metanephrines urine 24h |
| 14835-3 | Methanol [Moles/?volume] in Serum or Plasma | Methanol | Methanol |
| 14836-1 | Methotrexate [Moles/?volume] in Serum or Plasma | Methotrexate | Methotrexate |
| 14852-8 | Norepinephrine [Moles/?volume] in Plasma | Noradrenaline | Noradrenaline |
| 14853-6 | Norepinephrine [Moles/volume] in Urine | Noradrenaline urine | Noradrenaline urine |
| 14854-4 | Norepinephrine [Moles/time] in 24 hour Urine | Noradrenaline urine 24h | Noradrenaline urine 24h |
| 14856-9 | Nortriptyline [Moles/?volume] in Serum or Plasma | Nortriptyline - moles/volume | Nortriptyline - moles/volume |
| 14862-7 | Oxalate [Moles/?time] in 24 hour Urine | Oxalate urine 24hr | Oxalate urine 24hr |
| 14866-8 | Parathyrin.intact [Moles/?volume] in Serum or Plasma | Parathyroid Hormone (intact) - moles/volume | Parathyroid Hormone (intact) - moles/volume |
| 14874-2 | Phenobarbital [Moles/volume] in Serum or Plasma | Phenobarbitone | Phenobarbitone |
| 14877-5 | Phenytoin [Moles/volume] in Serum or Plasma | Phenytoin | Phenytoin |
| 14879-1 | Phosphate [Moles/volume] in Serum or Plasma | Phosphate | Phosphate |
| 14881-7 | Phosphate [Moles/?time] in 24 hour Urine | Phosphate urine 24h | Phosphate urine 24h |
| 14883-3 | Porphyrins [interpretation] in Serum or Plasma | Fluorescence | Fluorescence |
| 14885-8 | Pregnanediol [Moles/time] in 24 hour Urine | Pregnanediol urine 24h | Pregnanediol urine 24h |
| 14890-8 | Progesterone [Moles/volume] in Serum or Plasma | Progesterone | Progesterone |
| 14899-9 | Quinidine [Moles/?volume] in Serum or Plasma | Quinidine | Quinidine |
| 14905-4 | Retinol [Moles/?volume] in Serum or Plasma | Vitamin A | Vitamin A |
| 14909-6 | Salicylates [Moles/?volume] in Serum or Plasma | Salicylate - moles/volume | Salicylate - moles/volume |
| 14913-8 | Testosterone [Moles/volume] in Serum or Plasma | Testosterone | Testosterone |
| 14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma | Testosterone (free) | Testosterone (free) |
| 14915-3 | Theophylline [Moles/volume] in Serum or Plasma | Theophylline | Theophylline |
| 14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma | T4 (free) | T4 (free) |
| 14921-1 | Thyroxine (T4) [Moles/?volume] in Serum or Plasma | T4 (total) | T4 (total) |
| 14927-8 | Triglyceride [Moles/volume] in Serum or Plasma | Triglycerides | Triglycerides |
| 14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma | T3 (free) | T3 (free) |
| 14930-2 | Triiodothyronine (T3) [Moles/?volume] in Serum or Plasma | T3 (total) | T3 (total) |
| 14931-0 | Trimipramine [Moles/?volume] in Serum or Plasma | Trimipramine | Trimipramine |
| 14933-6 | Urate [Moles/volume] in Serum or Plasma | Urate | Urate |
| 14934-4 | Urate [Moles/?volume] in Urine | Urate urine | Urate urine |
| 14935-1 | Urate [Moles/?time] in 24 hour Urine | Urate urine 24h | Urate urine 24h |
| 14939-3 | Urea nitrogen [Moles/?time] in 24 hour Urine | Urea urine 24h | Urea urine 24h |
| 14946-8 | Valproate [Moles/volume] in Serum or Plasma | Valproate | Valproate |
| 14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine | VMA urine 24h | VMA urine 24h |
| 14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine | VMA/creat urine | VMA/creat urine |
| 14949-2 | Vasopressin [Moles/?volume] in Plasma | Arginine Vasopressin | Arginine Vasopressin |
| 149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephalexin suscep (MIC) | Cephalexin suscep (MIC) |
| 14955-9 | Zinc [Moles/?volume] in Serum or Plasma | Zinc | Zinc |
| 14956-7 | Microalbumin [Mass/time] in 24 hour Urine | Microalbumin urine 24h | Microalbumin urine 24h |
| 14957-5 | Microalbumin [Mass/volume] in Urine | Microalbumin urine | Microalbumin urine |
| 14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine | Microalbumin/creat urine | Microalbumin/creat urine |
| 14979-9 | aPTT in Platelet poor plasma by Coagulation assay | APTT | APTT |
| 14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO | Glucose (2h post 75g glucose) | Glucose (2h post 75g glucose) |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine | 5HIAA urine | 5HIAA urine |
| 15032-6 | Angiotensin II [Moles/?volume] in Plasma | Angiotensin II | Angiotensin II |
| 15034-2 | Bromide [Moles/?volume] in Serum or Plasma | Bromide | Bromide |
| 15038-3 | Citrate [Moles/?volume] in Serum or Plasma | Citrate | Citrate |
| 15057-3 | Androstanolone [Moles/?volume] in Serum or Plasma | Dihydrotestosterone | Dihydrotestosterone |
| 15058-1 | Dopamine [Moles/volume] in Urine | Dopamine urine | Dopamine urine |
| 15059-9 | Dopamine [Moles/time] in 24 hour Urine | Dopamine urine 24h | Dopamine urine 24h |
| 15061-5 | Erythropoietin (EPO) [Units/?volume] in Serum or Plasma | Erythropoietin | Erythropoietin |
| 15066-4 | Fatty acids.nonesterified [Moles/?volume] in Serum or Plasma | Fatty Acids (free) | Fatty Acids (free) |
| 15067-2 | Follitropin [Units/volume] in Serum or Plasma | FSH | FSH |
| 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma | Fructosamine | Fructosamine |
| 15072-2 | Gastrin [Moles/?volume] in Serum or Plasma | Gastrin - moles/volume | Gastrin - moles/volume |
| 15074-8 | Glucose [Moles/volume] in Blood | Glucose blood | Glucose blood |
| 15076-3 | Glucose [Moles/?volume] in Urine | Glucose urine | Glucose urine |
| 15081-3 | Prolactin [Units/volume] in Serum or Plasma | Prolactin | Prolactin |
| 15083-9 | Normetanephrine [Moles/?time] in 24 hour Urine | Normetanephrine urine 24h | Normetanephrine urine 24h |
| 15087-0 | Parathyrin related protein [Moles/?volume] in Serum or Plasma | Parathyroid Hormone Related Peptide | Parathyroid Hormone Related Peptide |
| 15097-9 | Vanillylmandelate [Moles/volume] in Urine | VMA urine | VMA urine |
| 15099-5 | Amiodarone [Moles/?volume] in Serum or Plasma | Amiodarone | Amiodarone |
| 15105-0 | Flecainide [Moles/?volume] in Serum or Plasma | Flecainide | Flecainide |
| 15107-6 | Imipramine [Moles/?volume] in Serum or Plasma | Imipramine - moles/volume | Imipramine - moles/volume |
| 15108-4 | Methadone [Moles/?volume] in Serum or Plasma | Methadone - moles/volume | Methadone - moles/volume |
| 15115-9 | Arsenic [Moles/?volume] in Urine | Arsenic urine | Arsenic urine |
| 15117-5 | Cadmium [Moles/?volume] in Blood | Cadmium blood | Cadmium blood |
| 15120-9 | Ethanol [Moles/volume] in Blood | Ethanol blood | Ethanol blood |
| 15148-0 | Alkaline phosphatase [Enzymatic activity/?volume] in Body fluid | Alk Phosphatase,fluid | Alk Phosphatase,fluid |
| 15176-1 | Cryoproteins identified in Serum or Plasma | Cryoproteins | Cryoproteins |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma | D-dimer (qual) | D-dimer (qual) |
| 15200-9 | Osmolality of Body fluid | Osmolality fluid | Osmolality fluid |
| 15210-8 | Thyroglobulin Ab [Presence] in Serum | Thyroglobulin Antibody - presence | Thyroglobulin Antibody - presence |
| 15359-3 | dRVVT actual/normal (normalized LA screen) | Dilute Russell viper venom time - actual normal | Dilute Russell viper venom time - actual normal |
| 15363-5 | Busulfan [Mass/?volume] in Serum or Plasma | Busulphan | Busulphan |
| 153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephaloglycin suscep (MIC) | Cephaloglycin suscep (MIC) |
| 15374-2 | Sulfonylurea [Presence] in Serum or Plasma | Sulphonylurea screen | Sulphonylurea screen |
| 15376-7 | Spermatozoa Abnormal/100 spermatozoa in Semen | Abnormal forms semen | Abnormal forms semen |
| 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay | Varicella zoster Ab IgG | Varicella zoster Ab IgG |
| 157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephaloridine suscep (MIC) | Cephaloridine suscep (MIC) |
| 16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Ethionamide suscep (MIC) | Ethionamide suscep (MIC) |
| 161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephalothin suscep (MIC) | Cephalothin suscep (MIC) |
| 16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) | Rifabutin suscep (MIC) | Rifabutin suscep (MIC) |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum | Hepatitis C Ab | Hepatitis C Ab |
| 16130-7 | Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection | HSV1 DNA (NAAT) | HSV1 DNA (NAAT) |
| 16131-5 | Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection | HSV2 DNA (NAAT) | HSV2 DNA (NAAT) |
| 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method | Benzodiazepine urine by Confirmatory method | Benzodiazepine urine by Confirmatory method |
| 16201-6 | Oxazepam [Mass/?volume] in Urine by Confirmatory method | Oxazepam urine by Confirmatory method | Oxazepam urine by Confirmatory method |
| 16206-5 | Temazepam [Presence] in Urine by Confirmatory method | Temazepam urine | Temazepam urine |
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method | Buprenorphine urine by Confirmation method | Buprenorphine urine by Confirmation method |
| 16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method | Phenothiazines urine - by Confirmatory method | Phenothiazines urine - by Confirmatory method |
| 16226-3 | Benzoylecgonine [Mass/?volume] in Urine by Confirmatory method | Benzoylecgonine urine - by Confirmatory method | Benzoylecgonine urine - by Confirmatory method |
| 16227-1 | Diazepam [Mass/?volume] in Urine by Confirmatory method | Diazepam urine by Confirmatory method | Diazepam urine by Confirmatory method |
| 16228-9 | Nordiazepam [Mass/?volume] in Urine by Confirmatory method | Nordiazepam urine - by Confirmatory method | Nordiazepam urine - by Confirmatory method |
| 16235-4 | Methamphetamine [Mass/?volume] in Urine by Confirmatory method | Methamphetamine urine by Confirmation method | Methamphetamine urine by Confirmation method |
| 16249-5 | Oxycodone [Mass/?volume] in Urine by Confirmatory method | Oxycodone urine - by Confirmatory method | Oxycodone urine - by Confirmatory method |
| 16250-3 | Codeine [Mass/?volume] in Urine by Confirmatory method | Codeine urine - by Confirmatory method | Codeine urine - by Confirmatory method |
| 16251-1 | Morphine [Mass/?volume] in Urine by Confirmatory method | Morphine urine by Confirmatory method | Morphine urine by Confirmatory method |
| 16254-5 | Phencyclidine [Mass/?volume] in Urine by Confirmatory method | Phencyclidine urine - by Confirmatory method | Phencyclidine urine - by Confirmatory method |
| 16276-8 | Bartonella henselae DNA [Presence] in Blood by NAA with probe detection | Bartonella DNA (NAAT) | Bartonella DNA (NAAT) |
| 16284-2 | Polio virus Ab [Units/?volume] in Serum | Polio Ab | Polio Ab |
| 16337-8 | Alkaline phosphatase [Enzymatic activity/?volume] in Urine | Alk Phosphatase, urine | Alk Phosphatase, urine |
| 16348-5 | Alpha hydroxyalprazolam [Mass/?volume] in Urine by Confirmatory method | Alpha hydroxy alprazolam urine by Confirmatory method | Alpha hydroxy alprazolam urine by Confirmatory method |
| 16362-6 | Ammonia [Moles/?volume] in Plasma | Ammonia | Ammonia |
| 16429-3 | Barbiturates [Presence] in Urine by Confirmatory method | Barbiturate urine by Confirmatory method | Barbiturate urine by Confirmatory method |
| 1648-5 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal | Tuberculin test (3d post 5TU) | Tuberculin test (3d post 5TU) |
| 165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephapirin suscep (MIC) | Cephapirin suscep (MIC) |
| 16550-6 | Carbohydrates [Identifier] in Urine | Carbohydrates urine | Carbohydrates urine |
| 16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Amoxicillin suscep (MIC) | Amoxicillin suscep (MIC) |
| 16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) | Clofazimine suscep (MIC) | Clofazimine suscep (MIC) |
| 16676-9 | Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture | C.diptheriae culture | C.diptheriae culture |
| 16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid | CK body fluid | CK body fluid |
| 16835-1 | Escherichia coli shiga-like toxin identified in Stool by Organism specific culture | Enterohaemorrhagic E. coli (EHEC) culture - shiga-like toxin | Enterohaemorrhagic E. coli (EHEC) culture - shiga-like toxin |
| 16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture | Enterohaemorrhagic E. coli (EHEC) culture - verotoxic | Enterohaemorrhagic E. coli (EHEC) culture - verotoxic |
| 16853-4 | Fat [Mass] in Stool | Fat Stl Qn | Fat Stl Qn |
| 16859-1 | Fibrinogen [Presence] in Platelet poor plasma | Fibrinogen (qual) | Fibrinogen (qual) |
| 16901-1 | Gliadin IgA Ab [Presence] in Serum | Gliadin Ab IgA | Gliadin Ab IgA |
| 16902-9 | Gliadin IgG Ab [Presence] in Serum | Gliadin Ab IgG | Gliadin Ab IgG |
| 169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephradine suscep (MIC) | Cephradine suscep (MIC) |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum | Hepatitis B core Ab | Hepatitis B core Ab |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum | Hepatitis B surface Ab | Hepatitis B surface Ab |
| 1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum | Acid phosphatase (prostatic) | Acid phosphatase (prostatic) |
| 17146-2 | CD4+?CD8+? cells/?100 cells in Blood | CD4/CD8 | CD4/CD8 |
| 1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma | Acid phosphatase | Acid phosphatase |
| 17263-5 | Methemalbumin [Presence] in Serum or Plasma | Methaemalbumin | Methaemalbumin |
| 173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Chloramphenicol suscep (MIC) | Chloramphenicol suscep (MIC) |
| 17395-5 | Oxymorphone [Mass/?volume] in Urine by Confirmatory method | Oxymorphone urine | Oxymorphone urine |
| 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | ALT | ALT |
| 1746-7 | Albumin [Mass/?volume] in Cerebral spinal fluid | Albumin CSF | Albumin CSF |
| 1747-5 | Albumin [Mass/volume] in Body fluid | Albumin body fluid | Albumin body fluid |
| 1751-7 | Albumin [Mass/volume] in Serum or Plasma | Albumin | Albumin |
| 17547-1 | Rotavirus Ag [Presence] in Stool | Rotavirus Ag faeces | Rotavirus Ag faeces |
| 1756-6 | Albumin in CSF/?Albumin in Serum or Plasma | Albumin CSF/Serum Ratio | Albumin CSF/Serum Ratio |
| 17571-1 | Scopolamine [Mass/?volume] in Urine | Scopolamine urine | Scopolamine urine |
| 17607-3 | Volume of Cerebral spinal fluid | Volume CSF | Volume CSF |
| 1761-6 | Aldolase [Enzymatic activity/?volume] in Serum or Plasma | Aldolase | Aldolase |
| 177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Chlortetracycline suscep (MIC) | Chlortetracycline suscep (MIC) |
| 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma | Alk phosphatase (bone) | Alk phosphatase (bone) |
| 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine | B-J protein urine 24h | B-J protein urine 24h |
| 17843-4 | Cancer Ag 72-4 [Units/?volume] in Serum or Plasma | CA 72-4 | CA 72-4 |
| 17857-4 | Rheumatoid factor [Titer] in Serum | Rheumatoid factor (titre) | Rheumatoid factor (titre) |
| 17869-9 | Orotate/Creatinine [Molar ratio] in Urine | Orotate/creatinine urine | Orotate/creatinine urine |
| 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid | Amylase body fluid | Amylase body fluid |
| 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma | Amylase | Amylase |
| 1799-6 | Amylase [Enzymatic activity/volume] in Urine | Amylase urine | Amylase urine |
| 1-8 | Acyclovir [Susceptibility] | Acyclovir suscep (qual) | Acyclovir suscep (qual) |
| 1805-1 | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma | Amylase (pancreatic) | Amylase (pancreatic) |
| 181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cinoxacin suscep (MIC) | Cinoxacin suscep (MIC) |
| 1824-2 | Alpha-1-Antichymotrypsin [Mass/?volume] in Serum | Alpha 1 antichymotrypsin | Alpha 1 antichymotrypsin |
| 1825-9 | Alpha 1 antitrypsin [Mass/?volume] in Serum or Plasma | Alpha 1 antitrypsin | Alpha 1 antitrypsin |
| 18261-8 | Cholesterol in LDL [Mass/?volume] in Serum or Plasma ultracentrifugate | Cholesterol in LDL | Cholesterol in LDL |
| 18263-4 | Cholesterol in HDL [Mass/?volume] in Serum or Plasma ultracentrifugate | Cholesterol in HDL | Cholesterol in HDL |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method | Cannabinoids, urine by Screen method | Cannabinoids, urine by Screen method |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood | Donath-Landsteiner Ab | Donath-Landsteiner Ab |
| 1834-1 | Alpha-1-Fetoprotein [Mass/?volume] in Serum or Plasma | Alpha feto protein | Alpha feto protein |
| 18358-2 | Methylenedioxymethamphetamine [Mass/?volume] in Urine by Confirmatory method | MDMA Urine by Confirmation method | MDMA Urine by Confirmation method |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method | Opiates urine by Confirmatory method | Opiates urine by Confirmatory method |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat | Grp A Strep Ag throat (rapid) | Grp A Strep Ag throat (rapid) |
| 185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ciprofloxacin suscep (MIC) | Ciprofloxacin suscep (MIC) |
| 1863-0 | Anion gap 4 in Serum or Plasma | Anion gap 4 | Anion gap 4 |
| 1869-7 | Apolipoprotein A-I [Mass/?volume] in Serum or Plasma | Apolipoprotein A1 | Apolipoprotein A1 |
| 1884-6 | Apolipoprotein B [Mass/?volume] in Serum or Plasma | Apolipoprotein B | Apolipoprotein B |
| 18855-7 | 5-Fluorocytosine [Susceptibility] | 5-Fluorocytosine suscep (qual) | 5-Fluorocytosine suscep (qual) |
| 18857-3 | Almecillin [Susceptibility] | Almecillin suscep (qual) | Almecillin suscep (qual) |
| 18859-9 | Amdinocillin [Susceptibility] | Amdinocillin suscep (qual) | Amdinocillin suscep (qual) |
| 18860-7 | Amikacin [Susceptibility] | Amikacin suscep (qual) | Amikacin suscep (qual) |
| 18861-5 | Amoxicillin [Susceptibility] | Amoxicillin suscep (qual) | Amoxicillin suscep (qual) |
| 18862-3 | Amoxicillin+Clavulanate [Susceptibility] | Amoxicillin Clav suscep (qual) | Amoxicillin Clav suscep (qual) |
| 18863-1 | Amphotericin B [Susceptibility] | Amphotericin B suscep (qual) | Amphotericin B suscep (qual) |
| 18864-9 | Ampicillin [Susceptibility] | Ampicillin suscep (qual) | Ampicillin suscep (qual) |
| 18865-6 | Ampicillin+Sulbactam [Susceptibility] | Ampicillin Sulb suscept (qual) | Ampicillin Sulb suscept (qual) |
| 18866-4 | Azithromycin [Susceptibility] | Azithromycin suscep (qual) | Azithromycin suscep (qual) |
| 18867-2 | Azlocillin [Susceptibility] | Azlocillin suscep (qual) | Azlocillin suscep (qual) |
| 18868-0 | Aztreonam [Susceptibility] | Aztreonam suscep (qual) | Aztreonam suscep (qual) |
| 18869-8 | Bacampicillin [Susceptibility] | Bacampicillin suscep (qual) | Bacampicillin suscep (qual) |
| 18870-6 | Bacitracin [Susceptibility] | Bacitracin suscep (qual) | Bacitracin suscep (qual) |
| 18871-4 | Butirosin [Susceptibility] | Butirosin suscep (qual) | Butirosin suscep (qual) |
| 18872-2 | Capreomycin [Susceptibility] | Capreomycin suscep (qual) | Capreomycin suscep (qual) |
| 18873-0 | Carbenicillin [Susceptibility] | Carbenicillin suscep (qual) | Carbenicillin suscep (qual) |
| 18874-8 | Cefaclor [Susceptibility] | Cefaclor suscep (qual) | Cefaclor suscep (qual) |
| 18875-5 | Cefadroxil [Susceptibility] | Cefadroxil suscep (qual) | Cefadroxil suscep (qual) |
| 18876-3 | Cefamandole [Susceptibility] | Cefamandole suscep (qual) | Cefamandole suscep (qual) |
| 18877-1 | Cefatrizine [Susceptibility] | Cefatrizine suscep (qual) | Cefatrizine suscep (qual) |
| 18878-9 | Cefazolin [Susceptibility] | Cefazolin suscep (qual) | Cefazolin suscep (qual) |
| 18879-7 | Cefepime [Susceptibility] | Cefepime suscep (qual) | Cefepime suscep (qual) |
| 18880-5 | Cefixime [Susceptibility] | Cefixime suscep (qual) | Cefixime suscep (qual) |
| 18881-3 | Cefmetazole [Susceptibility] | Cefmetazole suscep (qual) | Cefmetazole suscep (qual) |
| 18882-1 | Cefodizime [Susceptibility] | Cefodizime suscep (qual) | Cefodizime suscep (qual) |
| 18883-9 | Cefonicid [Susceptibility] | Cefonicid suscep (qual) | Cefonicid suscep (qual) |
| 18884-7 | Cefoperazone [Susceptibility] | Cefoperazone suscep (qual) | Cefoperazone suscep (qual) |
| 18885-4 | Ceforanide [Susceptibility] | Ceforanide suscep (qual) | Ceforanide suscep (qual) |
| 18886-2 | Cefotaxime [Susceptibility] | Cefotaxime suscep (qual) | Cefotaxime suscep (qual) |
| 18887-0 | Cefotetan [Susceptibility] | Cefotetan suscep (qual) | Cefotetan suscep (qual) |
| 18888-8 | Cefoxitin [Susceptibility] | Cefoxitin suscep (qual) | Cefoxitin suscep (qual) |
| 18889-6 | Cefpirome [Susceptibility] | Cefpirome suscep (qual) | Cefpirome suscep (qual) |
| 18890-4 | Cefpodoxime [Susceptibility] | Cefpodoxime suscep (qual) | Cefpodoxime suscep (qual) |
| 18891-2 | Cefprozil [Susceptibility] | Cefprozil suscep (qual) | Cefprozil suscep (qual) |
| 18892-0 | Cefsulodin [Susceptibility] | Cefsulodin suscep (qual) | Cefsulodin suscep (qual) |
| 18893-8 | Ceftazidime [Susceptibility] | Ceftazidime suscep (qual) | Ceftazidime suscep (qual) |
| 18894-6 | Ceftizoxime [Susceptibility] | Ceftizoxime suscep (qual) | Ceftizoxime suscep (qual) |
| 18895-3 | Ceftriaxone [Susceptibility] | Ceftriaxone suscep (qual) | Ceftriaxone suscep (qual) |
| 18896-1 | Cefuroxime Parenteral [Susceptibility] | Cefuroxime inject suscep qual | Cefuroxime inject suscep qual |
| 18897-9 | Cephalexin [Susceptibility] | Cephalexin suscep (qual) | Cephalexin suscep (qual) |
| 18898-7 | Cephaloglycin [Susceptibility] | Cephaloglycin suscep (qual) | Cephaloglycin suscep (qual) |
| 18899-5 | Cephaloridine [Susceptibility] | Cephaloridine suscep (qual) | Cephaloridine suscep (qual) |
| 18900-1 | Cephalothin [Susceptibility] | Cephalothin suscep (qual) | Cephalothin suscep (qual) |
| 18901-9 | Cephapirin [Susceptibility] | Cephapirin suscep (qual) | Cephapirin suscep (qual) |
| 18902-7 | Cephradine [Susceptibility] | Cephradine suscep (qual) | Cephradine suscep (qual) |
| 18903-5 | Chloramphenicol [Susceptibility] | Chloramphenicol suscep (qual) | Chloramphenicol suscep (qual) |
| 18904-3 | Chlortetracycline [Susceptibility] | Chlortetracycline suscep qual | Chlortetracycline suscep qual |
| 18905-0 | Cinoxacin [Susceptibility] | Cinoxacin suscep (qual) | Cinoxacin suscep (qual) |
| 18906-8 | Ciprofloxacin [Susceptibility] | Ciprofloxacin suscep (qual) | Ciprofloxacin suscep (qual) |
| 18907-6 | Clarithromycin [Susceptibility] | Clarithromycin suscep (qual) | Clarithromycin suscep (qual) |
| 18908-4 | Clindamycin [Susceptibility] | Clindamycin suscep (qual) | Clindamycin suscep (qual) |
| 18909-2 | Clotrimazole [Susceptibility] | Clotrimazole suscep (qual) | Clotrimazole suscep (qual) |
| 189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Clarithromycin suscep (MIC) | Clarithromycin suscep (MIC) |
| 18910-0 | Cloxacillin [Susceptibility] | Cloxacillin suscep (qual) | Cloxacillin suscep (qual) |
| 18911-8 | Colistimethate | Colistimethate suscep (qual) | Colistimethate suscep (qual) |
| 18912-6 | Colistin [Susceptibility] | Colistin suscep (qual) | Colistin suscep (qual) |
| 18913-4 | Cyclacillin [Susceptibility] | Cyclacillin suscep (qual) | Cyclacillin suscep (qual) |
| 18914-2 | Cycloserine [Susceptibility] | Cycloserine suscep (qual) | Cycloserine suscep (qual) |
| 18915-9 | Demeclocycline [Susceptibility] | Demeclocycline suscep (qual) | Demeclocycline suscep (qual) |
| 18916-7 | Dicloxacillin [Susceptibility] | Dicloxacillin suscep (qual) | Dicloxacillin suscep (qual) |
| 18917-5 | Doxycycline [Susceptibility] | Doxycycline suscep (qual) | Doxycycline suscep (qual) |
| 18918-3 | Enoxacin [Susceptibility] | Enoxacin suscep (qual) | Enoxacin suscep (qual) |
| 18919-1 | Erythromycin [Susceptibility] | Erythromycin suscep (qual) | Erythromycin suscep (qual) |
| 18921-7 | Ethambutol [Susceptibility] | Ethambutol suscep (qual) | Ethambutol suscep (qual) |
| 18922-5 | Ethionamide [Susceptibility] | Ethionamide suscep (qual) | Ethionamide suscep (qual) |
| 18923-3 | Floxacillin [Susceptibility] | Floxacillin suscep (qual) | Floxacillin suscep (qual) |
| 18924-1 | Fluconazole [Susceptibility] | Fluconazole suscep (qual) | Fluconazole suscep (qual) |
| 18926-6 | Framycetin [Susceptibility] | Framycetin suscep (qual) | Framycetin suscep (qual) |
| 18927-4 | Fusidate [Susceptibility] | Fusidate suscep (qual) | Fusidate suscep (qual) |
| 18928-2 | Gentamicin [Susceptibility] | Gentamicin suscep (qual) | Gentamicin suscep (qual) |
| 18929-0 | Gentamicin.high potency [Susceptibility] | Gentamicin high suscep (qual) | Gentamicin high suscep (qual) |
| 18930-8 | Gramicidin D [Susceptibility] | Gramicidin D suscep (qual) | Gramicidin D suscep (qual) |
| 18931-6 | Hetacillin [Susceptibility] | Hetacillin suscep (qual) | Hetacillin suscep (qual) |
| 18932-4 | Imipenem [Susceptibility] | Imipenem suscep (qual) | Imipenem suscep (qual) |
| 18934-0 | Isoniazid [Susceptibility] | Isoniazid suscep (qual) | Isoniazid suscep (qual) |
| 18935-7 | Kanamycin [Susceptibility] | Kanamycin suscep (qual) | Kanamycin suscep (qual) |
| 18936-5 | Kanamycin.high potency [Susceptibility] | Kanamycin high suscep (qual) | Kanamycin high suscep (qual) |
| 18937-3 | Ketoconazole [Susceptibility] | Ketoconazole suscep (qual) | Ketoconazole suscep (qual) |
| 18938-1 | Lincomycin [Susceptibility] | Lincomycin suscep (qual) | Lincomycin suscep (qual) |
| 18939-9 | Lomefloxacin [Susceptibility] | Lomefloxacin suscep (qual) | Lomefloxacin suscep (qual) |
| 18940-7 | Loracarbef [Susceptibility] | Loracarbef suscep (qual) | Loracarbef suscep (qual) |
| 18941-5 | Lymecycline [Susceptibility] | Lymecycline suscep (qual) | Lymecycline suscep (qual) |
| 18942-3 | Meclocycline [Susceptibility] | Meclocycline suscep (qual) | Meclocycline suscep (qual) |
| 18943-1 | Meropenem [Susceptibility] | Meropenem suscep (qual) | Meropenem suscep (qual) |
| 18944-9 | Methacycline [Susceptibility] | Methacycline suscep (qual) | Methacycline suscep (qual) |
| 18945-6 | Methicillin [Susceptibility] | Methicillin suscep (qual) | Methicillin suscep (qual) |
| 18946-4 | Metronidazole [Susceptibility] | Metronidazole suscep (qual) | Metronidazole suscep (qual) |
| 18947-2 | Mezlocillin [Susceptibility] | Mezlocillin suscep (qual) | Mezlocillin suscep (qual) |
| 18948-0 | Minocycline [Susceptibility] | Minocycline suscep (qual) | Minocycline suscep (qual) |
| 18949-8 | Miocamycin [Susceptibility] | Miocamycin suscep (qual) | Miocamycin suscep (qual) |
| 18950-6 | Moxalactam [Susceptibility] | Moxalactam suscep (qual) | Moxalactam suscep (qual) |
| 18951-4 | Nafcillin [Susceptibility] | Nafcillin suscep (qual) | Nafcillin suscep (qual) |
| 18952-2 | Nalidixate [Susceptibility] | Nalidixate suscep (qual) | Nalidixate suscep (qual) |
| 18953-0 | Neomycin [Susceptibility] | Neomycin suscep (qual) | Neomycin suscep (qual) |
| 18954-8 | Netilmicin [Susceptibility] | Netilmicin suscep (qual) | Netilmicin suscep (qual) |
| 18955-5 | Nitrofurantoin [Susceptibility] | Nitrofurantoin suscep (qual) | Nitrofurantoin suscep (qual) |
| 18956-3 | Norfloxacin [Susceptibility] | Norfloxacin suscep (qual) | Norfloxacin suscep (qual) |
| 18957-1 | Novobiocin [Susceptibility] | Novobiocin suscep (qual) | Novobiocin suscep (qual) |
| 18958-9 | Nystatin [Susceptibility] | Nystatin suscep (qual) | Nystatin suscep (qual) |
| 18959-7 | Ofloxacin [Susceptibility] | Ofloxacin suscep (qual) | Ofloxacin suscep (qual) |
| 18960-5 | Oleandomycin [Susceptibility] | Oleandomycin suscep (qual) | Oleandomycin suscep (qual) |
| 18961-3 | Oxacillin [Susceptibility] | Oxacillin suscep (qual) | Oxacillin suscep (qual) |
| 18962-1 | Oxytetracycline [Susceptibility] | Oxytetracycline suscep (qual) | Oxytetracycline suscep (qual) |
| 18963-9 | Pefloxacin [Susceptibility] | Pefloxacin suscep (qual) | Pefloxacin suscep (qual) |
| 18964-7 | Penicillin [Susceptibility] | Penicillin suscep (qual) | Penicillin suscep (qual) |
| 18965-4 | Penicillin G [Susceptibility] | Penicillin G suscep (qual) | Penicillin G suscep (qual) |
| 18966-2 | Penicillin V [Susceptibility] | Penicillin V suscep (qual) | Penicillin V suscep (qual) |
| 18967-0 | Phenethicillin [Susceptibility] | Phenethicillin suscep (qual) | Phenethicillin suscep (qual) |
| 18968-8 | Pipemidate [Susceptibility] | Pipemidate suscep (qual) | Pipemidate suscep (qual) |
| 18969-6 | Piperacillin [Susceptibility] | Piperacillin suscep (qual) | Piperacillin suscep (qual) |
| 18970-4 | Piperacillin+Tazobactam [Susceptibility] | Piperacillin Tazob suscep qual | Piperacillin Tazob suscep qual |
| 18971-2 | Pivampicillin [Susceptibility] | Pivampicillin suscep (qual) | Pivampicillin suscep (qual) |
| 18972-0 | Polymyxin B [Susceptibility] | Polymyxin B suscep (qual) | Polymyxin B suscep (qual) |
| 18973-8 | Pyrazinamide [Susceptibility] | Pyrazinamide suscep (qual) | Pyrazinamide suscep (qual) |
| 18974-6 | Rifampin [Susceptibility] | Rifampin suscep (qual) | Rifampin suscep (qual) |
| 18975-3 | Ristocetin [Susceptibility] | Ristocetin suscep (qual) | Ristocetin suscep (qual) |
| 18976-1 | Rolitetracycline [Susceptibility] | Rolitetracycline suscep (qual) | Rolitetracycline suscep (qual) |
| 18977-9 | Rosoxacin [Susceptibility] | Rosoxacin suscep (qual) | Rosoxacin suscep (qual) |
| 18978-7 | Roxithromycin [Susceptibility] | Roxithromycin suscep (qual) | Roxithromycin suscep (qual) |
| 18979-5 | Sisomicin [Susceptibility] | Sisomicin suscep (qual) | Sisomicin suscep (qual) |
| 18980-3 | Spectinomycin [Susceptibility] | Spectinomycin suscep (qual) | Spectinomycin suscep (qual) |
| 18981-1 | Spiramycin [Susceptibility] | Spiramycin suscep (qual) | Spiramycin suscep (qual) |
| 18982-9 | Streptomycin [Susceptibility] | Streptomycin suscep (qual) | Streptomycin suscep (qual) |
| 18983-7 | Streptomycin.high potency [Susceptibility] | Streptomycin high suscep qual | Streptomycin high suscep qual |
| 18984-5 | Sulfadiazine [Susceptibility] | Sulfadiazine suscep (qual) | Sulfadiazine suscep (qual) |
| 18985-2 | Sulfamethoxazole [Susceptibility] | Sulfamethoxazole suscep (qual) | Sulfamethoxazole suscep (qual) |
| 18986-0 | Sulfisoxazole [Susceptibility] | Sulfisoxazole suscep (qual) | Sulfisoxazole suscep (qual) |
| 18987-8 | Sulfonamide [Susceptibility] | Sulfonamide suscep (qual) | Sulfonamide suscep (qual) |
| 18988-6 | Talampicillin [Susceptibility] | Talampicillin suscep (qual) | Talampicillin suscep (qual) |
| 18989-4 | Teicoplanin [Susceptibility] | Teicoplanin suscep (qual) | Teicoplanin suscep (qual) |
| 18990-2 | Temafloxacin [Susceptibility] | Temafloxacin suscep (qual) | Temafloxacin suscep (qual) |
| 18991-0 | Temocillin [Susceptibility] | Temocillin suscep (qual) | Temocillin suscep (qual) |
| 18992-8 | Terbinafine [Susceptibility] | Terbinafine suscep (qual) | Terbinafine suscep (qual) |
| 18993-6 | Tetracycline [Susceptibility] | Tetracycline suscep (qual) | Tetracycline suscep (qual) |
| 18994-4 | Ticarcillin [Susceptibility] | Ticarcillin suscep (qual) | Ticarcillin suscep (qual) |
| 18995-1 | Ticarcillin+Clavulanate [Susceptibility] | Ticarcillin Clav suscep (qual) | Ticarcillin Clav suscep (qual) |
| 18996-9 | Tobramycin [Susceptibility] | Tobramycin suscep (qual) | Tobramycin suscep (qual) |
| 18997-7 | Trimethoprim [Susceptibility] | Trimethoprim suscep (qual) | Trimethoprim suscep (qual) |
| 18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] | Trimethoprim Sulfa suscep qual | Trimethoprim Sulfa suscep qual |
| 18999-3 | Troleandomycin [Susceptibility] | Troleandomycin suscep (qual) | Troleandomycin suscep (qual) |
| 19000-9 | Vancomycin [Susceptibility] | Vancomycin suscep (qual) | Vancomycin suscep (qual) |
| 19001-7 | Viomycin [Susceptibility] | Viomycin suscep (qual) | Viomycin suscep (qual) |
| 19048-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood | RBC (nucleated)/100 WBC | RBC (nucleated)/100 WBC |
| 19057-9 | ABO +? Rh group [Type] in Blood from newborn | ABO + Rh Group New Born | ABO + Rh Group New Born |
| 19072-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma | Calcium (pH 7.4 adjusted) | Calcium (pH 7.4 adjusted) |
| 19077-7 | Cells identified in Body fluid | Other cells body fluid | Other cells body fluid |
| 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | hCG | hCG |
| 19090-0 | Colony count [#/volume] in Urine | Colony count urine | Colony count urine |
| 19113-0 | IgE [Units/volume] in Serum or Plasma | IgE | IgE |
| 19141-1 | Propoxyphene [Presence] in Urine | Propoxyphene urine | Propoxyphene urine |
| 19149-4 | Rifabutin [Susceptibility] | Rifabutin suscep (qual) | Rifabutin suscep (qual) |
| 19176-7 | Alpha-1-Fetoprotein [Units/?volume] in Serum or Plasma | Alpha fetoprotein | Alpha fetoprotein |
| 19180-9 | Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma | hCG (beta free) | hCG (beta free) |
| 1920-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | AST | AST |
| 19261-7 | Amphetamines [Presence] in Urine by Screen method | Amphetamines-type substances urine by Screen method | Amphetamines-type substances urine by Screen method |
| 19270-8 | Barbiturates [Presence] in Urine by Screen method | Barbiturate urine by Screen method | Barbiturate urine by Screen method |
| 1928-1 | Immunoglobulin light chains [Presence] in Urine | B-J protein urine (qual) | B-J protein urine (qual) |
| 19289-8 | Cannabinoids [Presence] in Urine by Confirmatory method | Cannabinoids, urine by Confirmatory method | Cannabinoids, urine by Confirmatory method |
| 19295-5 | Opiates [Presence] in Urine by Screen method | Opiates urine by Screen method | Opiates urine by Screen method |
| 1929-9 | Immunoglobulin light chains [Mass/volume] in Urine | B-J protein urine | B-J protein urine |
| 193-3 | Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Clindamycin suscep (MIC) | Clindamycin suscep (MIC) |
| 19360-7 | Cocaine [Presence] in Urine by Confirmatory method | Cocaine urine - by Confirmatory method | Cocaine urine - by Confirmatory method |
| 19411-8 | Codeine [Presence] in Urine by Screen method | Codeine urine - by Screen method | Codeine urine - by Screen method |
| 1942-2 | Beta galactosidase [Enzymatic activity/?mass] in Tissue | Disaccharidase tissue | Disaccharidase tissue |
| 19429-0 | Propoxyphene [Presence] in Urine by Screen method | Propoxyphene urine - by Screen method | Propoxyphene urine - by Screen method |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or | Beta2-microglubulin | Beta2-microglubulin |
| 1953-9 | Beta-2-Microglobulin [Mass/?volume] in Urine | Beta2-microglubulin urine | Beta2-microglubulin urine |
| 19550-3 | Methadone [Presence] in Urine by Screen method | Methadone urine by Screen method | Methadone urine by Screen method |
| 19554-5 | Methamphetamine [Presence] in Urine by Screen method | Methamphetamine urine by Screen method | Methamphetamine urine by Screen method |
| 19561-0 | Methylenediamine [Presence] in Urine by Screen method | MDA Urine by Sceen method | MDA Urine by Sceen method |
| 19564-4 | Methylenediamine cutoff [Mass/?volume] in Urine for Confirmatory method | MDA Urine by Confirmation method | MDA Urine by Confirmation method |
| 19568-5 | Methylenedioxymethamphetamine [Presence] in Urine by Screen method | MDMA Urine by Screen method | MDMA Urine by Screen method |
| 19577-6 | Methylphenidate [Presence] in Urine by Screen method | Methylphenidate urine by Screen method | Methylphenidate urine by Screen method |
| 19578-4 | Methylphenidate [Presence] in Urine by Confirmatory method | Methylphenidate urine - by Confirmatory method | Methylphenidate urine - by Confirmatory method |
| 1959-6 | Bicarbonate [Moles/volume] in Blood | Bicarbonate blood | Bicarbonate blood |
| 19597-4 | Morphine [Presence] in Urine by Screen method | Morphine urine by Screen method | Morphine urine by Screen method |
| 19624-6 | Nordiazepam [Presence] in Urine by Screen method | Nordiazepam urine by Screen method | Nordiazepam urine by Screen method |
| 1963-8 | Bicarbonate [Moles/volume] in Serum or Plasma | Bicarbonate | Bicarbonate |
| 19638-6 | Oxazepam [Presence] in Urine by Screen method | Oxazepam urine by Screen method | Oxazepam urine by Screen method |
| 19642-8 | Oxycodone [Presence] in Urine by Screen method | Oxycodone urine - by Screen method | Oxycodone urine - by Screen method |
| 19659-2 | Phencyclidine [Presence] in Urine by Screen method | Phencyclidine urine - by Screen method | Phencyclidine urine - by Screen method |
| 19670-9 | Phenothiazines [Presence] in Urine by Screen method | Phenothiazines urine - by Screen method | Phenothiazines urine - by Screen method |
| 19710-3 | Tramadol [Presence] in Urine by Screen method | Tramadol urine | Tramadol urine |
| 197-4 | Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cloxacillin suscep (MIC) | Cloxacillin suscep (MIC) |
| 19762-4 | General categories [interpretation] of Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology general category | Cervical cytology general category |
| 19763-2 | Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology specimen site | Cervical cytology specimen site |
| 19764-0 | Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology statement of adequacy | Cervical cytology statement of adequacy |
| 19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology interpretation | Cervical cytology interpretation |
| 19772-3 | Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology preparation technique | Cervical cytology preparation technique |
| 19773-1 | Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain | Cervical cytology recommendation | Cervical cytology recommendation |
| 1988-5 | C reactive protein [Mass/volume] in Serum or Plasma | CRP | CRP |
| 1992-7 | Calcitonin [Mass/?volume] in Serum or Plasma | Calcitonin | Calcitonin |
| 1995-0 | Calcium.ionized [Moles/volume] in Serum or Plasma | Calcium (ionised) | Calcium (ionised) |
| 2000-8 | Calcium [Moles/volume] in Serum or Plasma | Calcium | Calcium |
| 2004-0 | Calcium [Moles/volume] in Urine | Calcium urine | Calcium urine |
| 201-4 | Colistimethate by Minimum inhibitory concentration (MIC) | Colistimethate suscep (MIC) | Colistimethate suscep (MIC) |
| 20388-5 | Nitrofurazone [Susceptibility] | Furacin topical suscep (qual) | Furacin topical suscep (qual) |
| 20389-3 | Mupirocin [Susceptibility] | Mupirocin suscep (qual) | Mupirocin suscep (qual) |
| 20390-1 | Silver sulfadiazine [Susceptibility] | Silvadine topical suscep qual | Silvadine topical suscep qual |
| 20391-9 | Mafenide [Susceptibility] | Mafenide suscep (qual) | Mafenide suscep (qual) |
| 2039-6 | Carcinoembryonic Ag [Mass/?volume] in Serum or Plasma | CEA | CEA |
| 20396-8 | Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Levofloxacin suscep (MIC) | Levofloxacin suscep (MIC) |
| 20397-6 | Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Sparfloxacin suscep (MIC) | Sparfloxacin suscep (MIC) |
| 20402-4 | CD16+?CD56+? cells [#/?volume] in Blood | lymphocyte markers - Cells.CD16+CD56+ | lymphocyte markers - Cells.CD16+CD56+ |
| 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid | Foetal Fibronectin (rapid) | Foetal Fibronectin (rapid) |
| 20447-9 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | HIV Viral Load (#/volume) | HIV Viral Load (#/volume) |
| 20453-7 | Epithelial cells [Presence] in Urine sediment by Light microscopy | Epithelial Cells urine | Epithelial Cells urine |
| 20454-5 | Protein [Presence] in Urine by Test strip | Protein urine (dipstick) | Protein urine (dipstick) |
| 20460-2 | Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefuroxime oral suscep (MIC) | Cefuroxime oral suscep (MIC) |
| 20483-4 | Mitochondria Ab [Titer] in Serum | Mitochondria Ab (titre) | Mitochondria Ab (titre) |
| 20490-9 | Epstein Barr virus capsid IgG Ab [Titer] in Serum | EBV VCA IgG (titre) | EBV VCA IgG (titre) |
| 20491-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum | EBV VCA IgM (titre) | EBV VCA IgM (titre) |
| 20495-8 | Gliadin IgA Ab [Units/?volume] in Serum by Immunoassay | Gliadin Ab IgA - units/volume | Gliadin Ab IgA - units/volume |
| 20496-6 | Gliadin IgG Ab [Units/?volume] in Serum by Immunoassay | Gliadin Ab IgG - units/volume | Gliadin Ab IgG - units/volume |
| 20507-0 | Reagin Ab [Presence] in Serum by RPR | Syphilis RPR (qual) | Syphilis RPR (qual) |
| 20510-4 | Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis | Lipoprotein (electrophoresis) | Lipoprotein (electrophoresis) |
| 20521-1 | Carboxy tetrahydrocannabinol [Mass/?volume] in Urine by Confirmatory method | Carboxy tetrahydronnabinol urine | Carboxy tetrahydronnabinol urine |
| 205-5 | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) | Colistin suscep (MIC) | Colistin suscep (MIC) |
| 20559-1 | Temazepam [Mass/?volume] in Urine by Confirmatory method | Temazepam, urine | Temazepam, urine |
| 20563-3 | Carboxyhemoglobin/Hemoglobin.total in Blood | Carboxyhaemoglobin | Carboxyhaemoglobin |
| 20565-8 | Carbon dioxide, total [Moles/?volume] in Blood | CO2 blood ( total) | CO2 blood ( total) |
| 20569-0 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma | CKMB/CK total | CKMB/CK total |
| 20570-8 | Hematocrit [Volume Fraction] of Blood | Haematocrit | Haematocrit |
| 20575-7 | Hepatitis A virus Ab [Presence] in Serum | Hepatitis A Ab (qual) | Hepatitis A Ab (qual) |
| 20576-5 | Galactose 1 phosphate uridyl transferase [Presence] in Blood | Galactose 1 phosphate uridyl transferase blood (qual) | Galactose 1 phosphate uridyl transferase blood (qual) |
| 20578-1 | Vancomycin [Mass/?volume] in Serum or Plasma | Vancomycin | Vancomycin |
| 20626-8 | Reducing substances [Units/?volume] in Urine by Test strip | Reducing substances urine | Reducing substances urine |
| 20629-2 | Levofloxacin [Susceptibility] | Levofloxacin suscep (qual) | Levofloxacin suscep (qual) |
| 2064-4 | Ceruloplasmin [Mass/?volume] in Serum or Plasma | Ceruloplasmin | Ceruloplasmin |
| 20662-3 | Allergens tested for in Serum | Allergy Testing | Allergy Testing |
| 2069-3 | Chloride [Moles/volume] in Blood | Chloride blood | Chloride blood |
| 20719-1 | Brucella abortus Ab [Titer] in Serum by Tube agglutination | Br. abortus Ab (SAT) | Br. abortus Ab (SAT) |
| 2072-7 | Chloride [Moles/?volume] in Body fluid | Chloride fluid | Chloride fluid |
| 20728-2 | Brucella abortus Ab [Presence] in Serum by Complement fixation | Br. abortus Ab (qual) | Br. abortus Ab (qual) |
| 2075-0 | Chloride [Moles/volume] in Serum or Plasma | Chloride | Chloride |
| 2077-6 | Chloride [Moles/?volume] in Sweat | Chloride sweat | Chloride sweat |
| 2078-4 | Chloride [Moles/?volume] in Urine | Chloride urine - moles/volume | Chloride urine - moles/volume |
| 2079-2 | Chloride [Moles/?time] in 24 hour Urine | Chloride urine - moles/time | Chloride urine - moles/time |
| 20-8 | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Amoxicillin Clav suscep (MIC) | Amoxicillin Clav suscep (MIC) |
| 209-7 | Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cyclacillin suscep (MIC) | Cyclacillin suscep (MIC) |
| 20981-7 | Verotoxin identified in Isolate | Verotoxin | Verotoxin |
| 2098-2 | Cholinesterase [Enzymatic activity/?volume] in Serum or Plasma | Cholinesterase | Cholinesterase |
| 2099-0 | Cholinesterase [Enzymatic activity/?volume] in Red Blood Cells | Cholinesterase RBC | Cholinesterase RBC |
| 21027-8 | Platelet aggregation [interpretation] in Platelet poor plasma | Plat Aggs | Plat Aggs |
| 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine | hCG urine (qual) | hCG urine (qual) |
| 21070-8 | Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) | Antibiotic XXX suscep (MIC) | Antibiotic XXX suscep (MIC) |
| 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma | hCG (qual) | hCG (qual) |
| 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | hCG (beta) | hCG (beta) |
| 21233-2 | Cryptosporidium sp Ag [Presence] in Stool | Cryptosporidia Ag faeces | Cryptosporidia Ag faeces |
| 21259-7 | Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination | Entamoeba histolytica Ab | Entamoeba histolytica Ab |
| 21363-7 | Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection | Legionella DNA (NAAT) | Legionella DNA (NAAT) |
| 21365-2 | Leptin [Mass/?volume] in Serum or Plasma | Leptin | Leptin |
| 21387-6 | Methylhippurate [Mass/?volume] in Urine | Xylene urine | Xylene urine |
| 213-9 | Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC) | Cycloserine suscep (MIC) | Cycloserine suscep (MIC) |
| 21436-1 | Ovary Ab [Presence] in Serum by Immunofluorescence | Ovarian autoantibody | Ovarian autoantibody |
| 21566-5 | Tolazamide [Presence] in Serum or Plasma | Tolazamide | Tolazamide |
| 21567-3 | Tolbutamide [Presence] in Serum or Plasma | Tolbutamide | Tolbutamide |
| 2157-6 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | CK | CK |
| 21582-2 | Tryptase [Mass/?volume] in Serum or Plasma | Tryptase | Tryptase |
| 21613-5 | Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection | C. trachomatis DNA (NAAT) | C. trachomatis DNA (NAAT) |
| 2164-2 | Creatinine renal clearance in 24 hour | Creatinine clearance | Creatinine clearance |
| 217-0 | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Demeclocycline suscep (MIC) | Demeclocycline suscep (MIC) |
| 221-2 | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dicloxacillin suscep (MIC) | Dicloxacillin suscep (MIC) |
| 22150-7 | Brucella abortus Ab [Titer] in Serum | Br. abortus Ab (titre) | Br. abortus Ab (titre) |
| 22244-8 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma | CMV IgG (qual) | CMV IgG (qual) |
| 22246-3 | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma | CMV IgG (titre) | CMV IgG (titre) |
| 22249-7 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma | CMV IgM (titre) | CMV IgM (titre) |
| 22298-4 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum | EBV NA IgG (titre) | EBV NA IgG (titre) |
| 22312-3 | Hepatitis A virus Ab [Units/volume] in Serum | Hepatitis A Ab | Hepatitis A Ab |
| 22313-1 | Hepatitis A virus IgG Ab [Units/volume] in Serum | Hepatitis A IgG | Hepatitis A IgG |
| 22314-9 | Hepatitis A virus IgM Ab [Presence] in Serum | Hepatitis A IgM (qual) | Hepatitis A IgM (qual) |
| 22320-6 | Hepatitis B virus e Ab [Presence] in Serum | Hepatitis B e Ab | Hepatitis B e Ab |
| 22322-2 | Hepatitis B virus surface Ab [Presence] in Serum | Hepatitis B surface Ab (qual) | Hepatitis B surface Ab (qual) |
| 22396-6 | Legionella pneumophila Ab [Titer] in Serum | Legionella Ab (titre) | Legionella Ab (titre) |
| 22425-3 | Mycoplasma pneumoniae Ab [Titer] in Serum | M. pneumoniae Ab (titre) | M. pneumoniae Ab (titre) |
| 22466-7 | Respiratory syncytial virus Ab [Titer] in Serum | RSV Ab | RSV Ab |
| 22496-4 | Rubella virus Ab [Presence] in Serum | Rubella Ab (qual) | Rubella Ab (qual) |
| 22497-2 | Rubella virus Ab [Titer] in Serum | Rubella Ab (titre) | Rubella Ab (titre) |
| 225-3 | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Doxycycline suscep (MIC) | Doxycycline suscep (MIC) |
| 22568-0 | Streptolysin O Ab [Titer] in Serum | Streptolysin O Ab (titre) | Streptolysin O Ab (titre) |
| 22580-5 | Toxoplasma gondii IgG Ab [Presence] in Serum | T. gondii IgG (qual) | T. gondii IgG (qual) |
| 22582-1 | Toxoplasma gondii IgG Ab [Titer] in Serum | T. gondii IgG (titre) | T. gondii IgG (titre) |
| 22584-7 | Toxoplasma gondii IgM Ab [Titer] in Serum | T. gondii IgM (titre) | T. gondii IgM (titre) |
| 22664-7 | Urea [Moles/volume] in Serum or Plasma | Urea | Urea |
| 22689-4 | Zinc [Moles/?time] in 24 hour Urine | Zinc urine 24hr | Zinc urine 24hr |
| 22700-9 | Urea [Moles/?volume] in Urine | Urea urine | Urea urine |
| 22704-1 | Carnitine free (C0)/?Creatinine [Molar ratio] in Urine | Carnitine urine (free) | Carnitine urine (free) |
| 22708-2 | Homovanillate/Creatinine [Molar ratio] in Urine | Homovanillate/creat urine | Homovanillate/creat urine |
| 2271-5 | Fat [Mass/time] in 72 hour Stool | Fat faeces 72h (per 24h) | Fat faeces 72h (per 24h) |
| 22745-4 | Ethanol [Moles/volume] in Urine | Ethanol urine | Ethanol urine |
| 22748-8 | Cholesterol in LDL [Moles/volume] in Serum or Plasma | Cholesterol (LDL) (assay) | Cholesterol (LDL) (assay) |
| 22749-6 | Amylase.pancreatic [Enzymatic activity/volume] in Urine | Amylase (pancreatic) urine | Amylase (pancreatic) urine |
| 2276-4 | Ferritin [Mass/volume] in Serum or Plasma | Ferritin | Ferritin |
| 229-5 | Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Enoxacin suscep (MIC) | Enoxacin suscep (MIC) |
| 2306-9 | Galactose [Presence] in Blood | Galactose blood (qual) | Galactose blood (qual) |
| 23159-7 | Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection | Leishmania DNA (NAAT) | Leishmania DNA (NAAT) |
| 23198-5 | Leptospira sp Ab [Titer] in Serum by Agglutination | Leptospira Ab (MAT) | Leptospira Ab (MAT) |
| 2324-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | GGT | GGT |
| 2333-3 | Gastrin [Mass/?volume] in Serum or Plasma | Gastrin - mass/volume | Gastrin - mass/volume |
| 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool | Occult blood (non-spec screen) | Occult blood (non-spec screen) |
| 233-7 | Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Erythromycin suscep (MIC) | Erythromycin suscep (MIC) |
| 2338-2 | Glucagon [Mass/?volume] in Serum or Plasma | Glucagon | Glucagon |
| 2356-4 | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells | G6PD (screen) | G6PD (screen) |
| 23627-3 | Clofazimine [Susceptibility] | Clofazimine suscep (qual) | Clofazimine suscep (qual) |
| 23628-1 | Sparfloxacin [Susceptibility] | Sparfloxacin suscep (qual) | Sparfloxacin suscep (qual) |
| 23629-9 | Para aminosalicylate [Susceptibility] | P-aminosalicylate suscep qual | P-aminosalicylate suscep qual |
| 23636-4 | Cefdinir [Susceptibility] | Cefdinir suscep (qual) | Cefdinir suscep (qual) |
| 23637-2 | Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefdinir suscep (MIC) | Cefdinir suscep (MIC) |
| 23638-0 | Grepafloxacin [Susceptibility] | Grepafloxacin suscep (qual) | Grepafloxacin suscep (qual) |
| 23639-8 | Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Grepafloxacin suscep (MIC) | Grepafloxacin suscep (MIC) |
| 23640-6 | Quinupristin+Dalfopristin [Susceptibility] | Quinupristin Dalfo suscep qual | Quinupristin Dalfo suscep qual |
| 23641-4 | Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) | Quinupristin Dalfo suscep MIC | Quinupristin Dalfo suscep MIC |
| 23642-2 | Trovafloxacin [Susceptibility] | Trovafloxacin suscep (qual) | Trovafloxacin suscep (qual) |
| 23643-0 | Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Trovafloxacin suscep (MIC) | Trovafloxacin suscep (MIC) |
| 23658-8 | Other Antibiotic [Susceptibility] | Antibiotic XXX suscep (qual) | Antibiotic XXX suscep (qual) |
| 23659-6 | Apramycin [Susceptibility] | Apramycin suscep (qual) | Apramycin suscep (qual) |
| 23709-9 | Ceftiofur [Susceptibility] | Ceftiofur suscep (qual) | Ceftiofur suscep (qual) |
| 23712-3 | Enrofloxacin [Susceptibility] | Enrofloxacin suscep (qual) | Enrofloxacin suscep (qual) |
| 23713-1 | Ethylene glycol [Presence] in Serum or Plasma | Ethylene glycol | Ethylene glycol |
| 23740-4 | Florfenicol [Susceptibility] | Florfenicol suscep (qual) | Florfenicol suscep (qual) |
| 23826-1 | Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection | B. pertussis DNA (NAAT) | B. pertussis DNA (NAAT) |
| 23831-1 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum | B. pertussis toxin IgG | B. pertussis toxin IgG |
| 2387-9 | Glycerol [Mass/?volume] in Serum or Plasma | Glycerol | Glycerol |
| 23883-2 | Inhibin A [Mass/?volume] in Serum or Plasma | Inhibin A | Inhibin A |
| 23905-3 | Mycophenolate [Mass/?volume] in Serum or Plasma | Mycophenolic Acid | Mycophenolic Acid |
| 23971-5 | Epstein Barr virus early IgG Ab [Titer] in Serum | EBV EA IgG (titre) | EBV EA IgG (titre) |
| 23991-3 | Dengue virus IgG Ab [Units/?volume] in Serum by Immunoassay | Dengue virus IgG Ab | Dengue virus IgG Ab |
| 23992-1 | Dengue virus IgM Ab [Units/?volume] in Serum by Immunoassay | Dengue virus IgM Ab | Dengue virus IgM Ab |
| 2399-4 | Glycosaminoglycans [Mass/?volume] in Urine | Glycosamino Glycan urine (quant) | Glycosamino Glycan urine (quant) |
| 24-0 | Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) | Amphotericin B suscep (MIC) | Amphotericin B suscep (MIC) |
| 241-0 | Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Ethambutol suscep (MIC) | Ethambutol suscep (MIC) |
| 24108-3 | Cancer Ag 19-9 [Units/?volume] in Serum or Plasma | CA 19-9 | CA 19-9 |
| 24109-1 | Progesterone [Moles/?volume] in Saliva (oral fluid) | Progesterone saliva | Progesterone saliva |
| 24110-9 | Treponema pallidum Ab [Presence] in Serum by Immunoassay | T. pallidum Ab (EIA) | T. pallidum Ab (EIA) |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection | N. gonorrhoeae DNA (NAAT) | N. gonorrhoeae DNA (NAAT) |
| 24117-4 | Ross river virus IgG Ab [Presence] in Serum by Immunoassay | Ross River virus IgG Ab | Ross River virus IgG Ab |
| 24118-2 | Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay | Barmah Forest virus IgM Ab | Barmah Forest virus IgM Ab |
| 24120-8 | Ross river virus IgM Ab [Presence] in Serum by Immunoassay | Ross River virus IgM Ab | Ross River virus IgM Ab |
| 24121-6 | Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay | Barmah Forest virus IgG Ab | Barmah Forest virus IgG Ab |
| 24124-0 | Casts [Presence] in Urine sediment by Light microscopy | Casts urine sediment | Casts urine sediment |
| 24125-7 | Androgen free Index in Serum or Plasma | Testosterone (free index) | Testosterone (free index) |
| 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination | Syphilis Ab Screen (Aggl) | Syphilis Ab Screen (Aggl) |
| 24377-4 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma | Platelet aggregtion-ADP | Platelet aggregtion-ADP |
| 24378-2 | Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma | Platelet aggregtion-epinephrine | Platelet aggregtion-epinephrine |
| 24379-0 | Platelet aggregation collagen induced [Presence] in Platelet rich plasma | Platelet aggregtion-collagen | Platelet aggregtion-collagen |
| 24380-8 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma | Platelet aggregtion-ristocetin | Platelet aggregtion-ristocetin |
| 24383-2 | Intrinsic factor Ab [Presence] in Serum by Immunoassay | Intrinsic factor Ab (qual) | Intrinsic factor Ab (qual) |
| 24390-7 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM | Cortisol (30m p 250ug Synacth) | Cortisol (30m p 250ug Synacth) |
| 24391-5 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM | Cortisol (1h p 250ug Synacth) | Cortisol (1h p 250ug Synacth) |
| 24393-1 | Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight | Cortisol (10h p 1mg Dexameth) | Cortisol (10h p 1mg Dexameth) |
| 24419-4 | Pathology report gross observation | Gross observation | Gross observation |
| 24467-3 | CD3+?CD4+? (T4 helper) cells [#/?volume] in Blood | lymphocyte markers - Cells.CD3+CD4+ | lymphocyte markers - Cells.CD3+CD4+ |
| 24471-5 | Platelet function (closure time) collagen+?Epinephrine induced [Time] in Blood | PFA Col/Epi | PFA Col/Epi |
| 24472-3 | Platelet function (closure time) collagen+?ADP induced [Time] in Blood | PFA Col/ADP | PFA Col/ADP |
| 245-1 | Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Floxacillin suscep (MIC) | Floxacillin suscep (MIC) |
| 24518-3 | Calcium/?Creatinine [Molar ratio] in Urine | Calcium/creatinine urine | Calcium/creatinine urine |
| 24521-7 | Epinephrine [Moles/volume] in Urine | Adrenaline urine | Adrenaline urine |
| 24522-5 | Epinephrine/Creatinine [Molar ratio] in Urine | Adrenaline/creat urine | Adrenaline/creat urine |
| 24523-3 | Norepinephrine/Creatinine [Molar ratio] in Urine | Noradrenaline/creat urine | Noradrenaline/creat urine |
| 24524-1 | Dopamine/Creatinine [Molar ratio] in Urine | Dopamine/creat urine | Dopamine/creat urine |
| 2458-8 | IgA [Mass/volume] in Serum or Plasma | IgA | IgA |
| 2460-4 | IgD [Mass/?volume] in Serum | IgD | IgD |
| 2464-6 | IgG [Mass/?volume] in Cerebral spinal fluid | IgG CSF | IgG CSF |
| 2465-3 | IgG [Mass/volume] in Serum or Plasma | IgG | IgG |
| 2466-1 | IgG subclass 1 [Mass/volume] in Serum | IgG subclass 1 | IgG subclass 1 |
| 2467-9 | IgG subclass 2 [Mass/volume] in Serum | IgG subclass 2 | IgG subclass 2 |
| 2468-7 | IgG subclass 3 [Mass/volume] in Serum | IgG subclass 3 | IgG subclass 3 |
| 2469-5 | IgG subclass 4 [Mass/volume] in Serum | IgG subclass 4 | IgG subclass 4 |
| 2470-3 | IgG/?Albumin [Mass Ratio] in Cerebral spinal fluid | IgG/Albumin CSF | IgG/Albumin CSF |
| 2472-9 | IgM [Mass/volume] in Serum or Plasma | IgM | IgM |
| 2483-6 | Insulin-like growth factor binding protein 3 [Mass/?volume] in Serum or Plasma | IGF Binding Protein 3 | IGF Binding Protein 3 |
| 2484-4 | Insulin-like growth factor-I [Mass/?volume] in Serum or Plasma | IGF1 | IGF1 |
| 249-3 | Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Fluconazole suscep (MIC) | Fluconazole suscep (MIC) |
| 2495-0 | Iodine [Mass/?volume] in Urine | Iodine urine - mass/volume | Iodine urine - mass/volume |
| 25095-1 | Deoxypyridinoline/?Creatinine [Molar ratio] in Urine | DPD / creat urine | DPD / creat urine |
| 25142-1 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak | Flucytosine peak | Flucytosine peak |
| 25143-9 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough | Flucytosine trough | Flucytosine trough |
| 25145-4 | Bacteria [Presence] in Urine sediment by Light microscopy | Bacteria urine sediment (microscopy) | Bacteria urine sediment (microscopy) |
| 2514-8 | Ketones [Presence] in Urine by Test strip | Ketones urine (dipstick) | Ketones urine (dipstick) |
| 25168-6 | Perhexiline [Mass/?volume] in Serum or Plasma | Perhexiline | Perhexiline |
| 25170-2 | Mercury [Moles/?volume] in Blood | Mercury blood | Mercury blood |
| 2520-5 | Lactate [Moles/?volume] in Cerebral spinal fluid | Lactate CSF | Lactate CSF |
| 2524-7 | Lactate [Moles/?volume] in Serum or Plasma | Lactate | Lactate |
| 25302-1 | Alanine aminotransferase [Enzymatic activity/?volume] in Body fluid | ALT, fluid | ALT, fluid |
| 253-5 | 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) | 5-Fluorocytosine suscep (MIC) | 5-Fluorocytosine suscep (MIC) |
| 25358-3 | C peptide [Moles/?time] in 24 hour Urine | C-Peptide urine 24hr | C-Peptide urine 24hr |
| 25360-9 | Cadmium [Moles/?volume] in Urine | Cadmium urine | Cadmium urine |
| 25361-7 | Caffeine [Moles/?volume] in Serum or Plasma | Caffeine | Caffeine |
| 25374-0 | Chromium [Moles/?volume] in Serum or Plasma | Chromium | Chromium |
| 25375-7 | Chymotrypsin [Enzymatic activity/?mass] in Stool | Chymotrypsin faeces | Chymotrypsin faeces |
| 25378-1 | Cobalt [Moles/?volume] in Serum or Plasma | Cobalt | Cobalt |
| 25386-4 | Creatinine [Moles/volume] in Body fluid | Creatinine body fluid | Creatinine body fluid |
| 25393-0 | Desethylamiodarone [Moles/?volume] in Serum or Plasma | Desethylamiodarone | Desethylamiodarone |
| 25411-0 | Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Fleroxacin suscep (MIC) | Fleroxacin suscep (MIC) |
| 25428-4 | Glucose [Presence] in Urine by Test strip | Glucose urine (dipstick) | Glucose urine (dipstick) |
| 25447-4 | Insulin Free [Moles/?volume] in Serum or Plasma | Insulin (free) | Insulin (free) |
| 25451-6 | Isoniazid [Moles/?volume] in Serum or Plasma | Isoniazid | Isoniazid |
| 25452-4 | Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Itraconazole suscep (MIC) | Itraconazole suscep (MIC) |
| 25458-1 | Lamotrigine [Moles/volume] in Serum or Plasma | Lamotrigine - moles/volume | Lamotrigine - moles/volume |
| 25466-4 | Manganese [Moles/?volume] in Blood | Manganese blood - moles/volume | Manganese blood - moles/volume |
| 25471-4 | Mercury [Moles/?time] in 24 hour Urine | Mercury urine 24hr | Mercury urine 24hr |
| 25474-8 | Metanephrines [Moles/?volume] in Serum or Plasma | Metanephrines | Metanephrines |
| 25489-6 | Normetanephrine [Moles/?volume] in Serum or Plasma | Normetanephrines | Normetanephrines |
| 25501-8 | Phosphate [Moles/?volume] in Body fluid | Phosphate fluid | Phosphate fluid |
| 2550-2 | Lactate/?Pyruvate [Molar ratio] in Blood | Lactate/pyruvate blood | Lactate/pyruvate blood |
| 25514-1 | Rubella virus IgG Ab [Presence] in Serum | Rubella IgG (qual) | Rubella IgG (qual) |
| 25521-6 | Selenium [Moles/?volume] in Serum or Plasma | Selenium | Selenium |
| 25524-0 | Serotonin [Moles/?volume] in Blood | Serotonin blood | Serotonin blood |
| 25541-4 | Topiramate [Moles/volume] in Serum or Plasma | Topiramate | Topiramate |
| 25542-2 | Toxoplasma gondii IgM Ab [Presence] in Serum | T. gondii IgM (qual) | T. gondii IgM (qual) |
| 25548-9 | Urate [Moles/?volume] in Body fluid | Urate fluid | Urate fluid |
| 25549-7 | Urea [Moles/?volume] in Body fluid | Urea fluid | Urea fluid |
| 25595-0 | Econazole [Susceptibility] | Econazole suscep (qual) | Econazole suscep (qual) |
| 25596-8 | Fosfomycin [Susceptibility] | Fosfomycin suscep (qual) | Fosfomycin suscep (qual) |
| 25597-6 | Josamycine [Susceptibility] | Josamycine suscep (qual) | Josamycine suscep (qual) |
| 25607-3 | Miconazole [Susceptibility] | Miconazole suscep (qual) | Miconazole suscep (qual) |
| 25608-1 | Nitroxoline [Susceptibility] | Nitroxoline suscep (qual) | Nitroxoline suscep (qual) |
| 25637-0 | Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Econazole suscep (MIC) | Econazole suscep (MIC) |
| 25638-8 | Eosinophil cationic protein (ECP) [Mass/?volume] in Serum | ECP | ECP |
| 25653-7 | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Fosfomycin suscep (MIC) | Fosfomycin suscep (MIC) |
| 256-8 | Foscarnet [Susceptibility] | Foscarnet suscep (qual) | Foscarnet suscep (qual) |
| 25702-2 | Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) | Josamycine suscep (MIC) | Josamycine suscep (MIC) |
| 25721-2 | Mianserin [Moles/?volume] in Serum or Plasma | Mianserin | Mianserin |
| 25722-0 | Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Miconazole suscep (MIC) | Miconazole suscep (MIC) |
| 25723-8 | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitroxoline suscep (MIC) | Nitroxoline suscep (MIC) |
| 2572-6 | Lipoprotein lipase [Enzymatic activity/?volume] in Serum or Plasma | Liporotein lipase | Liporotein lipase |
| 258-4 | Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) | Framycetin suscep (MIC) | Framycetin suscep (MIC) |
| 25867-3 | Echinococcus sp Ab [Titer] in Serum | Echinococcus Ab (titre) | Echinococcus Ab (titre) |
| 2589-0 | Lysozyme [Mass/?volume] in Serum or Plasma | Muramidase | Muramidase |
| 25907-7 | Elastase.pancreatic [Mass/?mass] in Stool | Elastase faeces | Elastase faeces |
| 25909-3 | Epinephrine/Creatinine [Molar ratio] in 24 hour Urine | Adrenaline/creat urine 24h | Adrenaline/creat urine 24h |
| 25931-7 | Homovanillate/Creatinine [Molar ratio] in 24 hour Urine | Homovanillate/creat urine 24h | Homovanillate/creat urine 24h |
| 2596-5 | Magnesium [Moles/?volume] in Body fluid | Magnesium fluid | Magnesium fluid |
| 2597-3 | Magnesium [Moles/?volume] in Red Blood Cells | Magnesium RBC | Magnesium RBC |
| 2598-1 | Magnesium [Moles/volume] in Urine | Magnesium urine | Magnesium urine |
| 2599-9 | Magnesium [Moles/time] in 24 hour Urine | Magnesium urine 24h | Magnesium urine 24h |
| 26004-2 | Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine | VMA/creat urine 24h | VMA/creat urine 24h |
| 26009-1 | Treponema pallidum Ab [Titer] in Serum by Hemagglutination | T. pallidum Ab (HA) | T. pallidum Ab (HA) |
| 2601-3 | Magnesium [Moles/volume] in Serum or Plasma | Magnesium | Magnesium |
| 26023-2 | Extractable nuclear Ab identified in Serum | ENA Identification | ENA Identification |
| 26043-0 | HLA-B27 [Presence] by NAA with probe detection | HLA B27 | HLA B27 |
| 2606-2 | Melanin [Presence] in Urine | Melanogen urine (qual) | Melanogen urine (qual) |
| 2614-6 | Methemoglobin/Hemoglobin.total in Blood | Methaemoglobin | Methaemoglobin |
| 262-6 | Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) | Fusidate suscep (MIC) | Fusidate suscep (MIC) |
| 2639-3 | Myoglobin [Mass/?volume] in Serum or Plasma | Myoglobin | Myoglobin |
| 2640-1 | Myoglobin [Presence] in Urine | Myoglobin urine | Myoglobin urine |
| 26444-0 | Basophils [#/volume] in Blood | Basophils | Basophils |
| 26446-5 | Blasts/100 leukocytes in Blood | Blasts (%) | Blasts (%) |
| 26449-9 | Eosinophils [#/volume] in Blood | Eosinophils | Eosinophils |
| 26450-7 | Eosinophils/100 leukocytes in Blood | Eosinophils (%) | Eosinophils (%) |
| 26453-1 | Erythrocytes [#/volume] in Blood | RBC | RBC |
| 26454-9 | Erythrocytes [#/volume] in Cerebral spinal fluid | RBC CSF | RBC CSF |
| 26455-6 | Erythrocytes [#/volume] in Body fluid | RBC body fluid | RBC body fluid |
| 26464-8 | Leukocytes [#/volume] in Blood | WBC | WBC |
| 26465-5 | Leukocytes [#/volume] in Cerebral spinal fluid | WBC CSF | WBC CSF |
| 26466-3 | Leukocytes [#/volume] in Body fluid | WBC body fluid | WBC body fluid |
| 26474-7 | Lymphocytes [#/volume] in Blood | Lymphocytes | Lymphocytes |
| 26475-4 | Lymphocytes [#/volume] in Cerebral spinal fluid | Lymphocytes CSF | Lymphocytes CSF |
| 26476-2 | Lymphocytes [#/volume] in Body fluid | Lymphocytes body fluid | Lymphocytes body fluid |
| 26477-0 | Variant lymphocytes [#/volume] in Blood | Lymphocytes (atypical) | Lymphocytes (atypical) |
| 26478-8 | Lymphocytes/100 leukocytes in Blood | Lymphocytes (%) | Lymphocytes (%) |
| 26484-6 | Monocytes [#/volume] in Blood | Monocytes | Monocytes |
| 26485-3 | Monocytes/100 leukocytes in Blood | Monocytes (%) | Monocytes (%) |
| 26489-5 | Mononuclear cells [#/volume] in Cerebral spinal fluid | Mononuclear cells CSF | Mononuclear cells CSF |
| 26490-3 | Mononuclear cells [#/volume] in Body fluid | Mononuclear cells body fluid | Mononuclear cells body fluid |
| 26499-4 | Neutrophils [#/volume] in Blood | Neutrophils | Neutrophils |
| 26500-9 | Neutrophils [#/volume] in Cerebral spinal fluid | Neutrophils CSF | Neutrophils CSF |
| 26507-4 | Band form neutrophils [#/volume] in Blood | Neutrophils (band) | Neutrophils (band) |
| 26508-2 | Band form neutrophils/100 leukocytes in Blood | Neutrophils (band) (%) | Neutrophils (band) (%) |
| 26511-6 | Neutrophils/100 leukocytes in Blood | Neutrophils (%) | Neutrophils (%) |
| 26515-7 | Platelets [#/volume] in Blood | Platelets | Platelets |
| 26523-1 | Promyelocytes [#/volume] in Blood | Promyelocytes | Promyelocytes |
| 265-9 | Ganciclovir [Susceptibility] | Ganciclovir suscep (qual) | Ganciclovir suscep (qual) |
| 26621-3 | Legionella sp Ag [Presence] in Unspecified specimen | Legionella Ag | Legionella Ag |
| 26705-4 | Epstein Barr virus nuclear IgM Ab [Titer] in Serum | EBV NA IgM (titre) | EBV NA IgM (titre) |
| 267-5 | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Gentamicin suscep (MIC) | Gentamicin suscep (MIC) |
| 2676-5 | Organic acids [Presence] in Urine | Organic acids urine | Organic acids urine |
| 26784-9 | Diazepam [Mass/?volume] in Serum or Plasma by Confirmatory method | Diazepam by Confirmatory method | Diazepam by Confirmatory method |
| 26833-4 | Hippurate [Presence] in Urine | Hippurate urine | Hippurate urine |
| 2685-6 | Alpha-1-Acid glycoprotein [Mass/?volume] in Serum or Plasma | Alpha 1 glycoprotein | Alpha 1 glycoprotein |
| 26885-4 | Ova and parasites identified in Unspecified specimen by Concentration. | Ova cysts parasites | Ova cysts parasites |
| 2692-2 | Osmolality of Serum or Plasma | Osmolality | Osmolality |
| 2695-5 | Osmolality of Urine | Osmolality urine | Osmolality urine |
| 26960-5 | Trypsin [Presence] in Stool | Trypsin faeces | Trypsin faeces |
| 26969-6 | Parietal cell Ab [Presence] in Serum by Immunofluorescence | Parietal cell Ab (qual) | Parietal cell Ab (qual) |
| 27071-0 | CD45 (Lymphs) cells [#/?volume] in Blood | lymphocyte markers - Cells.CD45 | lymphocyte markers - Cells.CD45 |
| 27081-9 | Itraconazole+?Hydroxyitraconazole [Mass/?volume] in Serum or Plasma | Itraconazole | Itraconazole |
| 27109-8 | Paroxetine [Presence] in Urine | Paroxetine urine | Paroxetine urine |
| 271-7 | Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) | Gramicidin D suscep (MIC) | Gramicidin D suscep (MIC) |
| 27198-1 | Bilirubin.total [Units/?volume] in Amniotic fluid by Spectrophotometry direct | Bilirubin amniotic fluid | Bilirubin amniotic fluid |
| 27200-5 | Nuclear Ab [Units/volume] in Serum | Antinuclear Ab | Antinuclear Ab |
| 2721-9 | Pancreatic polypeptide [Mass/?volume] in Serum or Plasma | Pancreatic Polypeptide | Pancreatic Polypeptide |
| 27252-6 | Choriogonadotropin.alpha subunit [Mass/?volume] in Serum or Plasma | Gonadotrophin Alpha subunit (total) | Gonadotrophin Alpha subunit (total) |
| 27265-8 | Giardia sp Ag [Presence] in Stool | Giardia Ag faeces | Giardia Ag faeces |
| 2731-8 | Parathyrin.intact [Mass/?volume] in Serum or Plasma | Parathyroid Hormone (intact) - mass/volume | Parathyroid Hormone (intact) - mass/volume |
| 27320-1 | Parietal cell Ab [Titer] in Serum | Parietal cell Ab (titre) | Parietal cell Ab (titre) |
| 27403-5 | Gamma glutamyl transferase [Enzymatic activity/?volume] in Urine | GGT urine | GGT urine |
| 2742-5 | Angiotensin converting enzyme [Enzymatic activity/?volume] in Serum or Plasma | Angiotensin converting enzyme | Angiotensin converting enzyme |
| 2748-2 | pH of Body fluid | pH body fluid | pH body fluid |
| 2752-4 | pH of Semen | pH semen | pH semen |
| 275-8 | Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Hetacillin suscep (MIC) | Hetacillin suscep (MIC) |
| 2758-1 | Phenol [Mass/?volume] in Urine | Phenol urine | Phenol urine |
| 27811-9 | Antithrombin actual/?normal in Platelet poor plasma by Chromogenic method | Antithrombin | Antithrombin |
| 27812-7 | Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay | Antithrombin Ag | Antithrombin Ag |
| 27815-0 | Coagulation factor XIII activity actual/?normal in Platelet poor plasma by Chromogenic method | Factor XIII assay | Factor XIII assay |
| 27816-8 | von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay | VWF:Ag | VWF:Ag |
| 27818-4 | Protein C actual/?normal in Platelet poor plasma by Chromogenic method | Protein C - by Chromogenic method | Protein C - by Chromogenic method |
| 27819-2 | Protein C actual/?normal in Platelet poor plasma by Coagulation assay | Protein C - by Coagulation assay | Protein C - by Coagulation assay |
| 27820-0 | Protein C Ag actual/normal in Platelet poor plasma by Immunoassay | Protein C Ag | Protein C Ag |
| 27821-8 | Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay | Protein S, Free | Protein S, Free |
| 27822-6 | Protein S actual/normal in Platelet poor plasma by Coagulation assay | Protein S | Protein S |
| 279-0 | Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Imipenem suscep (MIC) | Imipenem suscep (MIC) |
| 27977-8 | Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine | Noradrenaline/creat urine 24h | Noradrenaline/creat urine 24h |
| 27978-6 | Metanephrines/?Creatinine [Molar ratio] in 24 hour Urine | Metanephrines/creat urine 24h | Metanephrines/creat urine 24h |
| 2809-2 | Porphobilinogen [Presence] in Urine | Porphobilinogen urine (qual) | Porphobilinogen urine (qual) |
| 28-1 | Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ampicillin suscep (MIC) | Ampicillin suscep (MIC) |
| 2811-8 | Porphobilinogen [Moles/?volume] in Urine | Porphobilinogen urine | Porphobilinogen urine |
| 2812-6 | Porphobilinogen deaminase [Enzymatic activity/?volume] in Red Blood Cells | Porphobilinogen deaminase RBC | Porphobilinogen deaminase RBC |
| 2821-7 | Potassium [Moles/?volume] in Body fluid | Potassium fluid | Potassium fluid |
| 2823-3 | Potassium [Moles/volume] in Serum or Plasma | Potassium | Potassium |
| 2828-2 | Potassium [Moles/volume] in Urine | Potassium urine | Potassium urine |
| 2829-0 | Potassium [Moles/time] in 24 hour Urine | Potassium urine 24h | Potassium urine 24h |
| 28539-5 | MCH [Entitic mass] | MCH | MCH |
| 28540-3 | MCHC [Mass/volume] | MCHC | MCHC |
| 28542-9 | Platelet mean volume [Entitic volume] in Blood | MPV | MPV |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma | PSA | PSA |
| 287-3 | Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) | Isoniazid suscep (MIC) | Isoniazid suscep (MIC) |
| 2880-3 | Protein [Mass/volume] in Cerebral spinal fluid | Protein CSF | Protein CSF |
| 2881-1 | Protein [Mass/volume] in Body fluid | Protein body fluid | Protein body fluid |
| 2885-2 | Protein [Mass/volume] in Serum or Plasma | Protein | Protein |
| 2888-6 | Protein [Mass/volume] in Urine | Protein urine | Protein urine |
| 2889-4 | Protein [Mass/time] in 24 hour Urine | Protein urine 24h | Protein urine 24h |
| 2890-2 | Protein/Creatinine [Mass Ratio] in Urine | Protein/creat urine | Protein/creat urine |
| 2903-3 | Pyrimidine-5'-Nucleotidase [Enzymatic activity/?volume] in Blood | Pyrimidine 5'Nucleotidase | Pyrimidine 5'Nucleotidase |
| 291-5 | Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Kanamycin suscep (MIC) | Kanamycin suscep (MIC) |
| 2915-7 | Renin [Enzymatic activity/?volume] in Plasma | Renin Activity | Renin Activity |
| 29247-4 | Sirolimus [Mass/?volume] in Blood | Sirolimus blood | Sirolimus blood |
| 29254-0 | Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) | Linezolid suscep (MIC) | Linezolid suscep (MIC) |
| 29257-3 | Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection | M. pneumoniae DNA (NAAT) | M. pneumoniae DNA (NAAT) |
| 29258-1 | Linezolid [Susceptibility] | Linezolid suscep (qual) | Linezolid suscep (qual) |
| 29265-6 | Calcium [Moles/volume] corrected for albumin in Serum or Plasma | Calcium (albumin adjusted) | Calcium (albumin adjusted) |
| 29300-1 | Procedure type | Sample procedure | Sample procedure |
| 2947-0 | Sodium [Moles/volume] in Blood | Sodium blood | Sodium blood |
| 2950-4 | Sodium [Moles/?volume] in Body fluid | Sodium fluid | Sodium fluid |
| 2951-2 | Sodium [Moles/volume] in Serum or Plasma | Sodium | Sodium |
| 29520-4 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine | 5HIAA/creat urine | 5HIAA/creat urine |
| 29541-0 | HIV 1 RNA [Log #/volume] (viral load) in Plasma by NAA with probe detection | HIV Viral Load (log#/volume) | HIV Viral Load (log#/volume) |
| 2954-6 | Sodium [Moles/?volume] in Sweat | Sodium sweat | Sodium sweat |
| 2955-3 | Sodium [Moles/volume] in Urine | Sodium urine | Sodium urine |
| 29558-4 | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | Enterovirus RNA (NAAT) CSF | Enterovirus RNA (NAAT) CSF |
| 295-6 | Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Ketoconazole suscep (MIC) | Ketoconazole suscep (MIC) |
| 2956-1 | Sodium [Moles/time] in 24 hour Urine | Sodium urine 24h | Sodium urine 24h |
| 29577-4 | Fungal susceptibility panel | Fungal susceptibility | Fungal susceptibility |
| 29591-5 | Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Enterovirus RNA (NAAT) | Enterovirus RNA (NAAT) |
| 2963-7 | Somatotropin [Mass/?volume] in Serum or Plasma | Growth Hormone | Growth Hormone |
| 29652-5 | Dothiepin [Mass/?volume] in Serum or Plasma | Dothiepin - mass/volume | Dothiepin - mass/volume |
| 29653-3 | Dothiepin [Moles/?volume] in Serum or Plasma | Dothiepin - moles/volume | Dothiepin - moles/volume |
| 29659-0 | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay | Bordetella IgG Ab (qual) | Bordetella IgG Ab (qual) |
| 29660-8 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay | Parvovirus Ab IgG | Parvovirus Ab IgG |
| 29662-4 | Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay | Varicella zoster Ab IgM | Varicella zoster Ab IgM |
| 29747-3 | Tocopherols [Moles/?volume] in Serum or Plasma | Vitamin E | Vitamin E |
| 29764-8 | Iron [Moles/?volume] in Body fluid | Iron fluid | Iron fluid |
| 29765-5 | Cholesterol [Moles/volume] in Body fluid | Cholesterol body fluid | Cholesterol body fluid |
| 29766-3 | Triglyceride [Moles/?volume] in Body fluid | Triglyceride fluid | Triglyceride fluid |
| 29771-3 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay | Occult blood (human Hb spec) | Occult blood (human Hb spec) |
| 29877-8 | Methylmalonate [Presence] in Urine | Methylmalonic Acid - in urine | Methylmalonic Acid - in urine |
| 29891-9 | Helicobacter pylori [Presence] in Stomach by urea breath test | Urea Breath Test | Urea Breath Test |
| 29904-0 | Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection | T. gondii (NAAT) | T. gondii (NAAT) |
| 29908-1 | Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection | Parainfluenza virus 1 RNA (NAAT) | Parainfluenza virus 1 RNA (NAAT) |
| 29909-9 | Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection | Parainfluenza virus 2 RNA (NAAT) | Parainfluenza virus 2 RNA (NAAT) |
| 29910-7 | Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection | Parainfluenza virus 3 RNA (NAAT) | Parainfluenza virus 3 RNA (NAAT) |
| 29953-7 | Nuclear Ab [Titer] in Serum | Antinuclear Ab (titre) | Antinuclear Ab (titre) |
| 29954-5 | Extractable nuclear Ab [Units/?volume] in Serum by Immunoassay | ENA screen (EIA) | ENA screen (EIA) |
| 299-8 | Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Lincomycin suscep (MIC) | Lincomycin suscep (MIC) |
| 29990-9 | Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy | Semen (post vasectomy) (qual) | Semen (post vasectomy) (qual) |
| 30000-4 | Microalbumin/?Creatinine [Ratio] in Urine | Microalblumin:Creatinine Ratio | Microalblumin:Creatinine Ratio |
| 3002-3 | Thiocyanate [Mass/?volume] in Serum or Plasma | Thiocyanate | Thiocyanate |
| 3004-9 | Thiocyanate [Mass/?volume] in Urine | Thiocyanate urine | Thiocyanate urine |
| 3013-0 | Thyroglobulin [Mass/?volume] in Serum or Plasma | Thyroglobulin | Thyroglobulin |
| 30131-7 | Complement total hemolytic CH50 [Mass/?volume] in Serum or Plasma | CH50 | CH50 |
| 3016-3 | Thyrotropin [Units/volume] in Serum or Plasma | TSH | TSH |
| 30173-9 | Cortisol Free [Moles/volume] in Urine | Cortisol (free) urine | Cortisol (free) urine |
| 30180-4 | Basophils/100 leukocytes in Blood | Basophils (%) | Basophils (%) |
| 30206-7 | Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma | hCG (alpha free) | hCG (alpha free) |
| 30246-3 | Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection | CMV DNA (NAAT) (Serum/Plasma) | CMV DNA (NAAT) (Serum/Plasma) |
| 30248-9 | Transferrin receptor.soluble [Mass/?volume] in Serum or Plasma | Transferrin Receptor - mass/volume | Transferrin Receptor - mass/volume |
| 30298-4 | Lamivudine [Susceptibility] | Lamivudine suscep (qual) | Lamivudine suscep (qual) |
| 30299-2 | Amprenavir [Susceptibility] | Amprenavir suscep (qual) | Amprenavir suscep (qual) |
| 30300-8 | Didanosine [Susceptibility] | Didanosine suscep (qual) | Didanosine suscep (qual) |
| 30301-6 | Zalcitabine [Susceptibility] | Zalcitabine suscep (qual) | Zalcitabine suscep (qual) |
| 30302-4 | Stavudine [Susceptibility] | Stavudine suscep (qual) | Stavudine suscep (qual) |
| 30303-2 | Abacavir [Susceptibility] | Abacavir suscep (qual) | Abacavir suscep (qual) |
| 30304-0 | Adefovir [Susceptibility] | Adefovir suscep (qual) | Adefovir suscep (qual) |
| 30305-7 | Delavirdine [Susceptibility] | Delavirdine suscep (qual) | Delavirdine suscep (qual) |
| 30306-5 | Efavirenz [Susceptibility] | Efavirenz suscep (qual) | Efavirenz suscep (qual) |
| 30307-3 | Indinavir [Susceptibility] | Indinavir suscep (qual) | Indinavir suscep (qual) |
| 30308-1 | Ritonavir [Susceptibility] | Ritonavir suscep (qual) | Ritonavir suscep (qual) |
| 30309-9 | Nelfinavir [Susceptibility] | Nelfinavir suscep (qual) | Nelfinavir suscep (qual) |
| 30310-7 | Saquinavir [Susceptibility] | Saquinavir suscep (qual) | Saquinavir suscep (qual) |
| 30311-5 | Nevirapine [Susceptibility] | Nevirapine suscep (qual) | Nevirapine suscep (qual) |
| 30313-1 | Hemoglobin [Mass/?volume] in Arterial blood | Haemoglobin blood | Haemoglobin blood |
| 30316-4 | Alpha subunit free [Mass/?volume] in Serum or Plasma | Gonadotrophin Alpha subunit (free) | Gonadotrophin Alpha subunit (free) |
| 30325-5 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma | CMV IgM (qual) | CMV IgM (qual) |
| 30339-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum | EBV VCA IgG | EBV VCA IgG |
| 30340-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum | EBV VCA IgM | EBV VCA IgM |
| 30341-2 | Erythrocyte sedimentation rate | ESR | ESR |
| 3034-6 | Transferrin [Mass/volume] in Serum or Plasma | Transferrin | Transferrin |
| 30376-8 | Blasts [#/volume] in Blood | Blasts | Blasts |
| 303-8 | Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Lomefloxacin suscep (MIC) | Lomefloxacin suscep (MIC) |
| 30385-9 | Erythrocyte distribution width [Ratio] | RDW | RDW |
| 30391-7 | Erythrocytes [#/volume] in Urine | RBC urine | RBC urine |
| 30392-5 | Nucleated erythrocytes [#/volume] in Blood | RBC (nucleated) | RBC (nucleated) |
| 30397-4 | Hairy cells [#/volume] in Blood | Hairy Cells | Hairy Cells |
| 3040-3 | Lipase [Enzymatic activity/?volume] in Serum or Plasma | Lipase | Lipase |
| 30405-5 | Leukocytes [#/volume] in Urine | WBC urine | WBC urine |
| 3041-1 | Trichloroacetate [Mass/?volume] in Urine | Trichloroacetic acid urine | Trichloroacetic acid urine |
| 30412-1 | Lymphocytes Abnormal [#/volume] in Blood | Lymphocytes (abnormal) | Lymphocytes (abnormal) |
| 30422-0 | Lymphoma cells [#/volume] in Blood | Lymphoma cells | Lymphoma cells |
| 30428-7 | MCV [Entitic volume] | MCV | MCV |
| 30433-7 | Metamyelocytes [#/volume] in Blood | Metamyelocytes | Metamyelocytes |
| 30446-9 | Myelocytes [#/volume] in Blood | Myelocytes | Myelocytes |
| 30449-3 | Neutrophils.hypersegmented [#/volume] in Blood | Neutrophils (hyperseg) | Neutrophils (hyperseg) |
| 30450-1 | Neutrophils.hypersegmented/100 leukocytes in Blood | Neutrophils (hyperseg) (%) | Neutrophils (hyperseg) (%) |
| 30458-4 | Plasma cells [#/volume] in Blood | Plasma cells | Plasma cells |
| 30464-2 | Prolymphocytes [#/volume] in Blood | Prolymphocytes | Prolymphocytes |
| 30480-8 | Orotate [Presence] in Urine | Orotate urine | Orotate urine |
| 30522-7 | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method | CRP (high sensitivity) | CRP (high sensitivity) |
| 30524-3 | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting | Triglycerides (fasting) | Triglycerides (fasting) |
| 3056-9 | Trimethylamine [Mass/?volume] in Urine | Trimethylamine urine | Trimethylamine urine |
| 307-9 | Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC) | Loracarbef suscep (MIC) | Loracarbef suscep (MIC) |
| 30894-0 | Aldosterone/?Renin [Ratio] in Plasma | Aldosterone/Renin | Aldosterone/Renin |
| 30899-9 | Blood volume by Scintigraphy | Blood volume | Blood volume |
| 30903-9 | Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) | Neutrophil oxidative burst | Neutrophil oxidative burst |
| 31022-7 | Filaria identified in Unspecified specimen by Concentration | Filaria blood (conc) | Filaria blood (conc) |
| 31036-7 | Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Gatifloxacin suscep (MIC) | Gatifloxacin suscep (MIC) |
| 31037-5 | Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Moxifloxacin suscep (MIC) | Moxifloxacin suscep (MIC) |
| 31038-3 | Gatifloxacin [Susceptibility] | Gatifloxacin suscep (qual) | Gatifloxacin suscep (qual) |
| 31039-1 | Moxifloxacin [Susceptibility] | Moxifloxacin suscep (qual) | Moxifloxacin suscep (qual) |
| 311-1 | Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Lymecycline suscep (MIC) | Lymecycline suscep (MIC) |
| 31146-4 | Reagin Ab [Titer] in Cerebral spinal fluid by VDRL | VDRL CSF (titre) | VDRL CSF (titre) |
| 31152-2 | Immunoglobulin light chains [Presence] in 24 hour Urine | B-J protein urine 24h (qual) | B-J protein urine 24h (qual) |
| 31156-3 | Hemoglobin Barts/?Hemoglobin.total in Blood | Hb Bart's | Hb Bart's |
| 31204-1 | Hepatitis B virus core IgM Ab [Presence] in Serum | Hepatitis B core IgM | Hepatitis B core IgM |
| 31208-2 | Specimen source identified | Specimen type/site | Specimen type/site |
| 3129-4 | Menadione [Mass/?volume] in Serum or Plasma | Vitamin K | Vitamin K |
| 31348-6 | DNA double strand Ab [Presence] in Serum | DS DNA Ab (qual) | DS DNA Ab (qual) |
| 31418-7 | Heterophile Ab [Presence] in Serum | Infectious mono screen | Infectious mono screen |
| 315-2 | Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Meclocycline suscep (MIC) | Meclocycline suscep (MIC) |
| 3160-9 | Volume of Semen | Volume semen | Volume semen |
| 31616-6 | Rubella virus IgM Ab [Presence] in Serum | Rubella IgM (qual) | Rubella IgM (qual) |
| 31627-3 | Smith extractable nuclear Ab [Presence] in Serum | Smith extractable nuclear Ab | Smith extractable nuclear Ab |
| 3174-0 | Antithrombin [Units/?volume] in Platelet poor plasma by Chromogenic method | Antithrombin - units/volume | Antithrombin - units/volume |
| 31798-2 | Dengue virus Ag [Presence] in Serum | Dengue virus Ag | Dengue virus Ag |
| 3181-5 | Cardiolipin IgG Ab [Units/?volume] in Serum by Immunoassay | Cardiolipin Ab IgG | Cardiolipin Ab IgG |
| 3182-3 | Cardiolipin IgM Ab [Units/?volume] in Serum by Immunoassay | Cardiolipin Ab IgM | Cardiolipin Ab IgM |
| 31834-5 | Haemophilus influenzae B Ag [Presence] in Unspecified specimen | Haemophilus inflenzae B Ag | Haemophilus inflenzae B Ag |
| 31843-6 | Helicobacter pylori Ag [Presence] in Stool | H. pylori Ag faeces | H. pylori Ag faeces |
| 31844-4 | Hepatitis B virus e Ag [Presence] in Serum | Hepatitis B e Ag | Hepatitis B e Ag |
| 3185-6 | Coagulation factor IX inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay | Factor IX Inhibitor assay | Factor IX Inhibitor assay |
| 3186-4 | Coagulation factor IX activated [Units/?volume] in Platelet poor plasma by Coagulation assay | Factor IX assay - units/volume | Factor IX assay - units/volume |
| 31868-3 | Legionella pneumophila 1 Ag [Presence] in Urine | Legionella sero-group 1 Ag (urine) | Legionella sero-group 1 Ag (urine) |
| 31870-9 | Legionella pneumophila Ag [Presence] in Urine | Legionella Ag (urine) | Legionella Ag (urine) |
| 3187-2 | Coagulation factor IX activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor IX assay | Factor IX assay |
| 31910-3 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen | N. meningitidis A+?C+?w135+?Y Ag | N. meningitidis A+?C+?w135+?Y Ag |
| 31913-7 | Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen | N. meningitidis B Ag | N. meningitidis B Ag |
| 3193-0 | Coagulation factor V activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor V assay | Factor V assay |
| 319-4 | Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Methacycline suscep (MIC) | Methacycline suscep (MIC) |
| 31969-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen | Pneumococcal Ag | Pneumococcal Ag |
| 3198-9 | Coagulation factor VII activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor VII assay | Factor VII assay |
| 32018-4 | Hepatitis A virus IgG Ab [Presence] in Serum | Hepatitis A IgG (qual) | Hepatitis A IgG (qual) |
| 32042-4 | Thyroperoxidase Ab [Presence] in Serum or Plasma | Thyroid peroxidase Antibody | Thyroid peroxidase Antibody |
| 3204-5 | Coagulation factor VIII inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay | Factor VIII inhibitor assay | Factor VIII inhibitor assay |
| 3209-4 | Coagulation factor VIII activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor VIII assay | Factor VIII assay |
| 32095-2 | Methanol [Moles/?volume] in Urine | Methanol urine | Methanol urine |
| 32098-6 | Mexiletine [Moles/?volume] in Serum or Plasma | Mexiletine | Mexiletine |
| 3210-2 | Coagulation factor VIII activity [Units/?volume] in Platelet poor plasma by Chromogenic method | Factor VIII assay - units/volume | Factor VIII assay - units/volume |
| 32117-4 | Thiopental [Moles/?volume] in Serum or Plasma | Thiopentone | Thiopentone |
| 32140-6 | Hemoglobin F [Presence] in Blood by Kleihauer-Betke method | HbF (qual, Kleihauer) | HbF (qual, Kleihauer) |
| 3218-5 | Coagulation factor X activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor X | Factor X |
| 32210-7 | Protein Fractions [interpretation] in 24 hour Urine by Electrophoresis | Protein urine 24h (elph) | Protein urine 24h (elph) |
| 32217-2 | von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma | VWF Multimers | VWF Multimers |
| 32218-0 | Cyclic citrullinated peptide Ab [Units/?volume] in Serum by Immunoassay | CCP Ab | CCP Ab |
| 3226-8 | Coagulation factor XI activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor XI | Factor XI |
| 32286-7 | Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection | Hepatitis C genotype | Hepatitis C genotype |
| 32294-1 | Albumin/?Creatinine [Ratio] in Urine | Albumin:creatinine ratio | Albumin:creatinine ratio |
| 32295-8 | Aluminum [Moles/?time] in 24 hour Urine | Aluminium urine 24hr | Aluminium urine 24hr |
| 32-3 | Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Ampicillin Sulb suscep (MIC) | Ampicillin Sulb suscep (MIC) |
| 32309-7 | Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma | Cholesterol (total/HDL) | Cholesterol (total/HDL) |
| 3232-6 | Coagulation factor XII activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor XII | Factor XII |
| 32352-7 | Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability | Alk phosphatase (heat stable) | Alk phosphatase (heat stable) |
| 32356-8 | Yeast [Presence] in Urine sediment by Light microscopy | Yeasts urine | Yeasts urine |
| 323-6 | Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Methicillin suscep (MIC) | Methicillin suscep (MIC) |
| 32364-2 | Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection | Herpes virus 8 DNA (NAAT) | Herpes virus 8 DNA (NAAT) |
| 32368-3 | Ureaplasma sp identified in Unspecified specimen by Organism specific culture | Ureaplasma (culture) | Ureaplasma (culture) |
| 32372-5 | Fleroxacin [Susceptibility] | Fleroxacin suscep (qual) | Fleroxacin suscep (qual) |
| 32373-3 | Arbekacin [Susceptibility] | Arbekacin suscep (qual) | Arbekacin suscep (qual) |
| 32374-1 | Cefotiam [Susceptibility] | Cefotiam suscep (qual) | Cefotiam suscep (qual) |
| 32375-8 | Cefmenoxime [Susceptibility] | Cefmenoxime suscep (qual) | Cefmenoxime suscep (qual) |
| 32376-6 | Clinafloxacin [Susceptibility] | Clinafloxacin suscep (qual) | Clinafloxacin suscep (qual) |
| 32377-4 | Cefetamet [Susceptibility] | Cefetamet suscep (qual) | Cefetamet suscep (qual) |
| 32378-2 | Caspofungin [Susceptibility] | Caspofungin suscep (qual) | Caspofungin suscep (qual) |
| 32379-0 | Voriconazole [Susceptibility] | Voriconazole suscep (qual) | Voriconazole suscep (qual) |
| 32381-6 | Isepamicin [Susceptibility] | Isepamicin suscep (qual) | Isepamicin suscep (qual) |
| 32383-2 | Pristinamycin [Susceptibility] | Pristinamycin suscep (qual) | Pristinamycin suscep (qual) |
| 32384-0 | Thiacetazone [Susceptibility] | Thiacetazone suscep (qual) | Thiacetazone suscep (qual) |
| 3241-7 | Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay | Factor XIII screen | Factor XIII screen |
| 3243-3 | Thrombin time | Thrombin time | Thrombin time |
| 3244-1 | Clot Lysis [Time] in Platelet poor plasma by Coagulation assay | Euglobulin clot lysis time | Euglobulin clot lysis time |
| 32546-4 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells | G6PD | G6PD |
| 32547-2 | Ketones [Moles/?volume] in Serum or Plasma by Test strip | Ketones | Ketones |
| 32552-2 | Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells | Pyruvate kinase | Pyruvate kinase |
| 32554-8 | Thiamine [Moles/?volume] in Blood | Vitamin B1 blood | Vitamin B1 blood |
| 3255-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay | Fibrinogen | Fibrinogen |
| 32597-7 | Natamycin [Susceptibility] | Natamycin suscep (qual) | Natamycin suscep (qual) |
| 32603-3 | Itraconazole [Susceptibility] | Itraconazole suscep (qual) | Itraconazole suscep (qual) |
| 32610-8 | Amino acids [Moles/?volume] in Cerebral spinal fluid | Amino Acids CSF (quant) | Amino Acids CSF (quant) |
| 32631-4 | Nitroblue Tetrazolium Test (NBT) [Presence] in Blood | NBT Test | NBT Test |
| 32637-1 | Urease [Presence] in Tissue | CLO test | CLO test |
| 32654-6 | 6-Methylmercaptopurine [Entitic substance] in Red Blood Cells | 6-Methylmercatopurine | 6-Methylmercatopurine |
| 32660-3 | 6-Thioguanine [Entitic substance] in Red Blood Cells | 6-Thioguanine nucleotides blood | 6-Thioguanine nucleotides blood |
| 32661-1 | Adrenal Ab [Titer] in Serum | Adrenal Ab (titre) | Adrenal Ab (titre) |
| 32672-8 | Cold agglutinin [Presence] in Serum or Plasma | Cold Agglutinin (screen) | Cold Agglutinin (screen) |
| 32673-6 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma | CKMB | CKMB |
| 32674-4 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid | Cryptococcus Ag CSF (titre) | Cryptococcus Ag CSF (titre) |
| 32677-7 | DNA double strand Ab [Units/?volume] in Serum by Immunoassay | DS DNA Ab (EIA) | DS DNA Ab (EIA) |
| 32693-4 | Lactate [Moles/volume] in Blood | Lactate blood | Lactate blood |
| 32709-8 | Neutrophils [#/volume] in Body fluid | Neutrophils body fluid | Neutrophils body fluid |
| 3271-4 | LMW Heparin [Units/?volume] in Platelet poor plasma by Chromogenic method | Anti Xa | Anti Xa |
| 32724-7 | Trichomonas sp [Presence] in Urine by Light microscopy | Trichomonas urine (microscopy) | Trichomonas urine (microscopy) |
| 32766-8 | Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation | Trichomonas (microscopy) | Trichomonas (microscopy) |
| 327-7 | Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Metronidazole suscep (MIC) | Metronidazole suscep (MIC) |
| 32786-6 | Thyroperoxidase Ab [Titer] in Serum or Plasma | Thyroid microsomal Ab (titre) | Thyroid microsomal Ab (titre) |
| 32789-0 | Viscosity of Semen Qualitative | Viscosity semen | Viscosity semen |
| 3289-6 | Prothrombin activity actual/?normal in Platelet poor plasma by Coagulation assay | Factor II assay | Factor II assay |
| 3299-5 | Acetaminophen [Presence] in Urine | Paracetamol urine | Paracetamol urine |
| 33006-8 | Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection | CMV Viral load | CMV Viral load |
| 33007-6 | Protoporphyrin.zinc [Mass/?volume] in Blood | Zinc protoporphyrin blood | Zinc protoporphyrin blood |
| 33037-3 | Anion gap in Serum or Plasma | Anion gap | Anion gap |
| 33048-0 | Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC) | EMA Binding | EMA Binding |
| 331-9 | Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Mezlocillin suscep (MIC) | Mezlocillin suscep (MIC) |
| 3319-1 | Amikacin [Mass/volume] in Serum or Plasma --peak | Amikacin peak | Amikacin peak |
| 33204-9 | Troponin T.cardiac [Presence] in Serum or Plasma | Troponin T (qual) | Troponin T (qual) |
| 33210-6 | Transferrin receptor.soluble [Moles/?volume] in Serum or Plasma | Transferrin Receptor - moles/volume | Transferrin Receptor - moles/volume |
| 3321-7 | Amikacin [Mass/volume] in Serum or Plasma --trough | Amikacin trough | Amikacin trough |
| 33271-8 | Microscopic observation [Identifier] in Blood by Malaria thin smear | Malaria thin blood film | Malaria thin blood film |
| 33288-2 | Galactose 1 phosphate uridyl transferase [Presence] in DBS | Galactose 1 phosphate uridyl transferase dried blood spot (qual) | Galactose 1 phosphate uridyl transferase dried blood spot (qual) |
| 33295-7 | JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | JC virus (NAAT) | JC virus (NAAT) |
| 33313-8 | Rheumatoid factor IgA [Units/volume] in Serum | Rheumatoid factor IgA | Rheumatoid factor IgA |
| 33314-6 | Rheumatoid factor IgG [Units/volume] in Serum | Rheumatoid factor IgG | Rheumatoid factor IgG |
| 3333-2 | Amitriptyline [Mass/?volume] in Serum or Plasma | Amitriptyline - mass/volume | Amitriptyline - mass/volume |
| 3335-7 | Amitriptyline+?Nortriptyline [Mass/?volume] in Serum or Plasma | Amitriptyline+Nortriptyline� | Amitriptyline+Nortriptyline� |
| 3349-8 | Amphetamines [Presence] in Urine | Amphetamine-type substances, urine | Amphetamine-type substances, urine |
| 335-0 | Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Minocycline suscep (MIC) | Minocycline suscep (MIC) |
| 33525-7 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | Thrombin time (+ N plasma) | Thrombin time (+ N plasma) |
| 33526-5 | Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | Reptilase time (+ N plasma) | Reptilase time (+ N plasma) |
| 33614-9 | Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma | Carbohydrate Deficient Transferrin | Carbohydrate Deficient Transferrin |
| 33617-2 | HLA-DR+? cells [#/?volume] in Blood | lymphocyte markers - Cells.HLA-DR+ | lymphocyte markers - Cells.HLA-DR+ |
| 33627-1 | Tenofovir [Susceptibility] | Tenofovir suscep (qual) | Tenofovir suscep (qual) |
| 33628-9 | Cidofovir [Susceptibility] | Cidofovir suscep (qual) | Cidofovir suscep (qual) |
| 33666-9 | Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy | Dysmorphic RBC urine | Dysmorphic RBC urine |
| 33673-5 | Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate | Thrombin time (+protamine SO4) | Thrombin time (+protamine SO4) |
| 33721-2 | Bone marrow Pathology biopsy report | Bone marrow trephine | Bone marrow trephine |
| 33723-8 | Specimen length | Size | Size |
| 33725-3 | Tumor site | Tumour site | Tumour site |
| 33728-7 | Size.maximum dimension in Tumor | Width of tumour | Width of tumour |
| 33732-9 | Histology grade [Identifier] in Cancer specimen | Histological grade (tumour differentiation) | Histological grade (tumour differentiation) |
| 33739-4 | Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols | Lymphatic invasion | Lymphatic invasion |
| 33748-5 | Distance from anal verge | Distance from anal verge | Distance from anal verge |
| 33763-4 | Natriuretic peptide.B prohormone N-Terminal [Moles/?volume] in Serum or Plasma | ProBNP | ProBNP |
| 3377-9 | Barbiturates [Presence] in Urine | Barbiturate urine | Barbiturate urine |
| 33783-2 | Atrial natriuretic factor [Moles/?volume] in Plasma | Atrial Naturietic Peptide | Atrial Naturietic Peptide |
| 33824-4 | Iron [Moles/?volume] in Urine | Iron urine | Iron urine |
| 33872-3 | Cystine [Moles/?mass] in Leukocytes | Cystine (WBC) blood | Cystine (WBC) blood |
| 33899-6 | Bilirubin.conjugated+?indirect [Moles/?volume] in Serum or Plasma | Bilirubin neonatal | Bilirubin neonatal |
| 3390-2 | Benzodiazepines [Presence] in Urine | Benzodiazepine urine | Benzodiazepine urine |
| 339-2 | Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Miocamycin suscep (MIC) | Miocamycin suscep (MIC) |
| 3393-6 | Benzoylecgonine [Presence] in Urine | Benzoylecgonine urine | Benzoylecgonine urine |
| 33941-6 | Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection | Herpes virus 6 DNA (NAAT) | Herpes virus 6 DNA (NAAT) |
| 33944-0 | Lambda light chains.free [Mass/volume] in Serum or Plasma | Immunoglobulin Light Chains lambda (free) | Immunoglobulin Light Chains lambda (free) |
| 33950-7 | Magnesium/?Creatinine [Molar ratio] in Urine | Magnesium/creatinine urine | Magnesium/creatinine urine |
| 33959-8 | Procalcitonin [Mass/?volume] in Serum or Plasma | Procalcitonin | Procalcitonin |
| 3397-7 | Cocaine [Presence] in Urine | Cocaine urine | Cocaine urine |
| 3-4 | Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Almecillin suscep (MIC) | Almecillin suscep (MIC) |
| 3414-0 | Buprenorphine [Presence] in Urine | Buprenorphine urine | Buprenorphine urine |
| 34235-2 | Amylase/Creatinine [Ratio] in Urine | Amylase/creat urine | Amylase/creat urine |
| 34268-3 | Cobalt [Moles/?volume] in Urine | Cobalt urine | Cobalt urine |
| 34304-6 | Fluoride [Moles/?volume] in Urine | Fluoride urine | Fluoride urine |
| 34320-2 | Iodine [Moles/?volume] in Urine | Iodine urine - moles/volume | Iodine urine - moles/volume |
| 34338-4 | Mercury [Moles/?volume] in Urine | Mercury urine | Mercury urine |
| 343-4 | Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Moxalactam suscep (MIC) | Moxalactam suscep (MIC) |
| 34343-4 | Nickel [Moles/?volume] in Urine | Nickel urine | Nickel urine |
| 34350-9 | Oxalate/?Creatinine [Molar ratio] in Urine | Oxalate/creat urine | Oxalate/creat urine |
| 34357-4 | Porphobilinogen/?Creatinine [Molar ratio] in Urine | Porphobilinogen/creat urine | Porphobilinogen/creat urine |
| 34375-6 | Streptokinase Ab [Titer] in Serum | Streptokinase Ab (titre) | Streptokinase Ab (titre) |
| 34382-2 | Treponema pallidum Ab [Titer] in Serum by Immunofluorescence | T. pallidum Ab (IF) | T. pallidum Ab (IF) |
| 34385-5 | Urate/?Creatinine [Molar ratio] in Urine | Urate/creatinine urine | Urate/creatinine urine |
| 34387-1 | Zinc [Moles/?volume] in Urine | Zinc urine | Zinc urine |
| 34413-5 | Moclobemide [Moles/?volume] in Serum or Plasma | Moclobemide | Moclobemide |
| 34487-9 | Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection | Influenza A RNA (NAAT) | Influenza A RNA (NAAT) |
| 3453-8 | Cephalexin [Mass/?volume] in Serum or Plasma | Cephalexin | Cephalexin |
| 34571-0 | aPTT.lupus sensitive (LA screen) | aPTT.lupus sensitive | aPTT.lupus sensitive |
| 34594-2 | Schistosoma sp Ab [Titer] in Serum | Schistosomal Ab (titre) | Schistosomal Ab (titre) |
| 34615-5 | Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain | Iron stain blood | Iron stain blood |
| 34616-3 | Amino acids [Identifier] in Cerebral spinal fluid | Amino acids CSF (ident) | Amino acids CSF (ident) |
| 34628-8 | Methotrexate [Moles/?volume] in Cerebral spinal fluid | Methotrexate CSF | Methotrexate CSF |
| 34645-2 | Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection | C. pneumoniae DNA (NAAT) | C. pneumoniae DNA (NAAT) |
| 34701-3 | Heparin induced platelet AB [Presence] in Serum | HITS | HITS |
| 34713-8 | Clostridioides difficile toxin A+B [Presence] in Stool | Cl. difficile toxin faeces | Cl. difficile toxin faeces |
| 34717-9 | Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence | Coxiella Ab | Coxiella Ab |
| 3472-8 | Chlorpromazine [Presence] in Urine | Chlorpromazine urine | Chlorpromazine urine |
| 347-5 | Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nafcillin suscep (MIC) | Nafcillin suscep (MIC) |
| 3491-8 | Clomipramine [Mass/?volume] in Serum or Plasma | Clomipramine - mass/volume | Clomipramine - mass/volume |
| 34918-3 | Sezary cells [#/volume] in Blood | Sezary Cells | Sezary Cells |
| 34926-6 | Promonocytes [#/volume] in Blood | Promonocytes | Promonocytes |
| 3493-4 | Clomipramine+?Norclomipramine [Mass/?volume] in Serum or Plasma | Clomipramine+Norclomipramine�- mass/volume | Clomipramine+Norclomipramine�- mass/volume |
| 34993-6 | Smudge cells [#/volume] in Blood | Smear cells | Smear cells |
| 35026-4 | Monocytes [#/volume] in Cerebral spinal fluid | Monocytes CSF | Monocytes CSF |
| 35039-7 | Lymphocytes Plasmacytoid [#/volume] in Blood | Lymphocytes (plasmacytoid) | Lymphocytes (plasmacytoid) |
| 3507-1 | Codeine [Presence] in Urine | Codeine urine | Codeine urine |
| 35076-9 | Monocytes [#/volume] in Body fluid | Monocytes body fluid | Monocytes body fluid |
| 35082-7 | Lymphocytes Large Granular [#/volume] in Blood | Lymphocytes (large granular) | Lymphocytes (large granular) |
| 35112-2 | Floxacillin [Mass/volume] in Serum or Plasma | Flucloxacillin | Flucloxacillin |
| 351-7 | Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) | Nalidixate suscep (MIC) | Nalidixate suscep (MIC) |
| 3520-4 | Cyclosporine [Mass/?volume] in Blood | Cyclosporin blood | Cyclosporin blood |
| 35275-7 | Measles virus IgG Ab [Presence] in Serum by Immunoassay | Measles IgG | Measles IgG |
| 35276-5 | Measles virus IgM Ab [Presence] in Serum by Immunoassay | Measles IgM | Measles IgM |
| 35279-9 | Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence | Neutrophil cytoplasmic Ab | Neutrophil cytoplasmic Ab |
| 35280-7 | Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay | TTG Ab IgA (qual) | TTG Ab IgA (qual) |
| 3531-1 | Desipramine [Mass/?volume] in Serum or Plasma | Desipramine - mass/volume | Desipramine - mass/volume |
| 35352-4 | Mycobacterium tuberculosis genotype [Identifier] in Isolate | M. TB (genotype) | M. TB (genotype) |
| 3548-5 | Diazepam [Mass/?volume] in Serum or Plasma | Diazepam | Diazepam |
| 35491-0 | Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection | Leptospira DNA (NAAT) | Leptospira DNA (NAAT) |
| 3550-1 | Diazepam [Presence] in Urine | Diazepam urine | Diazepam urine |
| 35570-1 | Renin [Mass/?volume] in Plasma | Renin | Renin |
| 355-8 | Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Neomycin suscep (MIC) | Neomycin suscep (MIC) |
| 35668-3 | Gentamicin [Mass/?volume] in Serum or Plasma | Gentamicin | Gentamicin |
| 35670-9 | Tobramycin [Mass/?volume] in Serum or Plasma | Tobramycin | Tobramycin |
| 35698-0 | Metformin [Mass/volume] in Serum or Plasma | MetFORMIN [Mass/Vol] | MetFORMIN [Mass/Vol] |
| 35745-9 | Fat/?Total solids [Mass Ratio] in Stool | Steatocrit faeces | Steatocrit faeces |
| 35755-8 | Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Avilamycin suscep (MIC) | Avilamycin suscep (MIC) |
| 35756-6 | Avilamycin [Susceptibility] | Avilamycin suscep (qual) | Avilamycin suscep (qual) |
| 35761-6 | Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefditoren suscep (MIC) | Cefditoren suscep (MIC) |
| 35762-4 | Cefditoren [Susceptibility] | Cefditoren suscep (qual) | Cefditoren suscep (qual) |
| 35765-7 | Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefetamet suscep (MIC) | Cefetamet suscep (MIC) |
| 35770-7 | Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefotaxime Clav suscep (MIC) | Cefotaxime Clav suscep (MIC) |
| 35771-5 | Cefotaxime+Clavulanate [Susceptibility] | Cefotaxime Clav suscep (qual) | Cefotaxime Clav suscep (qual) |
| 35773-1 | Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefotiam suscep (MIC) | Cefotiam suscep (MIC) |
| 35775-6 | Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftazidime Clav suscep (MIC) | Ceftazidime Clav suscep (MIC) |
| 35776-4 | Ceftazidime+Clavulanate [Susceptibility] | Ceftazidime Clav suscep (qual) | Ceftazidime Clav suscep (qual) |
| 35778-0 | Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftibuten suscep (MIC) | Ceftibuten suscep (MIC) |
| 35779-8 | Ceftibuten [Susceptibility] | Ceftibuten suscep (qual) | Ceftibuten suscep (qual) |
| 35781-4 | Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftiofur suscep (MIC) | Ceftiofur suscep (MIC) |
| 35783-0 | Cefuroxime Oral [Susceptibility] | Cefuroxime oral suscep (qual) | Cefuroxime oral suscep (qual) |
| 35786-3 | Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Clinafloxacin suscep (MIC) | Clinafloxacin suscep (MIC) |
| 35788-9 | Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Daptomycin suscep (MIC) | Daptomycin suscep (MIC) |
| 35789-7 | Daptomycin [Susceptibility] | Daptomycin suscep (qual) | Daptomycin suscep (qual) |
| 3579-0 | Doxepin [Mass/?volume] in Serum or Plasma | Doxepin - mass/volume | Doxepin - mass/volume |
| 35791-3 | Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Difloxacin suscep (MIC) | Difloxacin suscep (MIC) |
| 35792-1 | Difloxacin [Susceptibility] | Difloxacin suscep (qual) | Difloxacin suscep (qual) |
| 35794-7 | Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dirithromycin suscep (MIC) | Dirithromycin suscep (MIC) |
| 35795-4 | Dirithromycin [Susceptibility] | Dirithromycin suscep (qual) | Dirithromycin suscep (qual) |
| 35798-8 | Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Enrofloxacin suscep (MIC) | Enrofloxacin suscep (MIC) |
| 35801-0 | Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Ertapenem suscep (MIC) | Ertapenem suscep (MIC) |
| 35802-8 | Ertapenem [Susceptibility] | Ertapenem suscep (qual) | Ertapenem suscep (qual) |
| 35804-4 | Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC) | Bambermycins suscep (MIC) | Bambermycins suscep (MIC) |
| 35805-1 | Bambermycins [Susceptibility] | Bambermycins suscep (qual) | Bambermycins suscep (qual) |
| 35808-5 | Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Florfenicol suscep (MIC) | Florfenicol suscep (MIC) |
| 35812-7 | Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Garenoxacin suscep (MIC) | Garenoxacin suscep (MIC) |
| 35813-5 | Garenoxacin [Susceptibility] | Garenoxacin suscep (qual) | Garenoxacin suscep (qual) |
| 35815-0 | Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Gemifloxacin suscep (MIC) | Gemifloxacin suscep (MIC) |
| 35816-8 | Gemifloxacin [Susceptibility] | Gemifloxacin suscep (qual) | Gemifloxacin suscep (qual) |
| 35821-8 | Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Isepamicin suscep (MIC) | Isepamicin suscep (MIC) |
| 35823-4 | Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Mupirocin suscep (MIC) | Mupirocin suscep (MIC) |
| 35826-7 | Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Orbifloxacin suscep (MIC) | Orbifloxacin suscep (MIC) |
| 35827-5 | Orbifloxacin [Susceptibility] | Orbifloxacin suscep (qual) | Orbifloxacin suscep (qual) |
| 35830-9 | Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Pirlimycin suscep (MIC) | Pirlimycin suscep (MIC) |
| 35831-7 | Pirlimycin [Susceptibility] | Pirlimycin suscep (qual) | Pirlimycin suscep (qual) |
| 35834-1 | Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Pristinamycin suscep (MIC) | Pristinamycin suscep (MIC) |
| 35837-4 | Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Salinomycin suscep (MIC) | Salinomycin suscep (MIC) |
| 35838-2 | Salinomycin [Susceptibility] | Salinomycin suscep (qual) | Salinomycin suscep (qual) |
| 35844-0 | Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Telithromycin suscep (MIC) | Telithromycin suscep (MIC) |
| 35845-7 | Telithromycin [Susceptibility] | Telithromycin suscep (qual) | Telithromycin suscep (qual) |
| 35847-3 | Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC) | Tiamulin suscep (MIC) | Tiamulin suscep (MIC) |
| 35848-1 | Tiamulin [Susceptibility] | Tiamulin suscep (qual) | Tiamulin suscep (qual) |
| 35850-7 | Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Tilmicosin suscep (MIC) | Tilmicosin suscep (MIC) |
| 35851-5 | Tilmicosin [Susceptibility] | Tilmicosin suscep (qual) | Tilmicosin suscep (qual) |
| 35853-1 | Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Trospectinomycin suscep (MIC) | Trospectinomycin suscep (MIC) |
| 35854-9 | Trospectinomycin [Susceptibility] | Trospectinomycin suscep (qual) | Trospectinomycin suscep (qual) |
| 35857-2 | Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Tylosin suscep (MIC) | Tylosin suscep (MIC) |
| 35858-0 | Tylosin [Susceptibility] | Tylosin suscep (qual) | Tylosin suscep (qual) |
| 35860-6 | Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Virginiamycin suscep (MIC) | Virginiamycin suscep (MIC) |
| 35861-4 | Virginiamycin [Susceptibility] | Virginiamycin suscep (qual) | Virginiamycin suscep (qual) |
| 35863-0 | Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Voriconazole suscep (MIC) | Voriconazole suscep (MIC) |
| 359-0 | Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Netilmicin suscep (MIC) | Netilmicin suscep (MIC) |
| 363-2 | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) | Nitrofurantoin suscep (MIC) | Nitrofurantoin suscep (MIC) |
| 36-4 | Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Azithromycin suscep (MIC) | Azithromycin suscep (MIC) |
| 3644-2 | Fluoxetine [Mass/?volume] in Serum or Plasma | Fluoxetine | Fluoxetine |
| 3663-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak | Gentamicin peak | Gentamicin peak |
| 3665-7 | Gentamicin [Mass/volume] in Serum or Plasma --trough | Gentamicin trough | Gentamicin trough |
| 367-3 | Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Norfloxacin suscep (MIC) | Norfloxacin suscep (MIC) |
| 36903-3 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection | Lymphogranuloma venerum DNA (NAAT) | Lymphogranuloma venerum DNA (NAAT) |
| 3690-5 | Imipramine [Mass/?volume] in Serum or Plasma | Imipramine - mass/volume | Imipramine - mass/volume |
| 36916-5 | Kappa light chains.free [Mass/volume] in Serum | Immunoglobulin Light Chains kappa (free) | Immunoglobulin Light Chains kappa (free) |
| 36921-5 | Herpes simplex virus 1+?2 IgG Ab [Presence] in Serum | HSV Ab (Type 1 and 2) | HSV Ab (Type 1 and 2) |
| 371-5 | Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Novobiocin suscep (MIC) | Novobiocin suscep (MIC) |
| 375-6 | Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ofloxacin suscep (MIC) | Ofloxacin suscep (MIC) |
| 3772-1 | Methadone [Mass/?volume] in Serum or Plasma | Methadone - mass/volume | Methadone - mass/volume |
| 3773-9 | Methadone [Presence] in Urine | Methadone urine | Methadone urine |
| 379-8 | Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Oleandomycin suscep (MIC) | Oleandomycin suscep (MIC) |
| 38180-6 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | Hepatitis C Viral Load (logIU/mL) | Hepatitis C Viral Load (logIU/mL) |
| 3827-3 | Morphine [Mass/?volume] in Serum or Plasma | Morphine | Morphine |
| 383-0 | Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Oxacillin suscep (MIC) | Oxacillin suscep (MIC) |
| 3830-7 | Morphine [Presence] in Urine | Morphine urine | Morphine urine |
| 38370-3 | Voriconazole [Mass/?volume] in Serum or Plasma | Voriconazole | Voriconazole |
| 38379-4 | Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection | Mycobacterium complexDNA (NAAT) | Mycobacterium complexDNA (NAAT) |
| 38387-7 | C3 nephritic factor [Presence] in Serum or Plasma | C3 nephritic factor | C3 nephritic factor |
| 38445-3 | Calprotectin [Mass/?mass] in Stool | Calprotectin faeces | Calprotectin faeces |
| 38504-7 | Thyroglobulin Ab [Titer] in Serum by Immunoflourescence | Thyroglob Ab Titr Ser IF | Thyroglob Ab Titr Ser IF |
| 3862-0 | Nordoxepin [Mass/?volume] in Serum or Plasma | Nordoxepin - mass/volume | Nordoxepin - mass/volume |
| 387-1 | Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Oxytetracycline suscep (MIC) | Oxytetracycline suscep (MIC) |
| 3872-9 | Nortriptyline [Mass/?volume] in Serum or Plasma | Nortriptyline - mass/volume | Nortriptyline - mass/volume |
| 3879-4 | Opiates [Presence] in Urine | Opiates urine | Opiates urine |
| 38917-1 | Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Metapneumovirus (NAAT) | Metapneumovirus (NAAT) |
| 3893-5 | Oxycodone [Mass/?volume] in Serum or Plasma | Oxycodone | Oxycodone |
| 390-5 | Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Pefloxacin suscep (MIC) | Pefloxacin suscep (MIC) |
| 392-1 | Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC) | Penicillin G suscep (MIC) | Penicillin G suscep (MIC) |
| 3924-8 | Pentobarbital [Mass/?volume] in Serum or Plasma | Pentobarbitone | Pentobarbitone |
| 39354-6 | Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase | Cholinesterase phenotype | Cholinesterase phenotype |
| 3936-2 | Phencyclidine [Presence] in Urine | Phencyclidine urine | Phencyclidine urine |
| 39469-2 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | Cholesterol (LDL) (calculated) | Cholesterol (LDL) (calculated) |
| 39528-5 | Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection | Adenovirus DNA (NAAT) | Adenovirus DNA (NAAT) |
| 39536-8 | Influenza virus A Ab [Units/?volume] in Serum by Complement fixation | Influenza A Ab | Influenza A Ab |
| 396-2 | Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC) | Penicillin V suscep (MIC) | Penicillin V suscep (MIC) |
| 39771-1 | Porphyrins [Moles/?volume] in Urine | Porphyrins urine | Porphyrins urine |
| 39774-5 | Porphyrins [Moles/?mass] in Stool | Porphyrins faeces | Porphyrins faeces |
| 39782-8 | Delta aminolevulinate/?Creatinine [Molar ratio] in Urine | ALA/creatinine urine | ALA/creatinine urine |
| 39784-4 | Porphyrins [Moles/?volume] in Red Blood Cells | Porphyrin RBC | Porphyrin RBC |
| 39798-4 | Warfarin [Moles/?volume] in Serum or Plasma | Warfarin | Warfarin |
| 400-2 | Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Phenethicillin suscep (MIC) | Phenethicillin suscep (MIC) |
| 4020-4 | Quinine [Presence] in Urine | Quinine - presence | Quinine - presence |
| 4023-8 | Salicylates [Presence] in Serum or Plasma | Salicylate -presence | Salicylate -presence |
| 4025-3 | Salicylates [Presence] in Urine | Salicylate urine | Salicylate urine |
| 40417-8 | Chromium [Moles/?time] in 24 hour Urine | Chromium urine 24hr | Chromium urine 24hr |
| 404-4 | Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) | Pipemidate suscep (MIC) | Pipemidate suscep (MIC) |
| 40440-0 | XXX microorganism serotype [Identifier] in Isolate by Agglutination | Micro-organism (serotyping) | Micro-organism (serotyping) |
| 40498-8 | Yersinia enterocolitica Ab [Titer] in Serum by Agglutination | Yersinia Ab | Yersinia Ab |
| 4057-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak | Tobramycin peak | Tobramycin peak |
| 4059-2 | Tobramycin [Mass/volume] in Serum or Plasma --trough | Tobramycin trough | Tobramycin trough |
| 40-6 | Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Azlocillin suscep (MIC) | Azlocillin suscep (MIC) |
| 40614-0 | Brucella sp Ab [Presence] in Serum by Agglutination | Brucella sp Ab (qual) | Brucella sp Ab (qual) |
| 40658-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay | Parvovirus Ab IgM | Parvovirus Ab IgM |
| 40674-4 | Toxocara canis IgG Ab [Presence] in Serum by Immunoassay | Toxocara Ab IgG | Toxocara Ab IgG |
| 40727-0 | Hepatitis D virus Ab [Presence] in Serum by Immunoassay | Hepatitis D Ab | Hepatitis D Ab |
| 40745-2 | Filaria identified in Blood | Filaria blood | Filaria blood |
| 40768-4 | Cryptococcus sp Ag [Titer] in Serum | Cryptococcus Ag (titre) | Cryptococcus Ag (titre) |
| 408-5 | Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Piperacillin suscep (MIC) | Piperacillin suscep (MIC) |
| 4092-3 | Vancomycin [Mass/volume] in Serum or Plasma --trough | Vancomycin trough | Vancomycin trough |
| 40958-1 | Cryptosporidium parvum identified in Stool | Cryptosporidium identification faeces | Cryptosporidium identification faeces |
| 40982-1 | Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection | Influenza B RNA (NAAT) | Influenza B RNA (NAAT) |
| 40988-8 | Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection | RSV (NAAT) | RSV (NAAT) |
| 41001-9 | Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Coronavirus RNA (NAAT) | Coronavirus RNA (NAAT) |
| 41010-0 | Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection | Parainfluenza virus 4 RNA (NAAT) | Parainfluenza virus 4 RNA (NAAT) |
| 41163-7 | Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection | T. pallidum (NAAT) | T. pallidum (NAAT) |
| 41171-0 | Collagen crosslinked C-telopeptide [Mass/?volume] in Serum or Plasma | C- Telopeptide | C- Telopeptide |
| 412-7 | Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Piperacillin Tazob suscep MIC | Piperacillin Tazob suscep MIC |
| 41479-7 | BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | BK virus (NAAT) | BK virus (NAAT) |
| 41499-5 | Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay | Legionella sero-group 1 Ag (urine) (EIA) | Legionella sero-group 1 Ag (urine) (EIA) |
| 41647-9 | Carbon dioxide, total [Moles/?volume] in Arterial blood by calculation | CO2 blood ( total) In Arterial blood | CO2 blood ( total) In Arterial blood |
| 41662-8 | Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Aztreonam Clav suscep (MIC) | Aztreonam Clav suscep (MIC) |
| 41665-1 | Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Biapenem suscep (MIC) | Biapenem suscep (MIC) |
| 41672-7 | Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefotetan Clav suscep (MIC) | Cefotetan Clav suscep (MIC) |
| 41675-0 | Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefoxitin Clav suscep (MIC) | Cefoxitin Clav suscep (MIC) |
| 41679-2 | Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefpodoxime Clav suscep (MIC) | Cefpodoxime Clav suscep (MIC) |
| 416-8 | Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Pivampicillin suscep (MIC) | Pivampicillin suscep (MIC) |
| 41681-8 | Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftriaxone Clav suscep (MIC) | Ceftriaxone Clav suscep (MIC) |
| 41687-5 | Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Clavulanate suscep (MIC) | Clavulanate suscep (MIC) |
| 41689-1 | Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dalbavancin suscep (MIC) | Dalbavancin suscep (MIC) |
| 41694-1 | Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Everninomicin suscep (MIC) | Everninomicin suscep (MIC) |
| 41708-9 | Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Oritavancin suscep (MIC) | Oritavancin suscep (MIC) |
| 41710-5 | Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ramoplanin suscep (MIC) | Ramoplanin suscep (MIC) |
| 41713-9 | Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Rosamicin suscep (MIC) | Rosamicin suscep (MIC) |
| 41718-8 | Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Sulbactam suscep (MIC) | Sulbactam suscep (MIC) |
| 41721-2 | Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Tazobactam suscep (MIC) | Tazobactam suscep (MIC) |
| 41725-3 | Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Thiamphenicol suscep (MIC) | Thiamphenicol suscep (MIC) |
| 41727-9 | Aztreonam+Clavulanate [Susceptibility] | Aztreonam Clav suscep (qual) | Aztreonam Clav suscep (qual) |
| 41728-7 | Biapenem [Susceptibility] | Biapenem suscep (qual) | Biapenem suscep (qual) |
| 41729-5 | Cefotetan+Clavulanate [Susceptibility] | Cefotetan Clav suscep (qual) | Cefotetan Clav suscep (qual) |
| 41730-3 | Cefoxitin+Clavulanate [Susceptibility] | Cefoxitin Clav suscep (qual) | Cefoxitin Clav suscep (qual) |
| 41731-1 | Cefpodoxime+Clavulanate [Susceptibility] | Cefpodoxime Clav suscep (qual) | Cefpodoxime Clav suscep (qual) |
| 41732-9 | Ceftriaxone+Clavulanate [Susceptibility] | Ceftriaxone Clav suscep (qual) | Ceftriaxone Clav suscep (qual) |
| 41733-7 | Clavulanate [Susceptibility] | Clavulanate suscep (qual) | Clavulanate suscep (qual) |
| 41734-5 | Dalbavancin [Susceptibility] | Dalbavancin suscep (qual) | Dalbavancin suscep (qual) |
| 41735-2 | Everninomicin [Susceptibility] | Everninomicin suscep (qual) | Everninomicin suscep (qual) |
| 41736-0 | Oritavancin [Susceptibility] | Oritavancin suscep (qual) | Oritavancin suscep (qual) |
| 41737-8 | Ramoplanin [Susceptibility] | Ramoplanin suscep (qual) | Ramoplanin suscep (qual) |
| 41738-6 | Rosamicin [Susceptibility] | Rosamicin suscep (qual) | Rosamicin suscep (qual) |
| 41739-4 | Sulbactam [Susceptibility] | Sulbactam suscep (qual) | Sulbactam suscep (qual) |
| 41740-2 | Tazobactam [Susceptibility] | Tazobactam suscep (qual) | Tazobactam suscep (qual) |
| 41853-3 | Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection | Orthopoxvirus DNA NAA+probe Ql (Specimen) | Orthopoxvirus DNA NAA+probe Ql (Specimen) |
| 41858-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine | EDDP urine | EDDP urine |
| 41984-6 | Lipoprotein analysis status/?results Set CPHS | Lipid Interpretation | Lipid Interpretation |
| 41993-7 | Atazanavir [Susceptibility] | Atazanavir suscep (qual) | Atazanavir suscep (qual) |
| 420-0 | Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC) | Polymyxin B suscep (MIC) | Polymyxin B suscep (MIC) |
| 42180-0 | C peptide [Moles/?volume] in Serum or Plasma --fasting | C-Peptide | C-Peptide |
| 42200-6 | DNA double strand Ab [Units/?volume] in Serum by Radioimmunoassay (RIA) | DS DNA Ab (RIA) | DS DNA Ab (RIA) |
| 42217-0 | Striated muscle IgG Ab [Titer] in Serum | Skeletal muscle Ab | Skeletal muscle Ab |
| 42219-6 | Chromium [Moles/?volume] in Urine | Chromium urine | Chromium urine |
| 42221-2 | Manganese [Moles/?volume] in Urine | Manganese urine - moles/volume | Manganese urine - moles/volume |
| 42247-7 | Hemoglobin pattern [interpretation] in Blood by HPLC Narrative | HPLC Chromatogram | HPLC Chromatogram |
| 42330-1 | Bordetella pertussis IgG Ab [Units/?volume] in Serum by Immunoassay | Bordetella IgG Ab | Bordetella IgG Ab |
| 42351-7 | Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefepime Clav suscep (MIC) | Cefepime Clav suscep (MIC) |
| 42353-3 | Cefepime+Clavulanate [Susceptibility] | Cefepime Clavu suscep (qual) | Cefepime Clavu suscep (qual) |
| 42355-8 | Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Tigecycline suscep (MIC) | Tigecycline suscep (MIC) |
| 42357-4 | Tigecycline [Susceptibility] | Tigecycline suscep (qual) | Tigecycline suscep (qual) |
| 424-2 | Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Pyrazinamide suscep (MIC) | Pyrazinamide suscep (MIC) |
| 42535-5 | Tipranavir [Susceptibility] | Tipranavir suscep (qual) | Tipranavir suscep (qual) |
| 42595-9 | Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | Hepatitis B Viral Load (IU/mL) | Hepatitis B Viral Load (IU/mL) |
| 42807-8 | Parasite identified in Isolate | Parasite (ident) | Parasite (ident) |
| 428-3 | Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) | Rifampin suscep (MIC) | Rifampin suscep (MIC) |
| 43092-6 | Arbovirus NOS Ab [Titer] in Serum | Arbovirus Ab (titre) | Arbovirus Ab (titre) |
| 43180-9 | Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay | HSV Ab (Type 2) | HSV Ab (Type 2) |
| 43198-1 | Gamma hydroxybutyrate [Mass/?volume] in Urine by Confirmatory method | Gamma hydroxybutyrate urine - mass/volume | Gamma hydroxybutyrate urine - mass/volume |
| 432-5 | Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ristocetin suscep (MIC) | Ristocetin suscep (MIC) |
| 43271-6 | Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC) | Ceftobiprole suscep (MIC) | Ceftobiprole suscep (MIC) |
| 43272-4 | Ceftobiprole [Susceptibility] | Ceftobiprole suscep (qual) | Ceftobiprole suscep (qual) |
| 43279-9 | Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection | Hepatitis B virus mutation | Hepatitis B virus mutation |
| 43583-4 | Lipoprotein a [Moles/?volume] in Serum or Plasma | Lipoprotein (a) - moles/volume | Lipoprotein (a) - moles/volume |
| 43590-9 | Rabies virus Ab [Units/?volume] in Serum by Immunoassay | Rabies Ab | Rabies Ab |
| 436-6 | Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Rolitetracycline suscep (MIC) | Rolitetracycline suscep (MIC) |
| 43913-3 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection | Bordetella DNA (NAAT) | Bordetella DNA (NAAT) |
| 43979-4 | Aspergillus sp identified in Unspecified specimen by Organism specific culture | Aspergillus culture | Aspergillus culture |
| 440-8 | Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Rosoxacin suscep (MIC) | Rosoxacin suscep (MIC) |
| 44357-2 | Galactomannan Ag [Units/?volume] in Serum or Plasma by Immunoassay | Galactomannan Ag | Galactomannan Ag |
| 444-0 | Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Roxithromycin suscep (MIC) | Roxithromycin suscep (MIC) |
| 44448-9 | Beta 2 glycoprotein 1 IgG Ab [Units/?volume] in Serum or Plasma by Immunoassay | Beta-2-Glycoprotein 1 antibodies | Beta-2-Glycoprotein 1 antibodies |
| 44534-6 | HLA Ab [Presence] in Serum | HLA Antibodies (qual) | HLA Antibodies (qual) |
| 4476-8 | Complement C1 esterase inhibitor.functional [Mass/?volume] in Serum or Plasma | C1 Inhibitor function | C1 Inhibitor function |
| 4477-6 | Complement C1 esterase inhibitor [Mass/?volume] in Serum or Plasma | C1 inhibitor | C1 inhibitor |
| 44798-7 | Burkholderia sp identified in Unspecified specimen by Organism specific culture | Burkholderia (culture) | Burkholderia (culture) |
| 44-8 | Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) | Aztreonam suscep (MIC) | Aztreonam suscep (MIC) |
| 448-1 | Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Sisomicin suscep (MIC) | Sisomicin suscep (MIC) |
| 4484-2 | Complement C2 [Mass/?volume] in Serum or Plasma | C2 | C2 |
| 4485-9 | Complement C3 [Mass/?volume] in Serum or Plasma | C3 | C3 |
| 44918-1 | Dopamine/Creatinine [Molar ratio] in 24 hour Urine | Dopamine/creat urine 24h | Dopamine/creat urine 24h |
| 44924-9 | Normetanephrine/?Creatinine [Molar ratio] in 24 hour Urine | Normetanephrine/creat urine 24h | Normetanephrine/creat urine 24h |
| 4498-2 | Complement C4 [Mass/?volume] in Serum or Plasma | C4 | C4 |
| 4505-4 | Complement C5 [Mass/?volume] in Serum or Plasma | C5 | C5 |
| 4507-0 | Complement C6 [Mass/?volume] in Serum or Plasma | C6 | C6 |
| 4508-8 | Complement C7 [Mass/?volume] in Serum or Plasma | C7 | C7 |
| 4509-6 | Complement C8 [Mass/?volume] in Serum or Plasma | C8 | C8 |
| 4510-4 | Complement C9 [Mass/?volume] in Serum or Plasma | C9 | C9 |
| 4519-5 | Complement factor H [Mass/?volume] in Serum or Plasma | Factor H, I, CD46 Complement [Complement Factor H] | Factor H, I, CD46 Complement [Complement Factor H] |
| 452-3 | Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Spectinomycin suscep (MIC) | Spectinomycin suscep (MIC) |
| 45323-3 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood | Tuberculin test (interferon) | Tuberculin test (interferon) |
| 45335-7 | Bacteria Identification [Presence] in Isolate by Culture | Micro-organism (ident) | Micro-organism (ident) |
| 4542-7 | Haptoglobin [Mass/?volume] in Serum or Plasma | Haptoglobin | Haptoglobin |
| 4548-4 | Hemoglobin A1c/Hemoglobin.total in Blood | HbA1c | HbA1c |
| 4551-8 | Hemoglobin A2/Hemoglobin.total in Blood | HbA2 | HbA2 |
| 456-4 | Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Spiramycin suscep (MIC) | Spiramycin suscep (MIC) |
| 4576-5 | Hemoglobin F/Hemoglobin.total in Blood | HbF | HbF |
| 460-6 | Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Streptomycin suscep (MIC) | Streptomycin suscep (MIC) |
| 46094-9 | Plasmodium sp Ag [Presence] in Blood by Immunoassay | Malaria Ag (EIA) | Malaria Ag (EIA) |
| 46126-9 | Endomysium IgA Ab [Presence] in Serum by Immunofluorescence | Endomysial Ab IgA | Endomysial Ab IgA |
| 46127-7 | Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry | Haptoglobin by Nephelometry | Haptoglobin by Nephelometry |
| 46128-5 | Tissue transglutaminase IgA Ab [Units/?volume] in Serum by Immunoassay | TTG Ab IgA | TTG Ab IgA |
| 46130-1 | Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry | Pre albumin | Pre albumin |
| 46218-4 | 5-Fluorocytosine [Moles/?volume] in Serum or Plasma | Flucytosine | Flucytosine |
| 46266-3 | Myeloperoxidase Ab [Units/?volume] in Serum by Immunoassay | Myeloperoxidase Ab | Myeloperoxidase Ab |
| 46267-1 | Proteinase 3 Ab [Units/?volume] in Serum by Immunoassay | Proteinase 3 Ab | Proteinase 3 Ab |
| 46268-9 | ABO +? Rh group [Type] in Blood from Blood product unit--after transfusion reaction | ABO +? Rh Group (Blood Product Post Tx Rxn) | ABO +? Rh Group (Blood Product Post Tx Rxn) |
| 46270-5 | ABO group [Type] in Blood--after transfusion reaction | ABO Group (Post Tx Rxn) | ABO Group (Post Tx Rxn) |
| 46271-3 | Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction | Blood Group Ab (screen Post Tx Rxn) | Blood Group Ab (screen Post Tx Rxn) |
| 46272-1 | Appearance of Urine--after transfusion reaction | Appearance Urine (Post Tx Rxn) | Appearance Urine (Post Tx Rxn) |
| 46273-9 | Appearance of Serum--after transfusion reaction | Appearance Serum (Post Tx Rxn) | Appearance Serum (Post Tx Rxn) |
| 46274-7 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction | AHG (direct, polyspecific Post Tx Rxn) | AHG (direct, polyspecific Post Tx Rxn) |
| 46276-2 | Rh [Type] in Blood--after transfusion reaction | Rh Group (Post Tx Rxn) | Rh Group (Post Tx Rxn) |
| 4633-4 | Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method | HbF (Kleihauer) | HbF (Kleihauer) |
| 4639-1 | Unstable Hemoglobin [Presence] in Red Blood Cells | Hb (unstable) | Hb (unstable) |
| 4644-1 | Hemosiderin [Presence] in Urine | Haemosiderin | Haemosiderin |
| 464-8 | Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC) | Sulfadiazine suscep (MIC) | Sulfadiazine suscep (MIC) |
| 4679-7 | Reticulocytes/100 erythrocytes in Blood | Reticulocytes (%) | Reticulocytes (%) |
| 4685-4 | Sulfhemoglobin/Hemoglobin.total in Blood | Sulphaemoglobin | Sulphaemoglobin |
| 468-9 | Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Sulfamethoxazole suscep (MIC) | Sulfamethoxazole suscep (MIC) |
| 4691-2 | Viscosity of Plasma | Viscosity | Viscosity |
| 47092-2 | Natriuretic peptide B [Moles/?volume] in Serum or Plasma | BNP | BNP |
| 472-1 | Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Sulfisoxazole suscep (MIC) | Sulfisoxazole suscep (MIC) |
| 47255-5 | Procollagen type I.N-terminal propeptide [Mass/volume] in Serum | Procollagen | Procollagen |
| 47299-3 | DNA double strand Ab [Units/?volume] in Serum by Farr method | DS DNA Ab (Farr) | DS DNA Ab (Farr) |
| 47309-0 | Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/?1st specimen | H Influenza Type2 vaccine response | H Influenza Type2 vaccine response |
| 47393-4 | Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay | DGP/MGP Ab IgA | DGP/MGP Ab IgA |
| 47394-2 | Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay | Gliadin peptide | Gliadin peptide |
| 47532-7 | Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection | Mumps RNA (NAAT) | Mumps RNA (NAAT) |
| 47545-9 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine | 5HIAA/creat urine 24h | 5HIAA/creat urine 24h |
| 47596-2 | Calcium.ionized [Moles/?volume] in Blood by Ion-selective membrane electrode (ISE) | Calcium ( ionised) blood | Calcium ( ionised) blood |
| 476-2 | Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Sulfonamide suscep (MIC) | Sulfonamide suscep (MIC) |
| 47828-9 | Adiponectin [Mass/?volume] in Serum or Plasma | Adiponectin | Adiponectin |
| 47994-9 | Bilirubin.total [Moles/?volume] in Cord blood | Bilirubin cord | Bilirubin cord |
| 480-4 | Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Talampicillin suscep (MIC) | Talampicillin suscep (MIC) |
| 48062-4 | Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence | Cryptosporidium & Giardia Ag faeces (IF) | Cryptosporidium & Giardia Ag faeces (IF) |
| 48063-2 | Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay | Cryptosporidium & Giardia Ag | Cryptosporidium & Giardia Ag |
| 48111-9 | Glutathione.reduced [Moles/?mass] in Red Blood Cells | Reduced glutathione | Reduced glutathione |
| 48326-3 | Glipizide [Presence] in Serum or Plasma | Glipizide | Glipizide |
| 48327-1 | Glyburide [Presence] in Serum or Plasma | Glibenclamide | Glibenclamide |
| 48329-7 | Chlorpropamide [Presence] in Serum or Plasma | Chlorpropamide | Chlorpropamide |
| 48344-6 | Activated clotting time.kaolin induced of Platelet poor plasma | KCT | KCT |
| 48357-8 | Testosterone [Moles/?volume] in Saliva (oral fluid) | Testosterone saliva | Testosterone saliva |
| 48359-4 | Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination | Hydatid Ab (titre) | Hydatid Ab (titre) |
| 48377-6 | Mullerian inhibiting substance [Moles/?volume] in Serum or Plasma | Mullerian Hormone Ab | Mullerian Hormone Ab |
| 48378-4 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum | Immunoglobulin Light Chains (free) | Immunoglobulin Light Chains (free) |
| 48391-7 | Carbon dioxide, total [Moles/?volume] in Venous blood by calculation | CO2 blood ( total) in Venous blood | CO2 blood ( total) in Venous blood |
| 48398-2 | Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | Hepatitis B Viral Load (log IU/mL) | Hepatitis B Viral Load (log IU/mL) |
| 48419-6 | Immune complex.IgG [Mass/?volume] in Serum or Plasma by C1q binding assay | C1q Binding Assay | C1q Binding Assay |
| 48425-3 | Troponin T.cardiac [Mass/?volume] in Blood | Troponin T (rapid) | Troponin T (rapid) |
| 48432-9 | Fructose [Molar amount] in unspecified time Semen | Fructose seminal fluid (unspecified time) | Fructose seminal fluid (unspecified time) |
| 484-6 | Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) | Teicoplanin suscep (MIC) | Teicoplanin suscep (MIC) |
| 48508-6 | Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection | Measles RNA (NAAT) | Measles RNA (NAAT) |
| 48509-4 | Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection | Influenza A+B RNA (NAAT) | Influenza A+B RNA (NAAT) |
| 48618-3 | Cholesterol in VLDL [Mass/?volume] in Serum or Plasma ultracentrifugate | Cholesterol in VLDL | Cholesterol in VLDL |
| 48721-5 | Bartonella henselae IgG Ab [Units/?volume] in Serum by Immunofluorescence | Bartonella Ab | Bartonella Ab |
| 48807-2 | Bone marrow aspiration report | Bone marrow aspirate | Bone marrow aspirate |
| 488-7 | Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Temafloxacin suscep (MIC) | Temafloxacin suscep (MIC) |
| 48-9 | Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Bacampicillin suscep (MIC) | Bacampicillin suscep (MIC) |
| 49117-5 | Norovirus Ag [Presence] in Stool | Norovirus Ag faeces | Norovirus Ag faeces |
| 49233-0 | Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes | Cryptosporidium & Giardia Ag Rapid | Cryptosporidium & Giardia Ag Rapid |
| 49243-9 | Alkaline phosphatase isoenzymes [interpretation] in Serum or Plasma Narrative | Alk Phosphatase isoenzymes | Alk Phosphatase isoenzymes |
| 49244-7 | Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative | Alpha 1 antitrypsin phenotyping | Alpha 1 antitrypsin phenotyping |
| 49248-8 | Amino acid pattern [interpretation] in Urine Narrative | Amino Acids urine (pattern) | Amino Acids urine (pattern) |
| 49252-0 | Calculus analysis [interpretation] in Stone Narrative | Calculus analysis stone | Calculus analysis stone |
| 49268-6 | Glycosaminoglycans pattern [interpretation] in Urine Narrative | Glycosamino Glycan urine (pattern) | Glycosamino Glycan urine (pattern) |
| 49279-3 | Lactate dehydrogenase isoenzymes [interpretation] in Serum or Plasma Narrative | LDH isoenzymes (electrophoresis) | LDH isoenzymes (electrophoresis) |
| 492-9 | Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Temocillin suscep (MIC) | Temocillin suscep (MIC) |
| 49290-0 | Porphyrins [interpretation] in Stool Narrative | Porphyrin full analysis faeces | Porphyrin full analysis faeces |
| 49291-8 | Porphyrins [interpretation] in Urine Narrative | Porphyrin full analysis (HPLC) urine | Porphyrin full analysis (HPLC) urine |
| 49308-0 | Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative | Neutrophil cytoplasmic Ab (interpretation) | Neutrophil cytoplasmic Ab (interpretation) |
| 49316-3 | Hemoglobin pattern [interpretation] in Blood by Electrophoresis | Haemoglobin pattern | Haemoglobin pattern |
| 49323-9 | Hemoglobin pattern [interpretation] in Blood by Electrophesis citrate agar | Hb electrophoresis - acid gel | Hb electrophoresis - acid gel |
| 496-0 | Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Tetracycline suscep (MIC) | Tetracycline suscep (MIC) |
| 49671-1 | Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection | N. meningitidis DNA (NAAT) | N. meningitidis DNA (NAAT) |
| 49755-2 | Crystals [Presence] in Urine sediment by Light microscopy | Crystals urine - presence | Crystals urine - presence |
| 49836-0 | Platelet function (closure time) [interpretation] in Blood Narrative | PFA interpretation | PFA interpretation |
| 49863-4 | Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection | Aspergillus DNA (NAAT) | Aspergillus DNA (NAAT) |
| 4996-5 | Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection | CMV DNA (NAAT) (Blood) | CMV DNA (NAAT) (Blood) |
| 5000-5 | Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection | CMV DNA (NAAT) | CMV DNA (NAAT) |
| 500-9 | Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Ticarcillin suscep (MIC) | Ticarcillin suscep (MIC) |
| 5014-6 | Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection | HSV DNA (NAAT) | HSV DNA (NAAT) |
| 50377-1 | von Willebrand factor (vWf).collagen binding activity actual/?normal in Platelet poor plasma by Immunoassay | VWF:CBA | VWF:CBA |
| 50378-9 | von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay | VWF:CBA - ratio | VWF:CBA - ratio |
| 504-1 | Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Ticarcillin Clav suscep (MIC) | Ticarcillin Clav suscep (MIC) |
| 50410-0 | dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) | Dilute Russell viper venom time - screen to confirm ratio | Dilute Russell viper venom time - screen to confirm ratio |
| 5043-5 | Adrenal Ab [Titer] in Serum by Immunofluorescence | Adrenal Ab (titre) by Immunofluorescence | Adrenal Ab (titre) by Immunofluorescence |
| 5052-6 | Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) | Aspergillus Ab (precipitins) | Aspergillus Ab (precipitins) |
| 50544-6 | Everolimus [Mass/?volume] in Blood | Everolimus blood | Everolimus blood |
| 50548-7 | Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection | Resp virus DNA+RNA XXX NAA+probe | Resp virus DNA+RNA XXX NAA+probe |
| 50592-5 | Ecgonine methyl ester [Mass/?volume] in Urine by Confirmatory method | Ecgonine | Ecgonine |
| 5064-1 | Borrelia burgdorferi IgM Ab [Units/?volume] in Serum by Immunoassay | Lyme Disease Ab | Lyme Disease Ab |
| 50761-6 | A IgG Ab [Titer] in Serum or Plasma | Anti-A IgG (titre) | Anti-A IgG (titre) |
| 50762-4 | A IgM Ab [Titer] in Serum or Plasma | Anti-A (IgM) Titre | Anti-A (IgM) Titre |
| 50763-2 | B IgM Ab [Titer] in Serum or Plasma | Anti-B (IgM) Titre | Anti-B (IgM) Titre |
| 50764-0 | B IgG Ab [Titer] in Serum or Plasma | Anti-B IgG (Titre) | Anti-B IgG (Titre) |
| 508-2 | Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Tobramycin suscep (MIC) | Tobramycin suscep (MIC) |
| 50903-4 | Selenium [Moles/?volume] in Urine | Selenium urine | Selenium urine |
| 50936-4 | Vanadium [Moles/?volume] in Urine | Vanadium urine | Vanadium urine |
| 50968-7 | HLA Ab [Type] in Serum | HLA Antibodies (ident) | HLA Antibodies (ident) |
| 51164-2 | CD34 blasts [Units/?volume] in Bone marrow | CD34 Assay, bone marrow | CD34 Assay, bone marrow |
| 512-4 | Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC) | Trimethoprim suscep (MIC) | Trimethoprim suscep (MIC) |
| 5133-4 | Streptococcal DNAse B [Units/volume] in Serum | Strep DNAse B Ab | Strep DNAse B Ab |
| 51480-2 | Bacteria [#/volume] in Urine by Automated count | Bacteria count urine (auto) | Bacteria count urine (auto) |
| 51597-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO | Glucose (1h post 75g glucose) | Glucose (1h post 75g glucose) |
| 516-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Trimethoprim Sulfa suscep MIC | Trimethoprim Sulfa suscep MIC |
| 51694-8 | Carumonam [Susceptibility] | Carumonam suscep (qual) | Carumonam suscep (qual) |
| 51698-9 | Dapsone [Susceptibility] | Dapsone suscep (qual) | Dapsone suscep (qual) |
| 51710-2 | Leishmania sp identified in Unspecified specimen by Organism specific culture | Leishmania culture | Leishmania culture |
| 51719-3 | Paromomycin [Susceptibility] | Paramomycin suscep (qual) | Paramomycin suscep (qual) |
| 51724-3 | Cefuroxime [Susceptibility] | Cefuroxime suscep (qual) | Cefuroxime suscep (qual) |
| 51774-8 | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefuroxime suscep (MIC) | Cefuroxime suscep (MIC) |
| 51775-5 | Chromatin Ab [Units/?volume] in Serum or Plasma | Chromatin Ab | Chromatin Ab |
| 51776-3 | 7-Aminoclonazepam [Mass/?volume] in Urine by Confirmatory method | 7-aminoclonazepam urine | 7-aminoclonazepam urine |
| 51777-1 | 7-Aminoflunitrazepam [Mass/?volume] in Urine by Confirmatory method | 7-aminoflunitrazepam urine by Confirmatory method | 7-aminoflunitrazepam urine by Confirmatory method |
| 51781-3 | Carbon dioxide, total [Moles/?volume] in Capillary blood by calculation | CO2 blood ( total) - in Capillary blood | CO2 blood ( total) - in Capillary blood |
| 51844-9 | Cortisol [Moles/?volume] in Saliva (oral fluid) | Cortisol saliva | Cortisol saliva |
| 51916-5 | Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | HSV Ab (Type 1) | HSV Ab (Type 1) |
| 5195-3 | Hepatitis B virus surface Ag [Presence] in Serum | Hepatitis B surface Ag | Hepatitis B surface Ag |
| 5199-5 | Hepatitis C virus Ab [Presence] in Serum by Immunoblot | Hepatitis C Ab (IB) | Hepatitis C Ab (IB) |
| 520-7 | Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Troleandomycin suscep (MIC) | Troleandomycin suscep (MIC) |
| 52-1 | Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Butirosin suscep (MIC) | Butirosin suscep (MIC) |
| 52114-6 | Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells | AHG (direct, IgG) | AHG (direct, IgG) |
| 5226-6 | HTLV I+II Ab [Units/volume] in Serum by Immunoassay | HTLV 1+2 Ab | HTLV 1+2 Ab |
| 5230-8 | Influenza virus B Ab [Titer] in Serum by Complement fixation | Influenza B Ab | Influenza B Ab |
| 524-9 | Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Vancomycin suscep (MIC) | Vancomycin suscep (MIC) |
| 5253-0 | Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay | M. pneumoniae Ab (qual) | M. pneumoniae Ab (qual) |
| 5265-4 | Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence | Islet cell autoantibody | Islet cell autoantibody |
| 5271-2 | Parietal cell Ab [Titer] in Serum by Immunofluorescence | Parietal cell Ab (titre) by Immunofluorescence | Parietal cell Ab (titre) by Immunofluorescence |
| 528-0 | Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Viomycin suscep (MIC) | Viomycin suscep (MIC) |
| 52901-6 | Vanadium/?Creatinine [Molar ratio] in Urine | Vanadium/creat urine | Vanadium/creat urine |
| 5290-2 | Reagin Ab [Presence] in Cerebral spinal fluid by VDRL | VDRL CSF (qual) | VDRL CSF (qual) |
| 52913-1 | Selenium [Moles/?volume] in Red Blood Cells | Selenium RBC | Selenium RBC |
| 52915-6 | Aluminum [Moles/?volume] in Urine | Aluminium urine | Aluminium urine |
| 52929-7 | Mercury/?Creatinine [Molar ratio] in 24 hour Urine | Mercury/creat urine 24hr | Mercury/creat urine 24hr |
| 5295-1 | Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence | RSV Ab (IF) | RSV Ab (IF) |
| 52961-0 | Paraquat [Presence] in Urine | Paraquat urine | Paraquat urine |
| 52984-2 | Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay | CMV IgG avidity | CMV IgG avidity |
| 53007-1 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence | PM-Scl Ab (IF) | PM-Scl Ab (IF) |
| 53020-4 | Complement C1q Ab [Presence] in Serum | C1q Ab | C1q Ab |
| 53115-2 | Immature granulocytes [#/?volume] in Blood by Automated count | Immature Granulocytes | Immature Granulocytes |
| 531-4 | Zidovudine [Susceptibility] | Zidovudine suscep (qual) | Zidovudine suscep (qual) |
| 53523-7 | Vasoactive intestinal peptide [Moles/?volume] in Serum or Plasma | Vasoactive Intestinal Peptide | Vasoactive Intestinal Peptide |
| 53556-7 | Erythrocytes.Plasmodium sp infected/?100 erythrocytes in Blood | Malaria parasite load | Malaria parasite load |
| 53622-7 | von Willebrand factor (vWf) cleaving protease actual/?normal in Platelet poor plasma by Chromogenic method | ADAMSTS-13 | ADAMSTS-13 |
| 5369-4 | Streptokinase Ab [Units/volume] in Serum | Streptokinase Ab | Streptokinase Ab |
| 5370-2 | Streptolysin O Ab [Units/volume] in Serum or Plasma | Streptolysin O Ab | Streptolysin O Ab |
| 53731-6 | Posaconazole [Mass/?volume] in Serum or Plasma | Posaconazole | Posaconazole |
| 53812-4 | Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC) | Micafungin (MIC) | Micafungin (MIC) |
| 5381-9 | Thyroglobulin Ab [Titer] in Serum by Latex agglutination | Thyroglob Ab Titr Ser LA | Thyroglob Ab Titr Ser LA |
| 53819-9 | Thiopurine methyltransferase [Enzymatic activity/?volume] in Blood | Thiopurine Methyl Transferase blood | Thiopurine Methyl Transferase blood |
| 5386-8 | Toxocara canis Ab [Units/?volume] in Serum by Immunoassay | Toxocara Ab | Toxocara Ab |
| 53903-1 | Collection method - Specimen | Spec collection/description | Spec collection/description |
| 5393-4 | Treponema pallidum Ab [Presence] in Serum by Immunofluorescence | Syphilis Confirmation | Syphilis Confirmation |
| 53946-0 | Escherichia coli shiga-like toxin identified in Unspecified specimen | Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - specimen | Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - specimen |
| 54067-4 | Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection | Cl. difficile DNA (NAAT) | Cl. difficile DNA (NAAT) |
| 54091-4 | Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection | Rubella (NAAT) | Rubella (NAAT) |
| 54187-0 | Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Posaconazole suscep (MIC) | Posaconazole suscep (MIC) |
| 54188-8 | Posaconazole [Susceptibility] | Posaconazole suscep (qual) | Posaconazole suscep (qual) |
| 54218-3 | CD3+?CD4+? (T4 helper) cells/?CD3+?CD8+? (T8 suppressor cells) cells [# Ratio] in Blood | lymphocyte markers - Cells.CD3+CD4+/Cells.CD3+CD8+ | lymphocyte markers - Cells.CD3+CD4+/Cells.CD3+CD8+ |
| 54285-2 | Glycerol [Moles/?volume] in Urine | Glycerol urine | Glycerol urine |
| 54309-0 | Lactate/?Pyruvate [Molar ratio] in Cerebral spinal fluid | Lactate/Pyruvate CSF | Lactate/Pyruvate CSF |
| 543-9 | Mycobacterium sp identified in Unspecified specimen by Organism specific culture | Mycobacterium (culture) | Mycobacterium (culture) |
| 54905-5 | Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection | Norovirus GI RNA (NAAT) | Norovirus GI RNA (NAAT) |
| 54906-3 | Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection | Norovirus GII RNA (NAAT) | Norovirus GII RNA (NAAT) |
| 54914-7 | Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay | Hepatitis C Ag | Hepatitis C Ag |
| 54941-0 | Tungsten [Mass/?volume] in Urine | Tungsten urine | Tungsten urine |
| 55100-2 | Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture | RSV culture | RSV culture |
| 55343-8 | Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) | Anidulafungin suscep (MIC) | Anidulafungin suscep (MIC) |
| 55580-5 | Sulfapyridine [Moles/?volume] in Serum or Plasma | Sulphapyridine | Sulphapyridine |
| 55581-3 | Sulfasalazine [Moles/?volume] in Serum or Plasma | Sulphasalazine | Sulphasalazine |
| 5568-1 | Acetone [Mass/?volume] in Serum or Plasma | Acetone | Acetone |
| 5570-7 | Acetone [Mass/?volume] in Urine | Acetone urine | Acetone urine |
| 55805-6 | Cyclosporine [Mass/?volume] in Blood by LC/?MS/?MS | Cyclosporin blood - by LC/MS/MS | Cyclosporin blood - by LC/MS/MS |
| 5581-4 | Antimony [Mass/?volume] in Urine | Antimony urine | Antimony urine |
| 5590-5 | Barium [Mass/?volume] in Urine | Barium urine | Barium urine |
| 5598-8 | Bismuth [Mass/?volume] in Urine | Bismuth urine | Bismuth urine |
| 560-3 | Chlamydia sp identified in Unspecified specimen by Organism specific culture | Chlamydia (culture) | Chlamydia (culture) |
| 56126-6 | Copper [Mass/?mass] in Liver | Copper liver | Copper liver |
| 56145-6 | CD55+?CD59 deficient RBC+?Granulocytes [interpretation] in Blood Narrative | PNH by flow cytometry | PNH by flow cytometry |
| 56-2 | Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Capreomycin suscep (MIC) | Capreomycin suscep (MIC) |
| 562-9 | Clostridioides difficile [Presence] in Stool by Organism specific culture | Cl.difficile culture | Cl.difficile culture |
| 5646-5 | Ethylene glycol [Mass/volume] in Serum, Plasma or Blood | Ethylene glycol - mass/volume | Ethylene glycol - mass/volume |
| 5647-3 | Ethylene glycol [Mass/?volume] in Urine | Ethylene glycol urine | Ethylene glycol urine |
| 56536-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay | Thyroglob Ab Ser EIA-aCnc | Thyroglob Ab Ser EIA-aCnc |
| 56537-4 | Tissue transglutaminase IgG Ab [Units/?volume] in Serum by Immunoassay | TTG Ab IgG | TTG Ab IgG |
| 56539-0 | Intrinsic factor Ab [Units/?volume] in Serum by Immunoassay | Intrinsic factor Ab | Intrinsic factor Ab |
| 56540-8 | Glutamate decarboxylase 65 Ab [Units/?volume] in Serum by Immunoassay | GAD Ab | GAD Ab |
| 56717-2 | Histone Ab [Presence] in Serum by Immunoblot | Histone Ab | Histone Ab |
| 56718-0 | Islet cell 512 Ab [Units/?volume] in Serum by Immunoassay | IA2 Ab | IA2 Ab |
| 56721-4 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot | PM-Scl Ab (IB) | PM-Scl Ab (IB) |
| 56722-2 | Soluble liver Ab [Presence] in Serum by Immunoblot | Soluble liver antibody | Soluble liver antibody |
| 567-8 | Diphtheria identified in Unspecified specimen by Organism specific culture | C. diphtheriae (culture) | C. diphtheriae (culture) |
| 5681-2 | Manganese [Mass/?volume] in Blood | Manganese blood - mass/volume | Manganese blood - mass/volume |
| 5684-6 | Manganese [Mass/?volume] in Urine | Manganese urine - mass/volume | Manganese urine - mass/volume |
| 56888-1 | HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay | HIV 1+2 Ab plus HIV1 Ag (qual) | HIV 1+2 Ab plus HIV1 Ag (qual) |
| 56940-0 | Inhibin B [Mass/?volume] in Serum or Plasma by Immunoassay | Inhibin B | Inhibin B |
| 56972-3 | Prolactin [Mass/?volume] in Serum or Plasma --post precipitation | Macroprolaction | Macroprolaction |
| 56991-3 | Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay | T. gondii IgG avidity | T. gondii IgG avidity |
| 5699-4 | Molybdenum [Mass/?volume] in Urine | Molybdenum urine | Molybdenum urine |
| 57028-3 | Iron [Mass/?mass] in Liver | Iron liver | Iron liver |
| 57095-2 | Anidulafungin [Susceptibility] | Anidulafungin suscep (qual) | Anidulafungin suscep (qual) |
| 5711-7 | Pentachlorophenol [Mass/?volume] in Urine | Pentachlorophenol urine | Pentachlorophenol urine |
| 5722-4 | Selenium [Mass/?volume] in Blood | Selenium blood | Selenium blood |
| 5734-9 | Silver [Mass/?volume] in Serum or Plasma | Silver | Silver |
| 5735-6 | Silver [Mass/?volume] in Urine | Silver urine | Silver urine |
| 57378-2 | Porphyrins/?Creatinine [Molar ratio] in Urine | Porphyrins/creat urine | Porphyrins/creat urine |
| 57416-0 | Thyrotropin receptor Ab [Units/?volume] in Serum by Immunoassay | TSH receptorAb | TSH receptorAb |
| 5745-5 | Thallium [Mass/?volume] in Urine | Thallium urine | Thallium urine |
| 57502-7 | 11-Deoxycortisol [Moles/?volume] in Serum or Plasma --1 day post dose metyrapone | 11-Deoxycortisol (1d p metyrapone) | 11-Deoxycortisol (1d p metyrapone) |
| 5770-3 | Bilirubin.total [Presence] in Urine by Test strip | Bilirubin urine (dipstick) | Bilirubin urine (dipstick) |
| 57734-6 | Ketones [Presence] in Urine by Automated test strip | Ketones urine (qual) | Ketones urine (qual) |
| 57744-5 | Striated muscle Ab [Presence] in Serum by Immunofluorescence | Striated muscle Antibody | Striated muscle Antibody |
| 57745-2 | Adrenal Ab [Presence] in Serum by Immunofluorescence | Adrenal Ab(qual) | Adrenal Ab(qual) |
| 57746-0 | Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method | Gamma hydroxybutyrate urine | Gamma hydroxybutyrate urine |
| 57761-9 | Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay | HITS - by Immunoassay | HITS - by Immunoassay |
| 5782-8 | Crystals [type] in Urine sediment by Light microscopy | Crystals urine - type | Crystals urine - type |
| 57838-5 | dRVVT W excess phospholipid (LA confirm) | dRVVT excess phospholipid (PPP) [Time] | dRVVT excess phospholipid (PPP) [Time] |
| 57844-3 | Imatinib mesylate [Mass/?volume] in Serum or Plasma | Imatinib | Imatinib |
| 57901-1 | Clostridioides difficile glutamate dehydrogenase [Presence] in Stool | Cl. difficile Ag | Cl. difficile Ag |
| 5794-3 | Hemoglobin [Presence] in Urine by Test strip | Haemoglobin urine (dipstick) | Haemoglobin urine (dipstick) |
| 5799-2 | Leukocyte esterase [Presence] in Urine by Test strip | Leuc esterase urine (dipstick) | Leuc esterase urine (dipstick) |
| 580-1 | Fungus identified in Unspecified specimen by Culture | Fungi (culture) | Fungi (culture) |
| 5802-4 | Nitrite [Presence] in Urine by Test strip | Nitrite urine (dipstick) | Nitrite urine (dipstick) |
| 5803-2 | pH of Urine by Test strip | pH urine (dipstick) | pH urine (dipstick) |
| 5811-5 | Specific gravity of Urine by Test strip | SG urine (dipstick) | SG urine (dipstick) |
| 5818-0 | Urobilinogen [Presence] in Urine by Test strip | Urobilinogen urine (dipstick) | Urobilinogen urine (dipstick) |
| 58416-9 | MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method | MLH12 promoter methylation testing | MLH12 promoter methylation testing |
| 58436-7 | Casts [Type] in Urine sediment by Light microscopy | Casts urine sediment (type) | Casts urine sediment (type) |
| 5843-8 | Enterovirus identified in Unspecified specimen by Organism specific culture | Enterovirus culture | Enterovirus culture |
| 5846-1 | Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence | HSV1 Ag (IF) | HSV1 Ag (IF) |
| 5849-5 | Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence | HSV2 Ag (IF) | HSV2 Ag (IF) |
| 5854-5 | Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay | HSV Ag (EIA) | HSV Ag (EIA) |
| 5855-2 | Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence | HSV Ag (IF) | HSV Ag (IF) |
| 58570-3 | Corticotropin [Moles/?volume] in Plasma --1 day post dose metyrapone | ACTH (1d p metyrapone) | ACTH (1d p metyrapone) |
| 5859-4 | Herpes simplex virus identified in Unspecified specimen by Organism specific culture | HSV (culture) | HSV (culture) |
| 586-8 | Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture | Group B Streptococcus (cult) | Group B Streptococcus (cult) |
| 587-6 | Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture | H.pylori culture | H.pylori culture |
| 5877-6 | Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence | RSV Ag | RSV Ag |
| 58897-0 | Methyl ethyl ketone/?Creatinine [Mass Ratio] in Urine | Methylethylketone urine | Methylethylketone urine |
| 58900-2 | HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay | HIV 1+2 Ab plus HIV1 Ag | HIV 1+2 Ab plus HIV1 Ag |
| 5894-1 | Prothrombin time (PT) actual/Normal | PR | PR |
| 590-0 | Legionella sp identified in Sputum by Organism specific culture | Legionella (culture) | Legionella (culture) |
| 5901-4 | Prothrombin time (PT) in control Platelet poor plasma by Coagulation assay | Prothrombin time (control) | Prothrombin time (control) |
| 5902-2 | Prothrombin time (PT) | Prothrombin time | Prothrombin time |
| 59070-3 | Paraquat [Presence] in Serum or Plasma | Paraquat | Paraquat |
| 5909-7 | Blood smear finding [Identifier] in Blood by Light microscopy | Blood film morphology | Blood film morphology |
| 59176-8 | Zopiclone [Presence] in Urine | Zopiclone urine | Zopiclone urine |
| 59186-7 | Cyanide [Moles/?volume] in Blood | Cyanide blood | Cyanide blood |
| 59261-8 | Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol | HbA1c by IFCC protocol | HbA1c by IFCC protocol |
| 59287-3 | Benzylpiperazine [Mass/?volume] in Urine | Benzylpiperazine (BZP) urine | Benzylpiperazine (BZP) urine |
| 59394-7 | Glomerular basement membrane Ab [Units/?volume] in Serum by Immunoassay | GBM Ab | GBM Ab |
| 594-2 | Leptospira sp identified in Unspecified specimen by Organism specific culture | Leptospira (culture) | Leptospira (culture) |
| 59420-0 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification | HPV DNA (NAAT) - in Cervix | HPV DNA (NAAT) - in Cervix |
| 5942-8 | Reptilase time in control Platelet poor plasma by Coagulation assay | Reptilase time (control) | Reptilase time (control) |
| 5946-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | APTT (+ N plasma) | APTT (+ N plasma) |
| 59472-1 | Calcium.ionized [Mass/?volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE) | Calcium (ph 7.4), blood | Calcium (ph 7.4), blood |
| 5949-3 | aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | APTT (+ N plasma, control) | APTT (+ N plasma, control) |
| 5955-0 | Thrombin time in control Platelet poor plasma by Coagulation assay | Thrombin time (control) | Thrombin time (control) |
| 5956-8 | Prothrombin time (PT) factor substitution in control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | PT (+ N plasma, control) | PT (+ N plasma, control) |
| 5959-2 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma | Prothrombin time (+ N plasma) | Prothrombin time (+ N plasma) |
| 59965-4 | Quinine [Moles/?volume] in Serum or Plasma | Quinine - moles volume | Quinine - moles volume |
| 60017-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction | LDH fluid by Pyruvate to lactate reaction | LDH fluid by Pyruvate to lactate reaction |
| 60023-9 | Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Pyruvate to lactate reaction | LDH CSF by Pyruvate to lactate reaction | LDH CSF by Pyruvate to lactate reaction |
| 60024-7 | Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Lactate to pyruvate reaction | LDH CSF by Lactate to pyruvate reaction | LDH CSF by Lactate to pyruvate reaction |
| 60088-2 | Hyoscyamine [Mass/?volume] in Urine | Hyoscyamine urine | Hyoscyamine urine |
| 6014-5 | von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation | VWF:Rco - by Platelet aggregation | VWF:Rco - by Platelet aggregation |
| 60-4 | Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Carbenicillin suscep (MIC) | Carbenicillin suscep (MIC) |
| 60422-3 | Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection | Measles genotype | Measles genotype |
| 60463-7 | Insulin Ab [Moles/?volume] in Serum | Insulin Ab | Insulin Ab |
| 60517-0 | Iron/?Transferrin [Ratio] in Serum or Plasma | Transferrin saturation - ratio | Transferrin saturation - ratio |
| 61030-3 | 7-Aminoclonazepam [Presence] in Urine | 7-aminoclonazepam urine | 7-aminoclonazepam urine |
| 61033-7 | 7-Aminoflunitrazepam [Presence] in Urine | 7-aminoflunitrazepam urine | 7-aminoflunitrazepam urine |
| 61036-0 | Alpha hydroxyalprazolam [Presence] in Urine | Alpha hydroxy alprazolam urine | Alpha hydroxy alprazolam urine |
| 61152-5 | Albumin [Mass/?volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method | Albumin by BCP | Albumin by BCP |
| 61365-3 | Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection | Parainfluenza virus RNA (NAAT) | Parainfluenza virus RNA (NAAT) |
| 61406-5 | XXX blood group Ab [Titer] in Serum or Plasma | Blood Group Ab (titre) | Blood Group Ab (titre) |
| 614-8 | Mycobacterium sp identified in Isolate by Mycobacterial subtyping | Mycobacterium (ident) | Mycobacterium (ident) |
| 62238-1 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (CKD-EPI) | eGFR | eGFR |
| 623-9 | Bacteria identified in Sputum by Cystic fibrosis respiratory culture | Sputum (cystic fibrosis, cult) | Sputum (cystic fibrosis, cult) |
| 62467-6 | Galactomannan Ag [Units/?volume] in Unspecified specimen by Immunoassay | Galactomannan Ag unspecified specimen | Galactomannan Ag unspecified specimen |
| 6298-4 | Potassium [Moles/volume] in Blood | Potassium blood | Potassium blood |
| 6301-6 | INR in Platelet poor plasma by Coagulation assay | INR | INR |
| 6303-2 | dRVVT (LA screen) | Dilute Russell viper venom time | Dilute Russell viper venom time |
| 6306-5 | Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay | Adenovirus faecal Ag | Adenovirus faecal Ag |
| 6317-2 | Bordetella sp identified in Unspecified specimen by Organism specific culture | Bordetella (culture) | Bordetella (culture) |
| 6325-5 | Brucella abortus Ab [Titer] in Serum by Complement fixation | Br. abortus Ab | Br. abortus Ab |
| 63437-8 | Brucella abortus Ab [Titer] in Serum by Antihuman globulin | Br. abortus Ab (AHG) | Br. abortus Ab (AHG) |
| 635-3 | Bacteria identified in Unspecified specimen by Anaerobe culture | Anaerobes (culture) | Anaerobes (culture) |
| 6354-5 | Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay | C. trachomatis Ag (EIA) | C. trachomatis Ag (EIA) |
| 6355-2 | Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence | C. trachomatis Ag (IF) | C. trachomatis Ag (IF) |
| 637-9 | Plasmodium sp identified in Blood by Thick film | Malaria thick blood film | Malaria thick blood film |
| 64013-6 | Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay | Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - stool | Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - stool |
| 64233-0 | Benzylpiperazine [Presence] in Urine by Confirmatory method | Benzylpiperazine (BZP) urine by Confirmatory method | Benzylpiperazine (BZP) urine by Confirmatory method |
| 6450-1 | Legionella sp Ab [Titer] in Serum by Immunofluorescence | Legionella sp Ab (IF) | Legionella sp Ab (IF) |
| 64-6 | Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefadroxil suscep (MIC) | Cefadroxil suscep (MIC) |
| 6463-4 | Bacteria identified in Unspecified specimen by Culture | Bacteria (culture) | Bacteria (culture) |
| 6476-6 | Mumps virus IgG Ab [Presence] in Serum by Immunoassay | Mumps IgG | Mumps IgG |
| 6478-2 | Mumps virus IgM Ab [Presence] in Serum by Immunoassay | Mumps IgM | Mumps IgM |
| 6486-5 | Mycoplasma sp identified in Unspecified specimen by Organism specific culture | Mycoplasma (culture) | Mycoplasma (culture) |
| 65340-2 | Micafungin [Susceptibility] | Micafungin (qual) | Micafungin (qual) |
| 6562-3 | Treponema pallidum IgM Ab [Presence] in Serum | Syphilis Ab IgM | Syphilis Ab IgM |
| 6579-7 | Vibrio sp identified in Stool by Organism specific culture | Vibrio culture | Vibrio culture |
| 6584-7 | Virus identified in Unspecified specimen by Culture | Viruses (culture) | Viruses (culture) |
| 6598-7 | Troponin T.cardiac [Mass/volume] in Serum or Plasma | Troponin T | Troponin T |
| 660-1 | Microscopic observation [Identifier] in Unspecified specimen by Dark field examination | Microscopy (dark field exam) | Microscopy (dark field exam) |
| 6604-3 | Influenza virus identified in Unspecified specimen by Organism specific culture | Influenza culture | Influenza culture |
| 6609-2 | Listeria sp identified in Unspecified specimen by Organism specific culture | Listeria (culture) | Listeria (culture) |
| 6630-8 | Schistosoma sp Ab [Presence] in Serum by Hemagglutination | Schistosomal Ab (qual) | Schistosomal Ab (qual) |
| 664-3 | Microscopic observation [Identifier] in Unspecified specimen by Gram stain | Microscopy (Gram stain) | Microscopy (Gram stain) |
| 6644-9 | Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefepime suscep (MIC) | Cefepime suscep (MIC) |
| 6652-2 | Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Meropenem suscep (MIC) | Meropenem suscep (MIC) |
| 666-8 | Microscopic observation [Identifier] in Unspecified specimen by India ink prep | Microscopy (Indian ink prep) | Microscopy (Indian ink prep) |
| 66736-0 | Normalized silica clotting time of Platelet poor plasma | Silica clotting time | Silica clotting time |
| 667-6 | Microscopic observation [Identifier] in Unspecified specimen by KOH preparation | Microscopy (KOH prep) | Microscopy (KOH prep) |
| 6683-7 | Reptilase time | Reptilase time | Reptilase time |
| 66878-0 | Skin Ab [Titer] in Serum | Skin Ab | Skin Ab |
| 6689-4 | Glucose [Mass/volume] in Blood -- 2 hours post meal | Glucose (2h post meal) blood | Glucose (2h post meal) blood |
| 6-7 | Amantadine [Susceptibility] | Amantadine suscep (qual) | Amantadine suscep (qual) |
| 6709-0 | Hippurate [Mass/?volume] in Urine | Hippurate urine - mass/volume | Hippurate urine - mass/volume |
| 675-9 | Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam | Pinworm examination | Pinworm examination |
| 6768-6 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | Alkaline phosphatase | Alkaline phosphatase |
| 678-3 | Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain | Microscopy (Trichrome stain) | Microscopy (Trichrome stain) |
| 680-9 | Microscopic observation [Identifier] in Unspecified specimen by Wet preparation | Microscopy (wet prep) | Microscopy (wet prep) |
| 6825-4 | Crystals [type] in Body fluid by Light microscopy | Crystals body fluid | Crystals body fluid |
| 6827-0 | Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC) | Bacitracin suscep (MIC) | Bacitracin suscep (MIC) |
| 68324-3 | von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay | VWF:Rco - by Immunoassay | VWF:Rco - by Immunoassay |
| 6864-3 | Hemoglobin S [Presence] in Blood by Solubility test | HbS (solubility) | HbS (solubility) |
| 68-7 | Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefamandole suscep (MIC) | Cefamandole suscep (MIC) |
| 6873-4 | Beta hydroxybutyrate [Moles/?volume] in Serum or Plasma | Beta hydroxybutyrate | Beta hydroxybutyrate |
| 6875-9 | Cancer Ag 15-3 [Units/?volume] in Serum or Plasma | CA 15-3 | CA 15-3 |
| 68916-6 | dRVVT W excess phospholipid actual/normal (normalized LA confirm) | Dilute Russell viper venom time - phospholipid actual/normal | Dilute Russell viper venom time - phospholipid actual/normal |
| 68936-4 | Baker's yeast Ab [Units/?volume] in Serum by Immunoassay | Anti Saccharomyces Cerevisiae Antibodies | Anti Saccharomyces Cerevisiae Antibodies |
| 68969-5 | Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method | KCTI | KCTI |
| 6913-8 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence | C. pneumoniae Ab (titre) | C. pneumoniae Ab (titre) |
| 6916-1 | Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence | C. psittaci Ab | C. psittaci Ab |
| 6932-8 | Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Penicillin suscep (MIC) | Penicillin suscep (MIC) |
| 6933-6 | Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Streptomycin high suscep (MIC) | Streptomycin high suscep (MIC) |
| 6948-4 | Lamotrigine [Mass/?volume] in Serum or Plasma | Lamotrigine - mass/volume | Lamotrigine - mass/volume |
| 6954-2 | Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence | Bartonella Ab (titre) | Bartonella Ab (titre) |
| 698-1 | Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture | N. gonorrhoeae (culture) | N. gonorrhoeae (culture) |
| 6984-9 | Beta lactamase.extended spectrum [Susceptibility] | B-lactamase ESBL (qual) | B-lactamase ESBL (qual) |
| 6985-6 | Beta lactamase.usual [Susceptibility] | B-lactamase usual (qual) | B-lactamase usual (qual) |
| 69935-5 | Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection | Mycoplasma DNA (NAAT) | Mycoplasma DNA (NAAT) |
| 69937-1 | Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection | Trichomonas (NAAT) | Trichomonas (NAAT) |
| 69938-9 | Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Astrovirus RNA (NAAT) | Astrovirus RNA (NAAT) |
| 69949-6 | Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay | EBV VCA IgG avidity | EBV VCA IgG avidity |
| 69951-2 | Amylase.pancreatic/Creatinine(Ratio) in Urine | Amylase (pancreatic)/creat ur | Amylase (pancreatic)/creat ur |
| 70061-7 | Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection | HPV DNA (NAAT) - Specimen | HPV DNA (NAAT) - Specimen |
| 70147-4 | Methadone [Mass/?volume] in Urine by Screen method | Methadone urine - mass/volume by Screen method | Methadone urine - mass/volume by Screen method |
| 7018-5 | Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Gentamicin high suscep (MIC) | Gentamicin high suscep (MIC) |
| 70205-0 | Clonazepam [Moles/?volume] in Serum or Plasma by Screen method | Clonazepam - by Screen method | Clonazepam - by Screen method |
| 7024-3 | Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Kanamycin high suscep (MIC) | Kanamycin high suscep (MIC) |
| 70569-9 | Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay | Malaria antigen | Malaria antigen |
| 7106-8 | Aspergillus sp IgE Ab [Units/?volume] in Serum | Aspergillus IgE | Aspergillus IgE |
| 716-1 | Heinz bodies [Presence] in Blood by Light microscopy | Heinz bodies | Heinz bodies |
| 71792-6 | Procollagen type III.N-terminal propeptide [Mass/volume] in Serum | P3NP | P3NP |
| 71793-4 | Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination | T. pallidum Ab (PA) | T. pallidum Ab (PA) |
| 718-7 | Hemoglobin [Mass/volume] in Blood | Haemoglobin | Haemoglobin |
| 72111-8 | Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Sapovirus RNA (NAAT) | Sapovirus RNA (NAAT) |
| 72160-5 | Holo-transcobalamin II [Moles/?volume] in Serum | Active B12 | Active B12 |
| 72493-0 | Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection | CMV Viral load (serum/plasma) | CMV Viral load (serum/plasma) |
| 725-2 | Hemoglobin [Presence] in Urine | Haemoglobin urine | Haemoglobin urine |
| 72624-0 | Rivaroxaban [Mass/?volume] in Serum or Plasma | Rivaroxaban Assay | Rivaroxaban Assay |
| 72625-7 | Dabigatran [Mass/?volume] in Serum or Plasma | Dabigatran assay | Dabigatran assay |
| 72-9 | Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefatrizine suscep (MIC) | Cefatrizine suscep (MIC) |
| 73654-6 | Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method | Hepatitis C genotyping (NS3) | Hepatitis C genotyping (NS3) |
| 73655-3 | Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method | Hepatitis C genotyping (NS5) | Hepatitis C genotyping (NS5) |
| 73723-9 | Riboflavin [Moles/?volume] in Blood | Vitamin B2 blood | Vitamin B2 blood |
| 74096-9 | Tacrolimus [Mass/?volume] in Blood by Immunoassay | Tacrolimus blood - by Immunoassay | Tacrolimus blood - by Immunoassay |
| 74097-7 | Tacrolimus [Mass/?volume] in Blood by LC/?MS/?MS | Tacrolimus blood - by LC/MS/MS | Tacrolimus blood - by LC/MS/MS |
| 74442-5 | Pyridoxal phosphate [Moles/?volume] in Blood | Vitamin B6 blood | Vitamin B6 blood |
| 75050-5 | Coenzyme Q10 [Moles/volume] in Serum or Plasma | Coenzyme Q10 | Coenzyme Q10 |
| 75515-7 | Lupus anticoagulant aPTT and dRVVT screening panel W Reflex | Lupus anticoagulant two screening tests W Reflex panel Coag (PPP) | Lupus anticoagulant two screening tests W Reflex panel Coag (PPP) |
| 76-0 | Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefazolin suscep (MIC) | Cefazolin suscep (MIC) |
| 76346-6 | Microorganism identified in Isolate by MS.MALDI-TOF | Micro-organism (ident MS.MALDI-TOF) | Micro-organism (ident MS.MALDI-TOF) |
| 7799-0 | Fibrin D-dimer [Units/volume] in Platelet poor plasma | D-dimer | D-dimer |
| 7808-9 | Aspergillus sp Ab [Presence] in Serum | Aspergillus precipitins | Aspergillus precipitins |
| 7852-7 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma | CMV IgG | CMV IgG |
| 7853-5 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma | CMV IgM | CMV IgM |
| 7883-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum | EBV NA IgG | EBV NA IgG |
| 7905-3 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test | Hep B (HBsAg) Surface Ag (Neut) | Hep B (HBsAg) Surface Ag (Neut) |
| 7906-1 | Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection | Hepatitis D DNA (NAAT) | Hepatitis D DNA (NAAT) |
| 7918-6 | HIV 1+2 Ab [Presence] in Serum | HIV1+2 Ab (screen) | HIV1+2 Ab (screen) |
| 7948-3 | Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence | Legionella sero-group 1 Ab (IF) | Legionella sero-group 1 Ab (IF) |
| 7959-0 | Leptospira sp Ab [Titer] in Serum | Leptospira Ab (screen) (titre) | Leptospira Ab (screen) (titre) |
| 7968-1 | Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | Mumps RNA (NAAT) CSF | Mumps RNA (NAAT) CSF |
| 7993-9 | Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection | Rhinoviurs (NAAT) | Rhinoviurs (NAAT) |
| 7994-7 | Rickettsia sp Ab [Units/?volume] in Serum | Rickettsia Ab | Rickettsia Ab |
| 8012-7 | Rotavirus dsRNA [Presence] in Stool by NAA with probe detection | Rotavirus RNA (NAAT) | Rotavirus RNA (NAAT) |
| 8013-5 | Rubella virus Ab [Units/volume] in Serum | Rubella Ab | Rubella Ab |
| 8014-3 | Rubella virus IgG Ab [Units/volume] in Serum | Rubella IgG | Rubella IgG |
| 8015-0 | Rubella virus IgM Ab [Units/volume] in Serum | Rubella IgM | Rubella IgM |
| 80-2 | Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefixime suscep (MIC) | Cefixime suscep (MIC) |
| 8039-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum | T. gondii IgG | T. gondii IgG |
| 8040-8 | Toxoplasma gondii IgM Ab [Units/volume] in Serum | T. gondii IgM | T. gondii IgM |
| 80515-0 | Kappa light chains.free [Mass/volume] in Serum by Nephelometry | Immunoglobulin Light Chains kappa (free Nephelometry) | Immunoglobulin Light Chains kappa (free Nephelometry) |
| 80516-8 | Lambda light chains.free [Mass/volume] in Serum by Nephelometry | Immunoglobulin Light Chains (free Nephelometry) | Immunoglobulin Light Chains (free Nephelometry) |
| 80517-6 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry | Immunoglobulin Light Chains lambda (free Nephelometry) | Immunoglobulin Light Chains lambda (free Nephelometry) |
| 8061-4 | Nuclear Ab [Presence] in Serum | Antinuclear Ab (qual) | Antinuclear Ab (qual) |
| 8076-2 | Jo-1 extractable nuclear Ab [Presence] in Serum | Jo-1 extractable nuclear Ab | Jo-1 extractable nuclear Ab |
| 8091-1 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum | Ribonucleoprotein extractable nuclear Ab | Ribonucleoprotein extractable nuclear Ab |
| 8092-9 | SCL-70 extractable nuclear Ab [Presence] in Serum | SCL-70 extractable nuclear Ab | SCL-70 extractable nuclear Ab |
| 8093-7 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum | Sjogrens syndrome-A extractable nuclear Ab | Sjogrens syndrome-A extractable nuclear Ab |
| 8094-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum | Sjogrens syndrome-B extractable nuclear Ab | Sjogrens syndrome-B extractable nuclear Ab |
| 8095-2 | Smooth muscle Ab [Titer] in Serum | Smooth muscle Ab (titre) | Smooth muscle Ab (titre) |
| 8098-6 | Thyroglobulin Ab [Units/?volume] in Serum or Plasma | Thyroglobulin Antibody - units/volume | Thyroglobulin Antibody - units/volume |
| 8099-4 | Thyroperoxidase Ab [Units/?volume] in Serum or Plasma | Thyroperoxidase Ab | Thyroperoxidase Ab |
| 8116-6 | CD19 cells [#/?volume] in Blood | lymphocyte markers - CD19 cells | lymphocyte markers - CD19 cells |
| 81169-5 | Residual tumor [Interpretation] Cancer Narrative --postoperative | Margin - polypectomy | Margin - polypectomy |
| 8122-4 | CD3 cells [#/?volume] in Blood | Immunodeficiency Lymphocyte Markers (Subsets) | Immunodeficiency Lymphocyte Markers (Subsets) |
| 81317-0 | Additional pathological findings [Identifier] in Specimen | Other pathological finding | Other pathological finding |
| 8150-5 | Amphetamines [Mass/?volume] in Urine | Amphetamines-type substances urine - mass/volume | Amphetamines-type substances urine - mass/volume |
| 8161-2 | Bismuth [Mass/?volume] in Blood | Bismuth blood | Bismuth blood |
| 81691-8 | DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain | MMR prot Mlh1 Ca spec Ql ImStn | MMR prot Mlh1 Ca spec Ql ImStn |
| 81692-6 | DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain | MMR prot Msh2 Ca spec Ql ImStn | MMR prot Msh2 Ca spec Ql ImStn |
| 81693-4 | DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain | MMR prot Msh6 Ca spec Ql ImStn | MMR prot Msh6 Ca spec Ql ImStn |
| 81694-2 | Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain | MMR endo PMS2 Ca spec Ql ImStn | MMR endo PMS2 Ca spec Ql ImStn |
| 8275-0 | Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefpirome suscep (MIC) | Cefpirome suscep (MIC) |
| 8-3 | Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Amdinocillin suscep (MIC) | Amdinocillin suscep (MIC) |
| 83121-4 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay | Free T4 IA [Moles/Vol] | Free T4 IA [Moles/Vol] |
| 83126-3 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay | Free T3 IA [Moles/Vol] | Free T3 IA [Moles/Vol] |
| 84-4 | Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefaclor suscep (MIC) | Cefaclor suscep (MIC) |
| 84882-0 | Histologic type in Colorectal cancer specimen by WHO classification | Main diagnosis | Main diagnosis |
| 84883-8 | Deepest extent of tumor invasion [Type] in Colorectal cancer specimen | Depth of invasion | Depth of invasion |
| 85291-3 | Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy | Deep margin status | Deep margin status |
| 85299-6 | BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain | BRAF V600E mutation status | BRAF V600E mutation status |
| 882-1 | ABO and Rh group [Type] in Blood | ABO and Rh group | ABO and Rh group |
| 88-5 | Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefmetazole suscep (MIC) | Cefmetazole suscep (MIC) |
| 888-8 | Blood group antibodies identified in Serum or Plasma | Blood Group Ab (ident) | Blood Group Ab (ident) |
| 890-4 | Blood group antibody screen [Presence] in Serum or Plasma | Blood Group Ab (screen) | Blood Group Ab (screen) |
| 897-9 | Blood group antibody screen [Presence] in Serum or Plasma by Elution | Blood Group Ab Elution | Blood Group Ab Elution |
| 89873-4 | Unique identifier [Identifier] of Initial sample | Specimen identifier | Specimen identifier |
| 92-7 | Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefodizime suscep (MIC) | Cefodizime suscep (MIC) |
| 92837-4 | Perineural invasion [Presence] in Cancer specimen | Perineural invasion | Perineural invasion |
| 933-2 | Blood product type | Blood Product Type | Blood Product Type |
| 9335-1 | Appearance of Body fluid | Appearance body fluid | Appearance body fluid |
| 94306-8 | SARS-CoV-2 (COVID-19) RNA panel - Unspecified specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Unsp spec) | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Unsp spec) |
| 94307-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Unsp spec) | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Unsp spec) |
| 94308-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 Ql (Unsp spec) | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 Ql (Unsp spec) |
| 94309-2 | SARS-CoV-2 (COVID-19) RNA [Presence] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Unsp spec) | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Unsp spec) |
| 94310-0 | SARS-like Coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection | SARS-like CoV N gene NAA+probe Ql (Unsp spec) | SARS-like CoV N gene NAA+probe Ql (Unsp spec) |
| 94311-8 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 (Unsp spec) [ThreshNum] | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 (Unsp spec) [ThreshNum] |
| 94312-6 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 (Unsp spec) [ThreshNum] | SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 (Unsp spec) [ThreshNum] |
| 94313-4 | SARS-like Coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-like CoV N gene NAA+probe (Unsp spec) [ThreshNum] | SARS-like CoV N gene NAA+probe (Unsp spec) [ThreshNum] |
| 94314-2 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Unsp spec) | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Unsp spec) |
| 94315-9 | SARS-related coronavirus E gene [Presence] in Unspecified specimen by NAA with probe detection | SARS-related coronavirus E gene NAA+probe Ql (Unsp spec) | SARS-related coronavirus E gene NAA+probe Ql (Unsp spec) |
| 94316-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Unsp spec) | SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Unsp spec) |
| 94499-1 | Respiratory viral pathogens DNA and RNA panel - Respiratory specimen Qualitative by NAA with probe detection | Respiratory viral pathogens DNA and RNA panel NAA+probe Ql (Resp) | Respiratory viral pathogens DNA and RNA panel NAA+probe Ql (Resp) |
| 94500-6 | SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 RNA NAA+probe Ql (Resp) | SARS-CoV-2 RNA NAA+probe Ql (Resp) |
| 94501-4 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory specimen by NAA with probe detection | MERS-CoV RNA NAA+probe Ql (Resp) | MERS-CoV RNA NAA+probe Ql (Resp) |
| 94502-2 | SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS-related CoV RNA NAA+probe Ql (Resp) | SARS-related CoV RNA NAA+probe Ql (Resp) |
| 94503-0 | SARS coronavirus 2 IgG and IgM panel - Serum or Plasma Qualitative by Immunoassay | SARS-CoV-2 IgG and IgM panel IA.rapid Ql | SARS-CoV-2 IgG and IgM panel IA.rapid Ql |
| 94504-8 | SARS coronavirus 2 IgG and IgM panel - Serum or Plasma by Immunoassay | SARS-CoV-2 IgG and IgM panel IA | SARS-CoV-2 IgG and IgM panel IA |
| 94505-5 | SARS coronavirus 2 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgG IA Qn | SARS-CoV-2 IgG IA Qn |
| 94506-3 | SARS coronavirus 2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgM IA Qn | SARS-CoV-2 IgM IA Qn |
| 94507-1 | SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgG IA.rapid Ql | SARS-CoV-2 IgG IA.rapid Ql |
| 94508-9 | SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgM IA.rapid Ql | SARS-CoV-2 IgM IA.rapid Ql |
| 94509-7 | SARS coronavirus 2 E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 E gene NAA+probe (Unsp spec) [ThreshNum] | SARS-CoV-2 E gene NAA+probe (Unsp spec) [ThreshNum] |
| 94510-5 | SARS coronavirus 2 N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 N gene NAA+probe (Unsp spec) [ThreshNum] | SARS-CoV-2 N gene NAA+probe (Unsp spec) [ThreshNum] |
| 94511-3 | SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 ORF1ab region NAA+probe (Unsp spec) [ThreshNum] | SARS-CoV-2 ORF1ab region NAA+probe (Unsp spec) [ThreshNum] |
| 94531-1 | SARS Coronavirus 2 RNA panel - Respiratory specimen by NAA with probe detection | SARS-CoV-2 RNA panel NAA+probe (Resp) | SARS-CoV-2 RNA panel NAA+probe (Resp) |
| 94532-9 | SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS-related CoV+MERS coronavirus RNA NAA+probe Ql (Resp) | SARS-related CoV+MERS coronavirus RNA NAA+probe Ql (Resp) |
| 94533-7 | SARS coronavirus 2 N gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 N gene NAA+probe Ql (Resp) | SARS-CoV-2 N gene NAA+probe Ql (Resp) |
| 94534-5 | SARS coronavirus 2 RdRp gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 RdRp gene NAA+probe Ql (Resp) | SARS-CoV-2 RdRp gene NAA+probe Ql (Resp) |
| 94547-7 | SARS coronavirus 2 IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgG+IgM IA Ql | SARS-CoV-2 IgG+IgM IA Ql |
| 94558-4 | SARS coronavirus 2 Ag [Presence] in Respiratory specimen by Rapid immunoassay | SARS-CoV-2 Ag IA.rapid Ql (Resp) | SARS-CoV-2 Ag IA.rapid Ql (Resp) |
| 94559-2 | SARS coronavirus 2 ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 ORF1ab region NAA+probe Ql (Resp) | SARS-CoV-2 ORF1ab region NAA+probe Ql (Resp) |
| 94562-6 | SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgA IA Ql | SARS-CoV-2 IgA IA Ql |
| 94563-4 | SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgG IA Ql | SARS-CoV-2 IgG IA Ql |
| 94564-2 | SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgM IA Ql | SARS-CoV-2 IgM IA Ql |
| 94565-9 | SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection | SARS-CoV-2 RNA NAA+non-probe Ql (Nph) | SARS-CoV-2 RNA NAA+non-probe Ql (Nph) |
| 94639-2 | SARS coronavirus 2 ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 ORF1ab region NAA+probe Ql (Unsp spec) | SARS-CoV-2 ORF1ab region NAA+probe Ql (Unsp spec) |
| 94640-0 | SARS coronavirus 2 S gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 S gene NAA+probe Ql (Resp) | SARS-CoV-2 S gene NAA+probe Ql (Resp) |
| 94641-8 | SARS coronavirus 2 S gene [Presence] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 S gene NAA+probe Ql (Unsp spec) | SARS-CoV-2 S gene NAA+probe Ql (Unsp spec) |
| 94642-6 | SARS coronavirus 2 S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 S gene NAA+probe (Resp) [ThreshNum] | SARS-CoV-2 S gene NAA+probe (Resp) [ThreshNum] |
| 94643-4 | SARS coronavirus 2 S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 S gene NAA+probe (Unsp spec) [ThreshNum] | SARS-CoV-2 S gene NAA+probe (Unsp spec) [ThreshNum] |
| 94644-2 | SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 ORF1ab region NAA+probe (Resp) [ThreshNum] | SARS-CoV-2 ORF1ab region NAA+probe (Resp) [ThreshNum] |
| 94645-9 | SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection | SARS-CoV-2 RdRp gene NAA+probe (Unsp spec) [ThreshNum] | SARS-CoV-2 RdRp gene NAA+probe (Unsp spec) [ThreshNum] |
| 94646-7 | SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 RdRp gene NAA+probe (Resp) [ThreshNum] | SARS-CoV-2 RdRp gene NAA+probe (Resp) [ThreshNum] |
| 94647-5 | SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection | SARS-related CoV RNA NAA+probe Ql (Unsp spec) | SARS-related CoV RNA NAA+probe Ql (Unsp spec) |
| 94660-8 | SARS coronavirus 2 RNA [Presence] in Serum or Plasma by NAA with probe detection | SARS-CoV-2 RNA NAA+probe Ql | SARS-CoV-2 RNA NAA+probe Ql |
| 94661-6 | SARS coronavirus 2 Ab [Interpretation] in Serum or Plasma | SARS-CoV-2 Ab [Interp] | SARS-CoV-2 Ab [Interp] |
| 94720-0 | SARS coronavirus 2 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 IgA IA Qn | SARS-CoV-2 IgA IA Qn |
| 94745-7 | SARS coronavirus 2 RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID19) RNA NAA+probe (Resp) [ThreshNum] | SARS-CoV-2 (COVID19) RNA NAA+probe (Resp) [ThreshNum] |
| 94746-5 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA NAA+probe (Specimen) [ThreshNum] | SARS-CoV-2 (COVID-19) RNA NAA+probe (Specimen) [ThreshNum] |
| 94756-4 | SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS-CoV-2 N gene NAA+probe CDC primer-probe set N1 Ql (Resp) | SARS-CoV-2 N gene NAA+probe CDC primer-probe set N1 Ql (Resp) |
| 94757-2 | SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 N gene NAA+probe CDC primer-probe set N2 Ql (Resp) | SARS-CoV-2 N gene NAA+probe CDC primer-probe set N2 Ql (Resp) |
| 94758-0 | SARS coronavirus 2 E gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 E gene NAA+probe Ql (Resp) | SARS-CoV-2 E gene NAA+probe Ql (Resp) |
| 94759-8 | SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with probe detection | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nph) | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nph) |
| 94760-6 | SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection | SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nph) | SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nph) |
| 94761-4 | SARS coronavirus 2 IgG Ab [Presence] in DBS by Immunoassay | SARS-CoV-2 (COVID19) IgG IA Ql (DBS) | SARS-CoV-2 (COVID19) IgG IA Ql (DBS) |
| 94762-2 | SARS coronavirus 2 Ab [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID19) Ab IA Ql | SARS-CoV-2 (COVID19) Ab IA Ql |
| 94763-0 | SARS coronavirus 2 [Presence] in Unspecified specimen by Organism specific culture | SARS-CoV-2 (COVID19) Org specific cx Ql (Unsp spec) | SARS-CoV-2 (COVID19) Org specific cx Ql (Unsp spec) |
| 94764-8 | SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing | SARS-CoV-2 (COVID-19) genome sequence Nom (Islt/Spec) | SARS-CoV-2 (COVID-19) genome sequence Nom (Islt/Spec) |
| 94765-5 | SARS coronavirus 2 E gene [Presence] in Serum or Plasma by NAA with probe detection | SARS-CoV-2 E gene NAA+probe Ql | SARS-CoV-2 E gene NAA+probe Ql |
| 94766-3 | SARS coronavirus 2 N gene [Presence] in Serum or Plasma by NAA with probe detection | SARS-CoV-2 N gene NAA+probe Ql | SARS-CoV-2 N gene NAA+probe Ql |
| 94767-1 | SARS coronavirus 2 S gene [Presence] in Serum or Plasma by NAA with probe detection | SARS-CoV-2 S gene NAA+probe Ql | SARS-CoV-2 S gene NAA+probe Ql |
| 94768-9 | SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Rapid immunoassay | SARS-CoV-2 (COVID19) IgA IA.rapid Ql | SARS-CoV-2 (COVID19) IgA IA.rapid Ql |
| 94769-7 | SARS coronavirus 2 Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID19) Ab IA Qn | SARS-CoV-2 (COVID19) Ab IA Qn |
| 94819-0 | SARS coronavirus 2 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection | SARS-CoV-2 (COVID19) RNA NAA+probe (Unsp spec) [Log #/Vol] | SARS-CoV-2 (COVID19) RNA NAA+probe (Unsp spec) [Log #/Vol] |
| 94822-4 | SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by Sequencing | SARS-CoV-2 (COVID19) RNA Sequencing Ql (Sal) | SARS-CoV-2 (COVID19) RNA Sequencing Ql (Sal) |
| 94845-5 | SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Sal) | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Sal) |
| 95125-1 | SARS-CoV-2 (COVID19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID19) IgA+IgM IA Ql | SARS-CoV-2 (COVID19) IgA+IgM IA Ql |
| 95209-3 | SARS-CoV+SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay | SARS-CoV+SARS-CoV-2 (COVID19) Ag IA.rapid Ql (Resp) | SARS-CoV+SARS-CoV-2 (COVID19) Ag IA.rapid Ql (Resp) |
| 95380-2 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp) | Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp) |
| 95383-6 | Symptom resolution status | Symptomatic | Symptomatic |
| 95406-5 | SARS-CoV-2 (COVID19) RNA [Presence] in Nose by NAA with probe detection | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nose) | SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nose) |
| 95409-9 | SARS-CoV-2 (COVID19) N gene [Presence] in Nose by NAA with probe detection | SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nose) | SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nose) |
| 95410-7 | SARS-CoV-2 (COVID19) neutralizing antibody [Titer] in Serum by pVNT | SARS-CoV-2 (COVID19) neut ab pVNT (S) [Titer] | SARS-CoV-2 (COVID19) neut ab pVNT (S) [Titer] |
| 95411-5 | SARS-CoV-2 (COVID19) neutralizing antibody [Presence] in Serum by pVNT | SARS-CoV-2 (COVID19) neut ab pVNT Ql (S) | SARS-CoV-2 (COVID19) neut ab pVNT Ql (S) |
| 95416-4 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay | SARS-CoV-2 (COVID-19) IgM IA Ql (DBS) | SARS-CoV-2 (COVID-19) IgM IA Ql (DBS) |
| 95422-2 | Long Common NameInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Resp) | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Resp) |
| 95423-0 | Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection | Influenza virus A and B and SARS-CoV-2 (COVID-19) identified NAA+probe Nom (Resp) | Influenza virus A and B and SARS-CoV-2 (COVID-19) identified NAA+probe Nom (Resp) |
| 95424-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing | SARS-CoV-2 (COVID-19) RNA Sequencing Ql (Resp) | SARS-CoV-2 (COVID-19) RNA Sequencing Ql (Resp) |
| 95425-5 | Long Common NameSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Sal) | SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Sal) |
| 95427-1 | SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS-CoV-2 (COVID-19) IgA IF [Titer] | SARS-CoV-2 (COVID-19) IgA IF [Titer] |
| 95428-9 | SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS-CoV-2 (COVID-19) IgM IF [Titer] | SARS-CoV-2 (COVID-19) IgM IF [Titer] |
| 95429-7 | SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS-CoV-2 (COVID-19) IgG IF [Titer] | SARS-CoV-2 (COVID-19) IgG IF [Titer] |
| 95521-1 | Long Common NameSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [#/Vol] | SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [#/Vol] |
| 95522-9 | SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [Log #/Vol] | SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [Log #/Vol] |
| 95542-7 | SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | SARS-CoV-2 (COVID-19) IgG+IgM IA.rapid Ql (S/P/Bld) | SARS-CoV-2 (COVID-19) IgG+IgM IA.rapid Ql (S/P/Bld) |
| 9558-8 | CD20 cells [#/?volume] in Blood | CD20 assay | CD20 assay |
| 9559-6 | CD5 cells [#/?volume] in Blood | lymphocyte markers - CD5 cells | lymphocyte markers - CD5 cells |
| 95608-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection | SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Resp) | SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Resp) |
| 95609-4 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing | SARS-CoV-2 (COVID-19) S gene Sequencing Ql (Resp) | SARS-CoV-2 (COVID-19) S gene Sequencing Ql (Resp) |
| 9571-1 | Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection | Parvovirus DNA (NAAT) | Parvovirus DNA (NAAT) |
| 95823-1 | SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-related coronavirus E gene NAA+probe Ql (Sal) | SARS-related coronavirus E gene NAA+probe Ql (Sal) |
| 95824-9 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Ql (Sal) | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Ql (Sal) |
| 95825-6 | SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay | SARS-CoV-2 (COVID-19) Ab IA Ql (DBS) | SARS-CoV-2 (COVID-19) Ab IA Ql (DBS) |
| 95826-4 | SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal) | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal) |
| 95941-1 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel NAA+probe (Resp) | Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel NAA+probe (Resp) |
| 95942-9 | Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay | Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel IA.rapid (Upper resp) | Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel IA.rapid (Upper resp) |
| 95970-0 | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements Sequencing Ql (Bld) | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements Sequencing Ql (Bld) |
| 95971-8 | SARS CoV-2 stimulated gamma interferon [Presence] in Blood | SARS CoV-2 stimulated gamma interferon Ql (Bld) | SARS CoV-2 stimulated gamma interferon Ql (Bld) |
| 95972-6 | SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood | SARS CoV-2 stimulated gamma interferon release by T-cells corrected for background Qn (Bld) | SARS CoV-2 stimulated gamma interferon release by T-cells corrected for background Qn (Bld) |
| 95973-4 | SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood | SARS CoV-2 stimulated gamma interferon release by T-cells Qn (Bld) | SARS CoV-2 stimulated gamma interferon release by T-cells Qn (Bld) |
| 95974-2 | SARS CoV-2 stimulated gamma interferon panel - Blood | SARS CoV-2 stimulated gamma interferon panel (Bld) | SARS CoV-2 stimulated gamma interferon panel (Bld) |
| 96091-4 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) RdRp gene, Saliva | SARS-CoV-2 (COVID-19) RdRp gene, Saliva |
| 96094-8 | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp) | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp) |
| 96115-1 | Long Common NameLevel of tumor invasion [Type] in Colorectal cancer specimen by Haggitt | Haggitt level | Haggitt level |
| 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay | SARS-CoV-2 (COVID-19) Ab Panel IA (DBS) | SARS-CoV-2 (COVID-19) Ab Panel IA (DBS) |
| 96119-3 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay | SARS-CoV-2 (COVID-19) Ag IA Ql (Upper resp) | SARS-CoV-2 (COVID-19) Ag IA Ql (Upper resp) |
| 96120-1 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Lower resp) | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Lower resp) |
| 96121-9 | SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection | SARS-related coronavirus E gene NAA+probe Ql (Lower resp) | SARS-related coronavirus E gene NAA+probe Ql (Lower resp) |
| 96122-7 | SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-related coronavirus E gene NAA+probe Ql (Upper resp) | SARS-related coronavirus E gene NAA+probe Ql (Upper resp) |
| 96123-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Upper resp) | SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Upper resp) |
| 9627-1 | Imipramine+?Desipramine [Mass/?volume] in Serum or Plasma | Imipramine + Desipramine | Imipramine + Desipramine |
| 96603-6 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT | SARS-CoV-2 (COVID-19) S protein RBD neut ab sVNT Ql | SARS-CoV-2 (COVID-19) S protein RBD neut ab sVNT Ql |
| 96741-4 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing | SARS-CoV-2 (COVID-19) variant Sequencing Nom (Specimen) | SARS-CoV-2 (COVID-19) variant Sequencing Nom (Specimen) |
| 96742-2 | SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID-19) IgG IA [Mass/Vol] | SARS-CoV-2 (COVID-19) IgG IA [Mass/Vol] |
| 96751-3 | SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method | SARS-CoV-2 (COVID-19) S gene mutation detected Molgen Nom (Specimen) | SARS-CoV-2 (COVID-19) S gene mutation detected Molgen Nom (Specimen) |
| 96752-1 | SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method | SARS-CoV-2 (COVID-19) S gene mutation Molgen Ql (Specimen) | SARS-CoV-2 (COVID-19) S gene mutation Molgen Ql (Specimen) |
| 96755-4 | SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative | SARS-CoV-2 (COVID-19) variant interpretation Nar (Specimen) | SARS-CoV-2 (COVID-19) variant interpretation Nar (Specimen) |
| 96763-8 | SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) E gene NAA+probe Ql (Resp) | SARS-CoV-2 (COVID-19) E gene NAA+probe Ql (Resp) |
| 96764-6 | SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) E gene NAA+probe (Resp) [ThreshNum] | SARS-CoV-2 (COVID-19) E gene NAA+probe (Resp) [ThreshNum] |
| 96765-3 | SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) S gene NAA+probe Ql (Sal) | SARS-CoV-2 (COVID-19) S gene NAA+probe Ql (Sal) |
| 96797-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Oropharyngeal wash) | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Oropharyngeal wash) |
| 96-8 | Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC) | Cefonicid suscep (MIC) | Cefonicid suscep (MIC) |
| 96829-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen donor) | SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen donor) |
| 96894-1 | SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel - Specimen by Molecular genetics method | SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel Molgen (Specimen) | SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel Molgen (Specimen) |
| 96895-8 | SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method | SARS-CoV-2 (COVID-19) lineage Molgen Nom (Specimen) | SARS-CoV-2 (COVID-19) lineage Molgen Nom (Specimen) |
| 96896-6 | SARS coronavirus 2 (COVID-19) clade [Type] in Specimen by Molecular genetics method | SARS coronavirus 2 (COVID-19) clade Molgen Nom (Specimen) | SARS coronavirus 2 (COVID-19) clade Molgen Nom (Specimen) |
| 96897-4 | SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Oropharyngeal wash) | SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Oropharyngeal wash) |
| 96898-2 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS-CoV-2 (COVID-19) N gene NAA+probe (Oropharyngeal wash) [ThreshNum] | SARS-CoV-2 (COVID-19) N gene NAA+probe (Oropharyngeal wash) [ThreshNum] |
| 96899-0 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe (Oropharyngeal wash) [ThreshNum] | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe (Oropharyngeal wash) [ThreshNum] |
| 96900-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS-CoV-2 (COVID-19) S gene NAA+probe (Oropharyngeal wash) [ThreshNum] | SARS-CoV-2 (COVID-19) S gene NAA+probe (Oropharyngeal wash) [ThreshNum] |
| 96957-6 | SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) M gene NAA+probe Ql (Upper resp) | SARS-CoV-2 (COVID-19) M gene NAA+probe Ql (Upper resp) |
| 96986-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection | SARS-CoV-2 (COVID-19) N gene NAA+non-probe Ql (Nose) | SARS-CoV-2 (COVID-19) N gene NAA+non-probe Ql (Nose) |
| 9699-0 | Paroxetine [Mass/?volume] in Serum or Plasma | Paroxetine | Paroxetine |
| 97097-0 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | SARS-CoV-2 (COVID-19) Ag IA.rapid Ql (Upper resp) | SARS-CoV-2 (COVID-19) Ag IA.rapid Ql (Upper resp) |
| 97098-8 | SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) Nsp2 gene NAA+probe Ql (Upper resp) | SARS-CoV-2 (COVID-19) Nsp2 gene NAA+probe Ql (Upper resp) |
| 97104-4 | SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Qn (Upper resp) | SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Qn (Upper resp) |
| 9721-2 | Salivary gland Ab [Titer] in Serum | Salivary gland Ab (titre) | Salivary gland Ab (titre) |
| 9780-8 | Spermatozoa [#/volume] in Semen | Sperm count semen | Sperm count semen |
| 9781-6 | Acanthamoeba sp identified in Unspecified specimen by Organism specific culture | Acanthamoeba (culture) | Acanthamoeba (culture) |
| 9786-5 | Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain | PAS Stain | PAS Stain |
| 9787-3 | Sarcoptes scabiei identified in Skin by Light microscopy | Scabies skin scraping | Scabies skin scraping |
| 9790-7 | Methyl bromide [Mass/?volume] in Serum or Plasma | Methyl Bromide | Methyl Bromide |
| 98069-8 | SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay | SARS-CoV-2 (COVID-19) Ab IA.rapid Ql (Sal) | SARS-CoV-2 (COVID-19) Ab IA.rapid Ql (Sal) |
| 9811-1 | Chromogranin A [Mass/?volume] in Serum or Plasma | Chromogranin A | Chromogranin A |
| 98131-6 | SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Resp) | SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Resp) |
| 98132-4 | SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Resp) | SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Resp) |
| 9816-0 | Actinomyces sp identified in Unspecified specimen by Organism specific culture | Actinomyces (culture) | Actinomyces (culture) |
| 9826-9 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | Syphilis Confirmation CSF | Syphilis Confirmation CSF |
| 9838-4 | Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence | Liver/Kidney Ab -Titer | Liver/Kidney Ab -Titer |
| 98493-0 | SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Sal) | SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Sal) |
| 98494-8 | SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Sal) | SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Sal) |
| 98732-1 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID-19) S protein RBD neut ab IA [Titer] | SARS-CoV-2 (COVID-19) S protein RBD neut ab IA [Titer] |
| 98733-9 | Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay | Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD) neut ab IA [%] | Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD) neut ab IA [%] |
| 98734-7 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay | SARS-CoV-2 (COVID-19) S protein RBD neut ab IA Qn | SARS-CoV-2 (COVID-19) S protein RBD neut ab IA Qn |
| 98846-9 | SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay | SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells corrected for background IA Qn (Bld) | SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells corrected for background IA Qn (Bld) |
| 98847-7 | SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay | SARS coronavirus 2 stimulated gamma interferon release by lymphocytes corrected for background IA Qn (Bld) | SARS coronavirus 2 stimulated gamma interferon release by lymphocytes corrected for background IA Qn (Bld) |
| 11481-9 | Human papilloma virus identified in Specimen | HPV Test Results | HPV Test Results |
| 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid | Lipase (Body fld) [Catalytic activity/Vol] | Lipase (Body fld) [Catalytic activity/Vol] |
| 20373-7 | Amikacin [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin SlowMyco | Amikacin SlowMyco |
| 20376-0 | Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria | Clofazimine SlowMyco | Clofazimine SlowMyco |
| 20377-8 | Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin SlowMyco | Ciprofloxacin SlowMyco |
| 20381-0 | Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol SlowMyco | Ethambutol SlowMyco |
| 20382-8 | Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide SlowMyco | Ethionamide SlowMyco |
| 20383-6 | Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid SlowMyco | Isoniazid SlowMyco |
| 20385-1 | rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin SlowMyco | rifAMPin SlowMyco |
| 20386-9 | Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin SlowMyco | Rifabutin SlowMyco |
| 20461-0 | Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria | Pyrazinamide SlowMyco | Pyrazinamide SlowMyco |
| 21976-6 | Cancer outcome status | Cancer outcome status | Cancer outcome status |
| 21978-2 | Source of follow-up information Cancer | Source of follow-up information | Source of follow-up information |
| 22633-2 | Pathology report site of origin Narrative | Site of origin | Site of origin |
| 22634-0 | Pathology report gross observation Narrative | Gross observation | Gross observation |
| 22637-3 | Pathology report final diagnosis Narrative | Final diagnosis | Final diagnosis |
| 23607-5 | Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin SlowMyco | Capreomycin SlowMyco |
| 23608-3 | cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria | cycloSERINE SlowMyco | cycloSERINE SlowMyco |
| 23611-7 | Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria | Para aminosalicylate SlowMyco | Para aminosalicylate SlowMyco |
| 25174-4 | Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 8.0 ug/mL SlowMyco | Amikacin 8.0 ug/mL SlowMyco |
| 25175-1 | Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 16.0 ug/mL SlowMyco | Amikacin 16.0 ug/mL SlowMyco |
| 25176-9 | Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 32.0 ug/mL SlowMyco | Amikacin 32.0 ug/mL SlowMyco |
| 25177-7 | Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 12.0 ug/mL SlowMyco | Amikacin 12.0 ug/mL SlowMyco |
| 25178-5 | Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 30.0 ug/mL SlowMyco | Amikacin 30.0 ug/mL SlowMyco |
| 25179-3 | Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 6.0 ug/mL SlowMyco | Amikacin 6.0 ug/mL SlowMyco |
| 25180-1 | Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin 2.0 ug/mL SlowMyco | Ciprofloxacin 2.0 ug/mL SlowMyco |
| 25181-9 | Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin 4.0 ug/mL SlowMyco | Ciprofloxacin 4.0 ug/mL SlowMyco |
| 25183-5 | Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide 11.0 ug/mL SlowMyco | Ethionamide 11.0 ug/mL SlowMyco |
| 25184-3 | rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin 14.0 ug/mL SlowMyco | rifAMPin 14.0 ug/mL SlowMyco |
| 25186-8 | Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Pyrazinamide 25.0 ug/mL SlowMyco | Pyrazinamide 25.0 ug/mL SlowMyco |
| 25187-6 | Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 7.5 ug/mL SlowMyco | Ethambutol 7.5 ug/mL SlowMyco |
| 25188-4 | Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin 8.0 ug/mL SlowMyco | Ciprofloxacin 8.0 ug/mL SlowMyco |
| 25189-2 | Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin 5.0 ug/mL SlowMyco | Ciprofloxacin 5.0 ug/mL SlowMyco |
| 25194-2 | Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 5.0 ug/mL SlowMyco | Ethambutol 5.0 ug/mL SlowMyco |
| 25195-9 | Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 10.0 ug/mL SlowMyco | Ethambutol 10.0 ug/mL SlowMyco |
| 25196-7 | Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide 5.0 ug/mL SlowMyco | Ethionamide 5.0 ug/mL SlowMyco |
| 25198-3 | Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide 15.0 ug/mL SlowMyco | Ethionamide 15.0 ug/mL SlowMyco |
| 25199-1 | Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin 1.0 ug/mL SlowMyco | Rifabutin 1.0 ug/mL SlowMyco |
| 25200-7 | Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin 2.0 ug/mL SlowMyco | Rifabutin 2.0 ug/mL SlowMyco |
| 25201-5 | Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin 4.0 ug/mL SlowMyco | Rifabutin 4.0 ug/mL SlowMyco |
| 25202-3 | rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin 1.0 ug/mL SlowMyco | rifAMPin 1.0 ug/mL SlowMyco |
| 25203-1 | rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin 2.0 ug/mL SlowMyco | rifAMPin 2.0 ug/mL SlowMyco |
| 25204-9 | rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin 5.0 ug/mL SlowMyco | rifAMPin 5.0 ug/mL SlowMyco |
| 25207-2 | cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | cycloSERINE 10.0 ug/mL SlowMyco | cycloSERINE 10.0 ug/mL SlowMyco |
| 25208-0 | cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | cycloSERINE 20.0 ug/mL SlowMyco | cycloSERINE 20.0 ug/mL SlowMyco |
| 25209-8 | cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | cycloSERINE 30.0 ug/mL SlowMyco | cycloSERINE 30.0 ug/mL SlowMyco |
| 25210-6 | Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin 10.0 ug/mL SlowMyco | Capreomycin 10.0 ug/mL SlowMyco |
| 25211-4 | Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin 20.0 ug/mL SlowMyco | Capreomycin 20.0 ug/mL SlowMyco |
| 25212-2 | Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin 30.0 ug/mL SlowMyco | Capreomycin 30.0 ug/mL SlowMyco |
| 25215-5 | Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Para aminosalicylate 2.0 ug/mL SlowMyco | Para aminosalicylate 2.0 ug/mL SlowMyco |
| 25216-3 | Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Para aminosalicylate 8.0 ug/mL SlowMyco | Para aminosalicylate 8.0 ug/mL SlowMyco |
| 25217-1 | Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 0.1 ug/mL SlowMyco | Isoniazid 0.1 ug/mL SlowMyco |
| 25218-9 | Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 0.2 ug/mL SlowMyco | Isoniazid 0.2 ug/mL SlowMyco |
| 25219-7 | Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 1.0 ug/mL SlowMyco | Isoniazid 1.0 ug/mL SlowMyco |
| 25229-6 | Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Pyrazinamide 100.0 ug/mL SlowMyco | Pyrazinamide 100.0 ug/mL SlowMyco |
| 25230-4 | Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 2.5 ug/mL SlowMyco | Ethambutol 2.5 ug/mL SlowMyco |
| 25231-2 | Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide 10.0 ug/mL SlowMyco | Ethionamide 10.0 ug/mL SlowMyco |
| 29315-9 | Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 0.4 ug/mL SlowMyco | Isoniazid 0.4 ug/mL SlowMyco |
| 29757-2 | Colposcopy study | Colposcopy study | Colposcopy study |
| 41500-0 | Linezolid [Susceptibility] by Method for Slow-growing mycobacteria | Linezolid SlowMyco | Linezolid SlowMyco |
| 41502-6 | Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin SlowMyco | Moxifloxacin SlowMyco |
| 42642-9 | Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 2.0 ug/mL SlowMyco | Amikacin 2.0 ug/mL SlowMyco |
| 42651-0 | Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 5.0 ug/mL SlowMyco | Isoniazid 5.0 ug/mL SlowMyco |
| 42655-1 | Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin 0.5 ug/mL SlowMyco | Rifabutin 0.5 ug/mL SlowMyco |
| 43986-9 | Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Clofazimine 2.0 ug/mL SlowMyco | Clofazimine 2.0 ug/mL SlowMyco |
| 43988-5 | Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Clofazimine 0.5 ug/mL SlowMyco | Clofazimine 0.5 ug/mL SlowMyco |
| 43989-3 | Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Clofazimine 1.0 ug/mL SlowMyco | Clofazimine 1.0 ug/mL SlowMyco |
| 45215-1 | Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 2.0 ug/mL SlowMyco | Isoniazid 2.0 ug/mL SlowMyco |
| 48169-7 | Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 1.5 ug/mL SlowMyco | Amikacin 1.5 ug/mL SlowMyco |
| 48170-5 | Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin 3.0 ug/mL SlowMyco | Capreomycin 3.0 ug/mL SlowMyco |
| 48685-2 | Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Para aminosalicylate 10.0 ug/mL SlowMyco | Para aminosalicylate 10.0 ug/mL SlowMyco |
| 55194-5 | Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin 1.0 ug/mL SlowMyco | Ciprofloxacin 1.0 ug/mL SlowMyco |
| 55674-6 | Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 2.0 ug/mL SlowMyco | Ethambutol 2.0 ug/mL SlowMyco |
| 55685-2 | Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid 10.0 ug/mL SlowMyco | Isoniazid 10.0 ug/mL SlowMyco |
| 55711-6 | Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Pyrazinamide 200.0 ug/mL SlowMyco | Pyrazinamide 200.0 ug/mL SlowMyco |
| 55712-4 | rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin 40.0 ug/mL SlowMyco | rifAMPin 40.0 ug/mL SlowMyco |
| 56025-0 | Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol 8.0 ug/mL SlowMyco | Ethambutol 8.0 ug/mL SlowMyco |
| 56026-8 | Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Pyrazinamide 300.0 ug/mL SlowMyco | Pyrazinamide 300.0 ug/mL SlowMyco |
| 60564-2 | Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 1.0 ug/mL SlowMyco | Amikacin 1.0 ug/mL SlowMyco |
| 60565-9 | Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin 4.0 ug/mL SlowMyco | Amikacin 4.0 ug/mL SlowMyco |
| 61355-4 | Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Capreomycin 5.0 ug/mL SlowMyco | Capreomycin 5.0 ug/mL SlowMyco |
| 63565-6 | Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria | Prothionamide SlowMyco | Prothionamide SlowMyco |
| 76043-9 | Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin 0.5 ug/mL SlowMyco | Moxifloxacin 0.5 ug/mL SlowMyco |
| 76044-7 | Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin 1.0 ug/mL SlowMyco | Moxifloxacin 1.0 ug/mL SlowMyco |
| 76045-4 | Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin 2.0 ug/mL SlowMyco | Moxifloxacin 2.0 ug/mL SlowMyco |
| 8100-0 | Specimen preparation [Type] | Specimen preparation | Specimen preparation |
| 85690-6 | Rubella virus genotype in Specimen | Rubella virus genotype (Specimen) | Rubella virus genotype (Specimen) |
| 88704-2 | Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria | Bedaquiline SlowMyco | Bedaquiline SlowMyco |
| 88706-7 | Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Linezolid 1.0 ug/mL SlowMyco | Linezolid 1.0 ug/mL SlowMyco |
| 88707-5 | Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin 0.25 ug/mL SlowMyco | Moxifloxacin 0.25 ug/mL SlowMyco |
| 93497-6 | Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Moxifloxacin 3.0 ug/mL SlowMyco | Moxifloxacin 3.0 ug/mL SlowMyco |
| 48013-7 | Genomic reference sequence [ID] | Genomic reference sequence ID | Genomic reference sequence ID |
| 5394-2 | Treponema pallidum Ab [Titer] in Serum by Latex agglutination | T pallidum Ab Titr Ser LA | T pallidum Ab Titr Ser LA |
| 66746-9 | Specimen type | Specimen type | Specimen type |
| 615-5 | Viral strain | Viral strain [Type] in Isolate by Viral subtyping | Viral strain [Type] in Isolate by Viral subtyping |
| 9398-9 | Reticulin Ab [Titer] in Serum | Reticulin Ab (titre) | Reticulin Ab (titre) |
https://standards.digital.health.nz/ns/loinc-nz-local-code
Generated Narrative: ValueSet
version: versionId: id (PrimitiveType/ValueSet.meta.versionId): native = id -> 1; Last updated: 2024-07-25 17:31:18+1200
Expansion based on:
This value set has 1,067 codes in it. In order to keep the publication size manageable, only a selection (1,000 codes) of the whole set of codes is shown.
| Code | System | Display |
| 1003-3 | http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 100383-9 | http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
| 1004-1 | http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 1005-8 | http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 1007-4 | http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
| 100-8 | http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1008-2 | http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
| 10331-7 | http://loinc.org | Rh [Type] in Blood |
| 10333-3 | http://loinc.org | Appearance of Cerebral spinal fluid |
| 10334-1 | http://loinc.org | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 104-0 | http://loinc.org | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10501-5 | http://loinc.org | Lutropin [Units/volume] in Serum or Plasma |
| 10574-2 | http://loinc.org | Fructose [Moles/volume] in Semen |
| 10579-1 | http://loinc.org | Leukocytes [#/volume] in Semen |
| 10580-9 | http://loinc.org | Liquefaction [Time] in Semen |
| 10602-1 | http://loinc.org | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
| 10603-9 | http://loinc.org | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
| 10604-7 | http://loinc.org | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
| 10605-4 | http://loinc.org | Spermatozoa Agglutinated/100 spermatozoa in Semen |
| 10611-2 | http://loinc.org | Spermatozoa Immotile/100 spermatozoa in Semen |
| 10613-8 | http://loinc.org | Spermatozoa Viable/100 spermatozoa in Semen |
| 10620-3 | http://loinc.org | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
| 10622-9 | http://loinc.org | Spermatozoa Normal/100 spermatozoa in Semen |
| 10624-5 | http://loinc.org | Spermatozoa Rapid/100 spermatozoa in Semen |
| 10626-0 | http://loinc.org | Spermatozoa Slow/100 spermatozoa in Semen |
| 10635-1 | http://loinc.org | Acanthamoeba sp identified in Eye by Organism specific culture |
| 10653-4 | http://loinc.org | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10697-1 | http://loinc.org | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10715-1 | http://loinc.org | Schistosoma sp identified in Urine sediment by Light microscopy |
| 10718-5 | http://loinc.org | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
| 10720-1 | http://loinc.org | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10728-4 | http://loinc.org | Trichomonas sp identified in Genital specimen by Organism specific culture |
| 10739-1 | http://loinc.org | Virus identified in Specimen by Electron microscopy |
| 10753-2 | http://loinc.org | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
| 108-1 | http://loinc.org | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10835-7 | http://loinc.org | Lipoprotein a [Mass/volume] in Serum or Plasma |
| 10839-9 | http://loinc.org | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
| 10840-7 | http://loinc.org | Atropine [Mass/volume] in Urine |
| 10860-5 | http://loinc.org | Varicella zoster virus [Presence] in Specimen by Organism specific culture |
| 10886-0 | http://loinc.org | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
| 10998-3 | http://loinc.org | oxyCODONE [Presence] in Urine |
| 11011-4 | http://loinc.org | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 11018-9 | http://loinc.org | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
| 11060-1 | http://loinc.org | Reducing substances [Presence] in Stool |
| 11067-6 | http://loinc.org | Bleeding time |
| 11084-1 | http://loinc.org | Reagin Ab [Titer] in Serum |
| 11085-8 | http://loinc.org | Schistosoma sp identified in Stool by Concentration |
| 11135-1 | http://loinc.org | Appearance of Spun Cerebral spinal fluid |
| 11227-6 | http://loinc.org | Pyruvate kinase [Presence] in Blood |
| 112-3 | http://loinc.org | cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 11257-3 | http://loinc.org | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 11266-4 | http://loinc.org | Streptococcus agalactiae Ag [Presence] in Specimen |
| 11483-5 | http://loinc.org | Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection |
| 11545-1 | http://loinc.org | Microscopic observation [Identifier] in Specimen by Acid fast stain |
| 11546-9 | http://loinc.org | Microscopic observation [Identifier] in Specimen by Other stain |
| 11555-0 | http://loinc.org | Base excess in Blood by calculation |
| 11556-8 | http://loinc.org | Oxygen [Partial pressure] in Blood |
| 11557-6 | http://loinc.org | Carbon dioxide [Partial pressure] in Blood |
| 11558-4 | http://loinc.org | pH of Blood |
| 11572-5 | http://loinc.org | Rheumatoid factor [Units/volume] in Serum or Plasma |
| 11573-3 | http://loinc.org | Rheumatoid factor IgM [Units/volume] in Serum |
| 11579-0 | http://loinc.org | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
| 11580-8 | http://loinc.org | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
| 116-4 | http://loinc.org | cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 120-6 | http://loinc.org | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12176-4 | http://loinc.org | Amino acids [Moles/volume] in Serum or Plasma |
| 12195-4 | http://loinc.org | Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
| 12241-6 | http://loinc.org | Osmotic fragility of Red Blood Cells by Diluted RBC |
| 12254-9 | http://loinc.org | Volume of Body fluid |
| 12256-4 | http://loinc.org | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
| 12293-7 | http://loinc.org | Cotinine [Presence] in Urine |
| 12308-3 | http://loinc.org | HYDROcodone [Presence] in Urine |
| 12319-0 | http://loinc.org | Thioridazine [Presence] in Urine |
| 12327-3 | http://loinc.org | Ketamine [Presence] in Urine |
| 12389-3 | http://loinc.org | OLANZapine [Mass/volume] in Serum or Plasma |
| 12467-7 | http://loinc.org | Amino acids [Identifier] in Urine |
| 124-8 | http://loinc.org | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12-5 | http://loinc.org | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12708-4 | http://loinc.org | Tin [Mass/volume] in Urine |
| 12841-3 | http://loinc.org | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
| 12851-2 | http://loinc.org | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
| 128-9 | http://loinc.org | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 12916-3 | http://loinc.org | Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
| 12998-1 | http://loinc.org | Methylene chloride [Mass/volume] in Blood |
| 13000-5 | http://loinc.org | Mandelate [Mass/volume] in Urine |
| 1304-5 | http://loinc.org | D Ab [Titer] in Serum or Plasma |
| 13046-8 | http://loinc.org | Variant lymphocytes/100 leukocytes in Blood |
| 13087-2 | http://loinc.org | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
| 13238-1 | http://loinc.org | Epstein Barr virus Ab [Units/volume] in Serum |
| 13304-1 | http://loinc.org | HLA-DR [Type] |
| 13309-0 | http://loinc.org | Duffy group Ag [Type] on Red Blood Cells |
| 13310-8 | http://loinc.org | Kell group Ag [Type] on Red Blood Cells |
| 13311-6 | http://loinc.org | MNS group Ag [Type] on Red Blood Cells |
| 13316-5 | http://loinc.org | Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture |
| 13317-3 | http://loinc.org | Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
| 13359-5 | http://loinc.org | Character of Semen |
| 133-9 | http://loinc.org | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 13438-7 | http://loinc.org | Protein Fractions [Interpretation] in Urine by Electrophoresis |
| 13488-2 | http://loinc.org | aPTT in Control Platelet poor plasma by Coagulation assay |
| 13513-7 | http://loinc.org | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
| 13514-5 | http://loinc.org | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
| 13532-7 | http://loinc.org | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
| 13533-5 | http://loinc.org | Acid hemolysis [Presence] of Blood |
| 13539-2 | http://loinc.org | Phosphate [Moles/volume] in Urine |
| 13590-5 | http://loinc.org | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
| 137-0 | http://loinc.org | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 13956-8 | http://loinc.org | Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection |
| 13964-2 | http://loinc.org | Methylmalonate [Moles/volume] in Serum or Plasma |
| 13965-9 | http://loinc.org | Homocysteine [Moles/volume] in Serum or Plasma |
| 13967-5 | http://loinc.org | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
| 13969-1 | http://loinc.org | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
| 13996-4 | http://loinc.org | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
| 14116-8 | http://loinc.org | IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
| 14117-6 | http://loinc.org | IgG clearance/Albumin clearance [Ratio] in Serum and CSF |
| 141-2 | http://loinc.org | cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14122-6 | http://loinc.org | Pyruvate [Moles/volume] in Cerebral spinal fluid |
| 14135-8 | http://loinc.org | CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood |
| 14136-6 | http://loinc.org | CD34 cells [#/volume] in Blood |
| 14196-0 | http://loinc.org | Reticulocytes [#/volume] in Blood |
| 14207-5 | http://loinc.org | Streptococcal DNAse B [Titer] in Serum |
| 14210-9 | http://loinc.org | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
| 14236-4 | http://loinc.org | Mitochondria Ab [Presence] in Serum |
| 14252-1 | http://loinc.org | Smooth muscle Ab [Presence] in Serum |
| 14272-9 | http://loinc.org | Liver kidney microsomal Ab [Presence] in Serum |
| 14286-9 | http://loinc.org | Carnitine free (C0) [Moles/volume] in Serum or Plasma |
| 14314-9 | http://loinc.org | Benzoylecgonine [Presence] in Urine by Screen method |
| 14316-4 | http://loinc.org | Benzodiazepines [Presence] in Urine by Screen method |
| 14332-1 | http://loinc.org | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14334-7 | http://loinc.org | Lithium [Moles/volume] in Serum or Plasma |
| 14398-2 | http://loinc.org | Creatinine [Mass/volume] in Cerebral spinal fluid |
| 14503-7 | http://loinc.org | Human papilloma virus 16+18 Ag [Presence] in Cervix |
| 14522-7 | http://loinc.org | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 145-3 | http://loinc.org | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14567-2 | http://loinc.org | 11-Deoxycortisol [Moles/volume] in Serum or Plasma |
| 14569-8 | http://loinc.org | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
| 14573-0 | http://loinc.org | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
| 14575-5 | http://loinc.org | Blood group antibody investigation [Interpretation] in Plasma or RBC |
| 14581-3 | http://loinc.org | Acetaminophen [Moles/volume] in Serum or Plasma |
| 14586-2 | http://loinc.org | Aldosterone [Moles/volume] in Serum or Plasma |
| 14593-8 | http://loinc.org | Aluminum [Moles/volume] in Serum or Plasma |
| 14597-9 | http://loinc.org | Amitriptyline [Moles/volume] in Serum or Plasma |
| 14603-5 | http://loinc.org | Androstenedione [Moles/volume] in Serum or Plasma |
| 14611-8 | http://loinc.org | Nuclear Ab pattern [Interpretation] in Serum |
| 14622-5 | http://loinc.org | Ascorbate [Moles/volume] in Serum or Plasma |
| 14628-2 | http://loinc.org | Bile acid [Moles/volume] in Serum or Plasma |
| 14629-0 | http://loinc.org | Bilirubin.direct [Moles/volume] in Serum or Plasma |
| 14630-8 | http://loinc.org | Bilirubin.indirect [Moles/volume] in Serum or Plasma |
| 14631-6 | http://loinc.org | Bilirubin.total [Moles/volume] in Serum or Plasma |
| 14635-7 | http://loinc.org | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma |
| 14637-3 | http://loinc.org | Calcium [Moles/time] in 24 hour Urine |
| 14638-1 | http://loinc.org | Calculus analysis [Interpretation] in Stone |
| 14639-9 | http://loinc.org | carBAMazepine [Moles/volume] in Serum or Plasma |
| 14642-3 | http://loinc.org | Carotene [Moles/volume] in Serum or Plasma |
| 14645-6 | http://loinc.org | chlorproMAZINE [Moles/volume] in Serum or Plasma |
| 14646-4 | http://loinc.org | Cholesterol in HDL [Moles/volume] in Serum or Plasma |
| 14647-2 | http://loinc.org | Cholesterol [Moles/volume] in Serum or Plasma |
| 14650-6 | http://loinc.org | Citrate [Moles/time] in 24 hour Urine |
| 14651-4 | http://loinc.org | cloBAZam [Moles/volume] in Serum or Plasma |
| 14652-2 | http://loinc.org | clomiPRAMINE [Moles/volume] in Serum or Plasma |
| 14654-8 | http://loinc.org | clomiPRAMINE+Norclomipramine [Moles/volume] in Serum or Plasma |
| 14655-5 | http://loinc.org | clonazePAM [Moles/volume] in Serum or Plasma |
| 14656-3 | http://loinc.org | cloZAPine [Moles/volume] in Serum or Plasma |
| 14665-4 | http://loinc.org | Copper [Moles/volume] in Serum or Plasma |
| 14666-2 | http://loinc.org | Copper [Moles/time] in 24 hour Urine |
| 14674-6 | http://loinc.org | Corticotropin [Moles/volume] in Plasma |
| 14675-3 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma |
| 14676-1 | http://loinc.org | Cortisol Free [Moles/time] in 24 hour Urine |
| 14678-7 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
| 14679-5 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
| 14682-9 | http://loinc.org | Creatinine [Moles/volume] in Serum or Plasma |
| 14683-7 | http://loinc.org | Creatinine [Moles/volume] in Urine |
| 14684-5 | http://loinc.org | Creatinine [Moles/time] in 24 hour Urine |
| 14685-2 | http://loinc.org | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
| 14688-6 | http://loinc.org | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
| 14691-0 | http://loinc.org | Desipramine [Moles/volume] in Serum or Plasma |
| 14695-1 | http://loinc.org | Nordoxepin [Moles/volume] in Serum or Plasma |
| 14698-5 | http://loinc.org | Digoxin [Moles/volume] in Serum or Plasma |
| 14702-5 | http://loinc.org | Disopyramide [Moles/volume] in Serum or Plasma |
| 14703-3 | http://loinc.org | DOPamine [Moles/volume] in Serum or Plasma |
| 14705-8 | http://loinc.org | Doxepin [Moles/volume] in Serum or Plasma |
| 14711-6 | http://loinc.org | EPINEPHrine [Moles/volume] in Plasma |
| 14712-4 | http://loinc.org | EPINEPHrine [Moles/time] in 24 hour Urine |
| 14715-7 | http://loinc.org | Estradiol (E2) [Moles/volume] in Serum or Plasma |
| 14719-9 | http://loinc.org | Ethanol [Moles/volume] in Serum or Plasma |
| 14720-7 | http://loinc.org | Ethosuximide [Moles/volume] in Serum or Plasma |
| 14722-3 | http://loinc.org | Extractable nuclear Ab [Presence] in Serum |
| 14726-4 | http://loinc.org | Fluoride [Moles/volume] in Serum or Plasma |
| 14731-4 | http://loinc.org | Folate [Moles/volume] in Red Blood Cells |
| 14732-2 | http://loinc.org | Folate [Moles/volume] in Serum or Plasma |
| 14744-7 | http://loinc.org | Glucose [Moles/volume] in Cerebral spinal fluid |
| 14745-4 | http://loinc.org | Glucose [Moles/volume] in Body fluid |
| 14749-6 | http://loinc.org | Glucose [Moles/volume] in Serum or Plasma |
| 14754-6 | http://loinc.org | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 14761-1 | http://loinc.org | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
| 14770-2 | http://loinc.org | Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
| 14771-0 | http://loinc.org | Fasting glucose [Moles/volume] in Serum or Plasma |
| 14782-7 | http://loinc.org | Homovanillate [Moles/volume] in Urine |
| 14783-5 | http://loinc.org | Homovanillate [Moles/time] in 24 hour Urine |
| 14785-0 | http://loinc.org | Hydroxyproline [Moles/time] in 24 hour Urine |
| 14796-7 | http://loinc.org | Insulin [Moles/volume] in Serum or Plasma |
| 14798-3 | http://loinc.org | Iron [Moles/volume] in Serum or Plasma |
| 14799-1 | http://loinc.org | Iron [Moles/time] in 24 hour Urine |
| 14800-7 | http://loinc.org | Iron binding capacity [Moles/volume] in Serum or Plasma |
| 14801-5 | http://loinc.org | Iron saturation [Molar fraction] in Serum or Plasma |
| 14803-1 | http://loinc.org | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
| 14804-9 | http://loinc.org | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
| 14805-6 | http://loinc.org | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
| 14807-2 | http://loinc.org | Lead [Moles/volume] in Blood |
| 14809-8 | http://loinc.org | Lead [Moles/time] in 24 hour Urine |
| 14812-2 | http://loinc.org | Lidocaine [Moles/volume] in Serum or Plasma |
| 14833-8 | http://loinc.org | Metanephrines [Moles/time] in 24 hour Urine |
| 14835-3 | http://loinc.org | Methanol [Moles/volume] in Serum or Plasma |
| 14836-1 | http://loinc.org | Methotrexate [Moles/volume] in Serum or Plasma |
| 14852-8 | http://loinc.org | Norepinephrine [Moles/volume] in Plasma |
| 14853-6 | http://loinc.org | Norepinephrine [Moles/volume] in Urine |
| 14854-4 | http://loinc.org | Norepinephrine [Moles/time] in 24 hour Urine |
| 14856-9 | http://loinc.org | Nortriptyline [Moles/volume] in Serum or Plasma |
| 14862-7 | http://loinc.org | Oxalate [Moles/time] in 24 hour Urine |
| 14866-8 | http://loinc.org | Parathyrin.intact [Moles/volume] in Serum or Plasma |
| 14874-2 | http://loinc.org | PHENobarbital [Moles/volume] in Serum or Plasma |
| 14877-5 | http://loinc.org | Phenytoin [Moles/volume] in Serum or Plasma |
| 14879-1 | http://loinc.org | Phosphate [Moles/volume] in Serum or Plasma |
| 14881-7 | http://loinc.org | Phosphate [Moles/time] in 24 hour Urine |
| 14883-3 | http://loinc.org | Porphyrins [Interpretation] in Serum or Plasma |
| 14885-8 | http://loinc.org | Pregnanediol [Moles/time] in 24 hour Urine |
| 14890-8 | http://loinc.org | Progesterone [Moles/volume] in Serum or Plasma |
| 14899-9 | http://loinc.org | quiNIDine [Moles/volume] in Serum or Plasma |
| 14905-4 | http://loinc.org | Retinol [Moles/volume] in Serum or Plasma |
| 14909-6 | http://loinc.org | Salicylates [Moles/volume] in Serum or Plasma |
| 14913-8 | http://loinc.org | Testosterone [Moles/volume] in Serum or Plasma |
| 14914-6 | http://loinc.org | Testosterone Free [Moles/volume] in Serum or Plasma |
| 14915-3 | http://loinc.org | Theophylline [Moles/volume] in Serum or Plasma |
| 14920-3 | http://loinc.org | Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
| 14921-1 | http://loinc.org | Thyroxine (T4) [Moles/volume] in Serum or Plasma |
| 14927-8 | http://loinc.org | Triglyceride [Moles/volume] in Serum or Plasma |
| 14928-6 | http://loinc.org | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
| 14930-2 | http://loinc.org | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
| 14931-0 | http://loinc.org | Trimipramine [Moles/volume] in Serum or Plasma |
| 14933-6 | http://loinc.org | Urate [Moles/volume] in Serum or Plasma |
| 14934-4 | http://loinc.org | Urate [Moles/volume] in Urine |
| 14935-1 | http://loinc.org | Urate [Moles/time] in 24 hour Urine |
| 14939-3 | http://loinc.org | Urea nitrogen [Moles/time] in 24 hour Urine |
| 14946-8 | http://loinc.org | Valproate [Moles/volume] in Serum or Plasma |
| 14947-6 | http://loinc.org | Vanillylmandelate [Moles/time] in 24 hour Urine |
| 14948-4 | http://loinc.org | Vanillylmandelate/Creatinine [Molar ratio] in Urine |
| 14949-2 | http://loinc.org | Vasopressin [Moles/volume] in Plasma |
| 149-5 | http://loinc.org | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14955-9 | http://loinc.org | Zinc [Moles/volume] in Serum or Plasma |
| 14956-7 | http://loinc.org | Microalbumin [Mass/time] in 24 hour Urine |
| 14957-5 | http://loinc.org | Microalbumin [Mass/volume] in Urine |
| 14959-1 | http://loinc.org | Microalbumin/Creatinine [Mass Ratio] in Urine |
| 14979-9 | http://loinc.org | aPTT in Platelet poor plasma by Coagulation assay |
| 14995-5 | http://loinc.org | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 15009-4 | http://loinc.org | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
| 15032-6 | http://loinc.org | Angiotensin II [Moles/volume] in Plasma |
| 15034-2 | http://loinc.org | Bromide [Moles/volume] in Serum or Plasma |
| 15038-3 | http://loinc.org | Citrate [Moles/volume] in Serum or Plasma |
| 15057-3 | http://loinc.org | Androstanolone [Moles/volume] in Serum or Plasma |
| 15058-1 | http://loinc.org | DOPamine [Moles/volume] in Urine |
| 15059-9 | http://loinc.org | DOPamine [Moles/time] in 24 hour Urine |
| 15061-5 | http://loinc.org | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
| 15066-4 | http://loinc.org | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
| 15067-2 | http://loinc.org | Follitropin [Units/volume] in Serum or Plasma |
| 15069-8 | http://loinc.org | Fructosamine [Moles/volume] in Serum or Plasma |
| 15072-2 | http://loinc.org | Gastrin [Moles/volume] in Serum or Plasma |
| 15074-8 | http://loinc.org | Glucose [Moles/volume] in Blood |
| 15076-3 | http://loinc.org | Glucose [Moles/volume] in Urine |
| 15081-3 | http://loinc.org | Prolactin [Units/volume] in Serum or Plasma |
| 15083-9 | http://loinc.org | Normetanephrine [Moles/time] in 24 hour Urine |
| 15087-0 | http://loinc.org | Parathyrin related protein [Moles/volume] in Serum or Plasma |
| 15097-9 | http://loinc.org | Vanillylmandelate [Moles/volume] in Urine |
| 15099-5 | http://loinc.org | Amiodarone [Moles/volume] in Serum or Plasma |
| 15105-0 | http://loinc.org | Flecainide [Moles/volume] in Serum or Plasma |
| 15107-6 | http://loinc.org | Imipramine [Moles/volume] in Serum or Plasma |
| 15108-4 | http://loinc.org | Methadone [Moles/volume] in Serum or Plasma |
| 15115-9 | http://loinc.org | Arsenic [Moles/volume] in Urine |
| 15117-5 | http://loinc.org | Cadmium [Moles/volume] in Blood |
| 15120-9 | http://loinc.org | Ethanol [Moles/volume] in Blood |
| 15148-0 | http://loinc.org | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
| 15176-1 | http://loinc.org | Cryoproteins identified in Serum or Plasma |
| 15179-5 | http://loinc.org | Fibrin D-dimer [Presence] in Platelet poor plasma |
| 15200-9 | http://loinc.org | Osmolality of Body fluid |
| 15210-8 | http://loinc.org | Thyroglobulin Ab [Presence] in Serum |
| 15359-3 | http://loinc.org | dRVVT actual/normal (normalized LA screen) |
| 15363-5 | http://loinc.org | Busulfan [Mass/volume] in Serum or Plasma |
| 153-7 | http://loinc.org | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 15374-2 | http://loinc.org | Sulfonylurea [Presence] in Serum or Plasma |
| 15376-7 | http://loinc.org | Spermatozoa Abnormal/100 spermatozoa in Semen |
| 15410-4 | http://loinc.org | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
| 157-8 | http://loinc.org | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16099-4 | http://loinc.org | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 161-0 | http://loinc.org | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16100-0 | http://loinc.org | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16128-1 | http://loinc.org | Hepatitis C virus Ab [Presence] in Serum |
| 16130-7 | http://loinc.org | Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with probe detection |
| 16131-5 | http://loinc.org | Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with probe detection |
| 16195-0 | http://loinc.org | Benzodiazepines [Presence] in Urine by Confirmatory method |
| 16201-6 | http://loinc.org | Oxazepam [Mass/volume] in Urine by Confirmatory method |
| 16206-5 | http://loinc.org | Temazepam [Presence] in Urine by Confirmatory method |
| 16208-1 | http://loinc.org | Buprenorphine [Presence] in Urine by Confirmatory method |
| 16221-4 | http://loinc.org | Phenothiazines [Presence] in Urine by Confirmatory method |
| 16226-3 | http://loinc.org | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
| 16227-1 | http://loinc.org | diazePAM [Mass/volume] in Urine by Confirmatory method |
| 16228-9 | http://loinc.org | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
| 16235-4 | http://loinc.org | Methamphetamine [Mass/volume] in Urine by Confirmatory method |
| 16249-5 | http://loinc.org | oxyCODONE [Mass/volume] in Urine by Confirmatory method |
| 16250-3 | http://loinc.org | Codeine [Mass/volume] in Urine by Confirmatory method |
| 16251-1 | http://loinc.org | Morphine [Mass/volume] in Urine by Confirmatory method |
| 16254-5 | http://loinc.org | Phencyclidine [Mass/volume] in Urine by Confirmatory method |
| 16276-8 | http://loinc.org | Bartonella henselae DNA [Presence] in Blood by NAA with probe detection |
| 16284-2 | http://loinc.org | Polio virus Ab [Units/volume] in Serum |
| 16337-8 | http://loinc.org | Alkaline phosphatase [Enzymatic activity/volume] in Urine |
| 16348-5 | http://loinc.org | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 16362-6 | http://loinc.org | Ammonia [Moles/volume] in Plasma |
| 16429-3 | http://loinc.org | Barbiturates [Presence] in Urine by Confirmatory method |
| 1648-5 | http://loinc.org | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal |
| 165-1 | http://loinc.org | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16550-6 | http://loinc.org | Carbohydrates [Identifier] in Urine |
| 16-6 | http://loinc.org | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16623-1 | http://loinc.org | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16676-9 | http://loinc.org | Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture |
| 16688-4 | http://loinc.org | Creatine kinase [Enzymatic activity/volume] in Body fluid |
| 16835-1 | http://loinc.org | Escherichia coli shiga-like toxin identified in Stool by Organism specific culture |
| 16836-9 | http://loinc.org | Escherichia coli verotoxic identified in Stool by Organism specific culture |
| 16853-4 | http://loinc.org | Fat [Mass] in Stool |
| 16859-1 | http://loinc.org | Fibrinogen [Presence] in Platelet poor plasma |
| 16901-1 | http://loinc.org | Gliadin IgA Ab [Presence] in Serum |
| 16902-9 | http://loinc.org | Gliadin IgG Ab [Presence] in Serum |
| 169-3 | http://loinc.org | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16933-4 | http://loinc.org | Hepatitis B virus core Ab [Presence] in Serum |
| 16935-9 | http://loinc.org | Hepatitis B virus surface Ab [Units/volume] in Serum |
| 1714-5 | http://loinc.org | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
| 17146-2 | http://loinc.org | CD4+CD8+ cells/100 cells in Blood |
| 1715-2 | http://loinc.org | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 17263-5 | http://loinc.org | Methemalbumin [Presence] in Serum or Plasma |
| 173-5 | http://loinc.org | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17395-5 | http://loinc.org | oxyMORphone [Mass/volume] in Urine by Confirmatory method |
| 1742-6 | http://loinc.org | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 1746-7 | http://loinc.org | Albumin [Mass/volume] in Cerebral spinal fluid |
| 1747-5 | http://loinc.org | Albumin [Mass/volume] in Body fluid |
| 1751-7 | http://loinc.org | Albumin [Mass/volume] in Serum or Plasma |
| 17547-1 | http://loinc.org | Rotavirus Ag [Presence] in Stool |
| 1756-6 | http://loinc.org | Albumin in CSF/Albumin in Serum or Plasma |
| 17571-1 | http://loinc.org | Scopolamine [Mass/volume] in Urine |
| 17607-3 | http://loinc.org | Volume of Cerebral spinal fluid |
| 1761-6 | http://loinc.org | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
| 177-6 | http://loinc.org | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1777-2 | http://loinc.org | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
| 17793-1 | http://loinc.org | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
| 17843-4 | http://loinc.org | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
| 17857-4 | http://loinc.org | Rheumatoid factor [Titer] in Serum |
| 17869-9 | http://loinc.org | Orotate/Creatinine [Molar ratio] in Urine |
| 1795-4 | http://loinc.org | Amylase [Enzymatic activity/volume] in Body fluid |
| 1798-8 | http://loinc.org | Amylase [Enzymatic activity/volume] in Serum or Plasma |
| 1799-6 | http://loinc.org | Amylase [Enzymatic activity/volume] in Urine |
| 1-8 | http://loinc.org | Acyclovir [Susceptibility] |
| 1805-1 | http://loinc.org | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma |
| 181-8 | http://loinc.org | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1824-2 | http://loinc.org | Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
| 1825-9 | http://loinc.org | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
| 18261-8 | http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 18263-4 | http://loinc.org | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 18282-4 | http://loinc.org | Cannabinoids [Presence] in Urine by Screen method |
| 18286-5 | http://loinc.org | Donath Landsteiner Ab [Presence] in Blood |
| 1834-1 | http://loinc.org | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
| 18358-2 | http://loinc.org | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 18390-5 | http://loinc.org | Opiates [Presence] in Urine by Confirmatory method |
| 18481-2 | http://loinc.org | Streptococcus pyogenes Ag [Presence] in Throat |
| 185-9 | http://loinc.org | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1863-0 | http://loinc.org | Anion gap 4 in Serum or Plasma |
| 1869-7 | http://loinc.org | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
| 1884-6 | http://loinc.org | Apolipoprotein B [Mass/volume] in Serum or Plasma |
| 18855-7 | http://loinc.org | 5-Fluorocytosine [Susceptibility] |
| 18857-3 | http://loinc.org | Almecillin [Susceptibility] |
| 18859-9 | http://loinc.org | Amdinocillin [Susceptibility] |
| 18860-7 | http://loinc.org | Amikacin [Susceptibility] |
| 18861-5 | http://loinc.org | Amoxicillin [Susceptibility] |
| 18862-3 | http://loinc.org | Amoxicillin+Clavulanate [Susceptibility] |
| 18863-1 | http://loinc.org | Amphotericin B [Susceptibility] |
| 18864-9 | http://loinc.org | Ampicillin [Susceptibility] |
| 18865-6 | http://loinc.org | Ampicillin+Sulbactam [Susceptibility] |
| 18866-4 | http://loinc.org | Azithromycin [Susceptibility] |
| 18867-2 | http://loinc.org | Azlocillin [Susceptibility] |
| 18868-0 | http://loinc.org | Aztreonam [Susceptibility] |
| 18869-8 | http://loinc.org | Bacampicillin [Susceptibility] |
| 18870-6 | http://loinc.org | Bacitracin [Susceptibility] |
| 18871-4 | http://loinc.org | Butirosin [Susceptibility] |
| 18872-2 | http://loinc.org | Capreomycin [Susceptibility] |
| 18873-0 | http://loinc.org | Carbenicillin [Susceptibility] |
| 18874-8 | http://loinc.org | Cefaclor [Susceptibility] |
| 18875-5 | http://loinc.org | Cefadroxil [Susceptibility] |
| 18876-3 | http://loinc.org | Cefamandole [Susceptibility] |
| 18877-1 | http://loinc.org | Cefatrizine [Susceptibility] |
| 18878-9 | http://loinc.org | ceFAZolin [Susceptibility] |
| 18879-7 | http://loinc.org | Cefepime [Susceptibility] |
| 18880-5 | http://loinc.org | Cefixime [Susceptibility] |
| 18881-3 | http://loinc.org | Cefmetazole [Susceptibility] |
| 18882-1 | http://loinc.org | Cefodizime [Susceptibility] |
| 18883-9 | http://loinc.org | Cefonicid [Susceptibility] |
| 18884-7 | http://loinc.org | Cefoperazone [Susceptibility] |
| 18885-4 | http://loinc.org | Ceforanide [Susceptibility] |
| 18886-2 | http://loinc.org | Cefotaxime [Susceptibility] |
| 18887-0 | http://loinc.org | cefoTEtan [Susceptibility] |
| 18888-8 | http://loinc.org | cefOXitin [Susceptibility] |
| 18889-6 | http://loinc.org | Cefpirome [Susceptibility] |
| 18890-4 | http://loinc.org | Cefpodoxime [Susceptibility] |
| 18891-2 | http://loinc.org | Cefprozil [Susceptibility] |
| 18892-0 | http://loinc.org | Cefsulodin [Susceptibility] |
| 18893-8 | http://loinc.org | cefTAZidime [Susceptibility] |
| 18894-6 | http://loinc.org | Ceftizoxime [Susceptibility] |
| 18895-3 | http://loinc.org | cefTRIAXone [Susceptibility] |
| 18896-1 | http://loinc.org | Cefuroxime Parenteral [Susceptibility] |
| 18897-9 | http://loinc.org | Cephalexin [Susceptibility] |
| 18898-7 | http://loinc.org | Cephaloglycin [Susceptibility] |
| 18899-5 | http://loinc.org | Cephaloridine [Susceptibility] |
| 18900-1 | http://loinc.org | Cephalothin [Susceptibility] |
| 18901-9 | http://loinc.org | Cephapirin [Susceptibility] |
| 18902-7 | http://loinc.org | Cephradine [Susceptibility] |
| 18903-5 | http://loinc.org | Chloramphenicol [Susceptibility] |
| 18904-3 | http://loinc.org | Chlortetracycline [Susceptibility] |
| 18905-0 | http://loinc.org | Cinoxacin [Susceptibility] |
| 18906-8 | http://loinc.org | Ciprofloxacin [Susceptibility] |
| 18907-6 | http://loinc.org | Clarithromycin [Susceptibility] |
| 18908-4 | http://loinc.org | Clindamycin [Susceptibility] |
| 18909-2 | http://loinc.org | Clotrimazole [Susceptibility] |
| 189-1 | http://loinc.org | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 18910-0 | http://loinc.org | Cloxacillin [Susceptibility] |
| 18911-8 | http://loinc.org | Colistimethate |
| 18912-6 | http://loinc.org | Colistin [Susceptibility] |
| 18913-4 | http://loinc.org | Cyclacillin [Susceptibility] |
| 18914-2 | http://loinc.org | cycloSERINE [Susceptibility] |
| 18915-9 | http://loinc.org | Demeclocycline [Susceptibility] |
| 18916-7 | http://loinc.org | Dicloxacillin [Susceptibility] |
| 18917-5 | http://loinc.org | Doxycycline [Susceptibility] |
| 18918-3 | http://loinc.org | Enoxacin [Susceptibility] |
| 18919-1 | http://loinc.org | Erythromycin [Susceptibility] |
| 18921-7 | http://loinc.org | Ethambutol [Susceptibility] |
| 18922-5 | http://loinc.org | Ethionamide [Susceptibility] |
| 18923-3 | http://loinc.org | Floxacillin [Susceptibility] |
| 18924-1 | http://loinc.org | Fluconazole [Susceptibility] |
| 18926-6 | http://loinc.org | Framycetin [Susceptibility] |
| 18927-4 | http://loinc.org | Fusidate [Susceptibility] |
| 18928-2 | http://loinc.org | Gentamicin [Susceptibility] |
| 18929-0 | http://loinc.org | Gentamicin.high potency [Susceptibility] |
| 18930-8 | http://loinc.org | Gramicidin D [Susceptibility] |
| 18931-6 | http://loinc.org | Hetacillin [Susceptibility] |
| 18932-4 | http://loinc.org | Imipenem [Susceptibility] |
| 18934-0 | http://loinc.org | Isoniazid [Susceptibility] |
| 18935-7 | http://loinc.org | Kanamycin [Susceptibility] |
| 18936-5 | http://loinc.org | Kanamycin.high potency [Susceptibility] |
| 18937-3 | http://loinc.org | Ketoconazole [Susceptibility] |
| 18938-1 | http://loinc.org | Lincomycin [Susceptibility] |
| 18939-9 | http://loinc.org | Lomefloxacin [Susceptibility] |
| 18940-7 | http://loinc.org | Loracarbef [Susceptibility] |
| 18941-5 | http://loinc.org | Lymecycline [Susceptibility] |
| 18942-3 | http://loinc.org | Meclocycline [Susceptibility] |
| 18943-1 | http://loinc.org | Meropenem [Susceptibility] |
| 18944-9 | http://loinc.org | Methacycline [Susceptibility] |
| 18945-6 | http://loinc.org | Methicillin [Susceptibility] |
| 18946-4 | http://loinc.org | metroNIDAZOLE [Susceptibility] |
| 18947-2 | http://loinc.org | Mezlocillin [Susceptibility] |
| 18948-0 | http://loinc.org | Minocycline [Susceptibility] |
| 18949-8 | http://loinc.org | Miocamycin [Susceptibility] |
| 18950-6 | http://loinc.org | Moxalactam [Susceptibility] |
| 18951-4 | http://loinc.org | Nafcillin [Susceptibility] |
| 18952-2 | http://loinc.org | Nalidixate [Susceptibility] |
| 18953-0 | http://loinc.org | Neomycin [Susceptibility] |
| 18954-8 | http://loinc.org | Netilmicin [Susceptibility] |
| 18955-5 | http://loinc.org | Nitrofurantoin [Susceptibility] |
| 18956-3 | http://loinc.org | Norfloxacin [Susceptibility] |
| 18957-1 | http://loinc.org | Novobiocin [Susceptibility] |
| 18958-9 | http://loinc.org | Nystatin [Susceptibility] |
| 18959-7 | http://loinc.org | Ofloxacin [Susceptibility] |
| 18960-5 | http://loinc.org | Oleandomycin [Susceptibility] |
| 18961-3 | http://loinc.org | Oxacillin [Susceptibility] |
| 18962-1 | http://loinc.org | Oxytetracycline [Susceptibility] |
| 18963-9 | http://loinc.org | Pefloxacin [Susceptibility] |
| 18964-7 | http://loinc.org | Penicillin [Susceptibility] |
| 18965-4 | http://loinc.org | Penicillin G [Susceptibility] |
| 18966-2 | http://loinc.org | Penicillin V [Susceptibility] |
| 18967-0 | http://loinc.org | Phenethicillin [Susceptibility] |
| 18968-8 | http://loinc.org | Pipemidate [Susceptibility] |
| 18969-6 | http://loinc.org | Piperacillin [Susceptibility] |
| 18970-4 | http://loinc.org | Piperacillin+Tazobactam [Susceptibility] |
| 18971-2 | http://loinc.org | Pivampicillin [Susceptibility] |
| 18972-0 | http://loinc.org | Polymyxin B [Susceptibility] |
| 18973-8 | http://loinc.org | Pyrazinamide [Susceptibility] |
| 18974-6 | http://loinc.org | rifAMPin [Susceptibility] |
| 18975-3 | http://loinc.org | Ristocetin [Susceptibility] |
| 18976-1 | http://loinc.org | Rolitetracycline [Susceptibility] |
| 18977-9 | http://loinc.org | Rosoxacin [Susceptibility] |
| 18978-7 | http://loinc.org | Roxithromycin [Susceptibility] |
| 18979-5 | http://loinc.org | Sisomicin [Susceptibility] |
| 18980-3 | http://loinc.org | Spectinomycin [Susceptibility] |
| 18981-1 | http://loinc.org | Spiramycin [Susceptibility] |
| 18982-9 | http://loinc.org | Streptomycin [Susceptibility] |
| 18983-7 | http://loinc.org | Streptomycin.high potency [Susceptibility] |
| 18984-5 | http://loinc.org | sulfADIAZINE [Susceptibility] |
| 18985-2 | http://loinc.org | Sulfamethoxazole [Susceptibility] |
| 18986-0 | http://loinc.org | sulfiSOXAZOLE [Susceptibility] |
| 18987-8 | http://loinc.org | Sulfonamide [Susceptibility] |
| 18988-6 | http://loinc.org | Talampicillin [Susceptibility] |
| 18989-4 | http://loinc.org | Teicoplanin [Susceptibility] |
| 18990-2 | http://loinc.org | Temafloxacin [Susceptibility] |
| 18991-0 | http://loinc.org | Temocillin [Susceptibility] |
| 18992-8 | http://loinc.org | Terbinafine [Susceptibility] |
| 18993-6 | http://loinc.org | Tetracycline [Susceptibility] |
| 18994-4 | http://loinc.org | Ticarcillin [Susceptibility] |
| 18995-1 | http://loinc.org | Ticarcillin+Clavulanate [Susceptibility] |
| 18996-9 | http://loinc.org | Tobramycin [Susceptibility] |
| 18997-7 | http://loinc.org | Trimethoprim [Susceptibility] |
| 18998-5 | http://loinc.org | Trimethoprim+Sulfamethoxazole [Susceptibility] |
| 18999-3 | http://loinc.org | Troleandomycin [Susceptibility] |
| 19000-9 | http://loinc.org | Vancomycin [Susceptibility] |
| 19001-7 | http://loinc.org | Viomycin [Susceptibility] |
| 19048-8 | http://loinc.org | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood |
| 19057-9 | http://loinc.org | ABO and Rh group [Type] in Blood from Newborn |
| 19072-8 | http://loinc.org | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma |
| 19077-7 | http://loinc.org | Cells identified in Body fluid |
| 19080-1 | http://loinc.org | Choriogonadotropin [Units/volume] in Serum or Plasma |
| 19090-0 | http://loinc.org | Colony count [#/volume] in Urine |
| 19113-0 | http://loinc.org | IgE [Units/volume] in Serum or Plasma |
| 19141-1 | http://loinc.org | Propoxyphene [Presence] in Urine |
| 19149-4 | http://loinc.org | Rifabutin [Susceptibility] |
| 19176-7 | http://loinc.org | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
| 19180-9 | http://loinc.org | Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma |
| 1920-8 | http://loinc.org | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 19261-7 | http://loinc.org | Amphetamines [Presence] in Urine by Screen method |
| 19270-8 | http://loinc.org | Barbiturates [Presence] in Urine by Screen method |
| 1928-1 | http://loinc.org | Immunoglobulin light chains [Presence] in Urine |
| 19289-8 | http://loinc.org | Cannabinoids [Presence] in Urine by Confirmatory method |
| 19295-5 | http://loinc.org | Opiates [Presence] in Urine by Screen method |
| 1929-9 | http://loinc.org | Immunoglobulin light chains [Mass/volume] in Urine |
| 193-3 | http://loinc.org | Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 19360-7 | http://loinc.org | Cocaine [Presence] in Urine by Confirmatory method |
| 19411-8 | http://loinc.org | Codeine [Presence] in Urine by Screen method |
| 1942-2 | http://loinc.org | Beta galactosidase [Enzymatic activity/mass] in Tissue |
| 19429-0 | http://loinc.org | Propoxyphene [Presence] in Urine by Screen method |
| 1952-1 | http://loinc.org | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
| 1953-9 | http://loinc.org | Beta-2-Microglobulin [Mass/volume] in Urine |
| 19550-3 | http://loinc.org | Methadone [Presence] in Urine by Screen method |
| 19554-5 | http://loinc.org | Methamphetamine [Presence] in Urine by Screen method |
| 19561-0 | http://loinc.org | Methylenediamine [Presence] in Urine by Screen method |
| 19564-4 | http://loinc.org | Methylenediamine cutoff [Mass/volume] in Urine for Confirmatory method |
| 19568-5 | http://loinc.org | Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
| 19577-6 | http://loinc.org | Methylphenidate [Presence] in Urine by Screen method |
| 19578-4 | http://loinc.org | Methylphenidate [Presence] in Urine by Confirmatory method |
| 1959-6 | http://loinc.org | Bicarbonate [Moles/volume] in Blood |
| 19597-4 | http://loinc.org | Morphine [Presence] in Urine by Screen method |
| 19624-6 | http://loinc.org | Nordiazepam [Presence] in Urine by Screen method |
| 1963-8 | http://loinc.org | Bicarbonate [Moles/volume] in Serum or Plasma |
| 19638-6 | http://loinc.org | Oxazepam [Presence] in Urine by Screen method |
| 19642-8 | http://loinc.org | oxyCODONE [Presence] in Urine by Screen method |
| 19659-2 | http://loinc.org | Phencyclidine [Presence] in Urine by Screen method |
| 19670-9 | http://loinc.org | Phenothiazines [Presence] in Urine by Screen method |
| 19710-3 | http://loinc.org | traMADol [Presence] in Urine by Screen method |
| 197-4 | http://loinc.org | Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 19762-4 | http://loinc.org | General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
| 19763-2 | http://loinc.org | Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 19764-0 | http://loinc.org | Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain |
| 19765-7 | http://loinc.org | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 19772-3 | http://loinc.org | Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain |
| 19773-1 | http://loinc.org | Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 1988-5 | http://loinc.org | C reactive protein [Mass/volume] in Serum or Plasma |
| 1992-7 | http://loinc.org | Calcitonin [Mass/volume] in Serum or Plasma |
| 1995-0 | http://loinc.org | Calcium.ionized [Moles/volume] in Serum or Plasma |
| 2000-8 | http://loinc.org | Calcium [Moles/volume] in Serum or Plasma |
| 2004-0 | http://loinc.org | Calcium [Moles/volume] in Urine |
| 201-4 | http://loinc.org | Colistimethate by Minimum inhibitory concentration (MIC) |
| 20388-5 | http://loinc.org | Nitrofurazone [Susceptibility] |
| 20389-3 | http://loinc.org | Mupirocin [Susceptibility] |
| 20390-1 | http://loinc.org | Silver sulfADIAZINE [Susceptibility] |
| 20391-9 | http://loinc.org | Mafenide [Susceptibility] |
| 2039-6 | http://loinc.org | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
| 20396-8 | http://loinc.org | levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20397-6 | http://loinc.org | Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20402-4 | http://loinc.org | CD16+CD56+ cells [#/volume] in Blood |
| 20404-0 | http://loinc.org | Fibronectin.fetal [Presence] in Vaginal fluid |
| 20447-9 | http://loinc.org | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 20453-7 | http://loinc.org | Epithelial cells [Presence] in Urine sediment by Light microscopy |
| 20454-5 | http://loinc.org | Protein [Presence] in Urine by Test strip |
| 20460-2 | http://loinc.org | Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20483-4 | http://loinc.org | Mitochondria Ab [Titer] in Serum |
| 20490-9 | http://loinc.org | Epstein Barr virus capsid IgG Ab [Titer] in Serum |
| 20491-7 | http://loinc.org | Epstein Barr virus capsid IgM Ab [Titer] in Serum |
| 20495-8 | http://loinc.org | Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
| 20496-6 | http://loinc.org | Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
| 20507-0 | http://loinc.org | Reagin Ab [Presence] in Serum by RPR |
| 20510-4 | http://loinc.org | Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis |
| 20521-1 | http://loinc.org | Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 205-5 | http://loinc.org | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20559-1 | http://loinc.org | Temazepam [Mass/volume] in Urine by Confirmatory method |
| 20563-3 | http://loinc.org | Carboxyhemoglobin/Hemoglobin.total in Blood |
| 20565-8 | http://loinc.org | Carbon dioxide, total [Moles/volume] in Blood |
| 20569-0 | http://loinc.org | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma |
| 20570-8 | http://loinc.org | Hematocrit [Volume Fraction] of Blood |
| 20575-7 | http://loinc.org | Hepatitis A virus Ab [Presence] in Serum |
| 20576-5 | http://loinc.org | Galactose 1 phosphate uridyl transferase [Presence] in Blood |
| 20578-1 | http://loinc.org | Vancomycin [Mass/volume] in Serum or Plasma |
| 20626-8 | http://loinc.org | Reducing substances [Units/volume] in Urine by Test strip |
| 20629-2 | http://loinc.org | levoFLOXacin [Susceptibility] |
| 2064-4 | http://loinc.org | Ceruloplasmin [Mass/volume] in Serum or Plasma |
| 20662-3 | http://loinc.org | Allergens tested for in Serum |
| 2069-3 | http://loinc.org | Chloride [Moles/volume] in Blood |
| 20719-1 | http://loinc.org | Brucella abortus Ab [Titer] in Serum by Tube agglutination |
| 2072-7 | http://loinc.org | Chloride [Moles/volume] in Body fluid |
| 20728-2 | http://loinc.org | Brucella abortus Ab [Presence] in Serum by Complement fixation |
| 2075-0 | http://loinc.org | Chloride [Moles/volume] in Serum or Plasma |
| 2077-6 | http://loinc.org | Chloride [Moles/volume] in Sweat |
| 2078-4 | http://loinc.org | Chloride [Moles/volume] in Urine |
| 2079-2 | http://loinc.org | Chloride [Moles/time] in 24 hour Urine |
| 20-8 | http://loinc.org | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 209-7 | http://loinc.org | Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 20981-7 | http://loinc.org | Verotoxin identified in Isolate |
| 2098-2 | http://loinc.org | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 2099-0 | http://loinc.org | Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 21027-8 | http://loinc.org | Platelet aggregation [Interpretation] in Platelet poor plasma |
| 2106-3 | http://loinc.org | Choriogonadotropin (pregnancy test) [Presence] in Urine |
| 21070-8 | http://loinc.org | Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2118-8 | http://loinc.org | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
| 21198-7 | http://loinc.org | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
| 21233-2 | http://loinc.org | Cryptosporidium sp Ag [Presence] in Stool |
| 21259-7 | http://loinc.org | Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination |
| 21363-7 | http://loinc.org | Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection |
| 21365-2 | http://loinc.org | Leptin [Mass/volume] in Serum or Plasma |
| 21387-6 | http://loinc.org | Methylhippurate [Mass/volume] in Urine |
| 213-9 | http://loinc.org | cycloSERINE [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 21436-1 | http://loinc.org | Ovary Ab [Presence] in Serum by Immunofluorescence |
| 21566-5 | http://loinc.org | TOLAZamide [Presence] in Serum or Plasma |
| 21567-3 | http://loinc.org | TOLBUTamide [Presence] in Serum or Plasma |
| 2157-6 | http://loinc.org | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
| 21582-2 | http://loinc.org | Tryptase [Mass/volume] in Serum or Plasma |
| 21613-5 | http://loinc.org | Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection |
| 2164-2 | http://loinc.org | Creatinine renal clearance in 24 hour Urine and Serum or Plasma |
| 217-0 | http://loinc.org | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 221-2 | http://loinc.org | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22150-7 | http://loinc.org | Brucella abortus Ab [Titer] in Serum |
| 22244-8 | http://loinc.org | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma |
| 22246-3 | http://loinc.org | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma |
| 22249-7 | http://loinc.org | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma |
| 22298-4 | http://loinc.org | Epstein Barr virus nuclear IgG Ab [Titer] in Serum |
| 22312-3 | http://loinc.org | Hepatitis A virus Ab [Units/volume] in Serum |
| 22313-1 | http://loinc.org | Hepatitis A virus IgG Ab [Units/volume] in Serum |
| 22314-9 | http://loinc.org | Hepatitis A virus IgM Ab [Presence] in Serum |
| 22320-6 | http://loinc.org | Hepatitis B virus e Ab [Presence] in Serum |
| 22322-2 | http://loinc.org | Hepatitis B virus surface Ab [Presence] in Serum |
| 22396-6 | http://loinc.org | Legionella pneumophila Ab [Titer] in Serum |
| 22425-3 | http://loinc.org | Mycoplasma pneumoniae Ab [Titer] in Serum |
| 22466-7 | http://loinc.org | Respiratory syncytial virus Ab [Titer] in Serum |
| 22496-4 | http://loinc.org | Rubella virus Ab [Presence] in Serum |
| 22497-2 | http://loinc.org | Rubella virus Ab [Titer] in Serum |
| 225-3 | http://loinc.org | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 22568-0 | http://loinc.org | Streptolysin O Ab [Titer] in Serum |
| 22580-5 | http://loinc.org | Toxoplasma gondii IgG Ab [Presence] in Serum |
| 22582-1 | http://loinc.org | Toxoplasma gondii IgG Ab [Titer] in Serum |
| 22584-7 | http://loinc.org | Toxoplasma gondii IgM Ab [Titer] in Serum |
| 22664-7 | http://loinc.org | Urea [Moles/volume] in Serum or Plasma |
| 22689-4 | http://loinc.org | Zinc [Moles/time] in 24 hour Urine |
| 22700-9 | http://loinc.org | Urea [Moles/volume] in Urine |
| 22704-1 | http://loinc.org | Carnitine free (C0)/Creatinine [Molar ratio] in Urine |
| 22708-2 | http://loinc.org | Homovanillate/Creatinine [Molar ratio] in Urine |
| 2271-5 | http://loinc.org | Fat [Mass/time] in 72 hour Stool |
| 22745-4 | http://loinc.org | Ethanol [Moles/volume] in Urine |
| 22748-8 | http://loinc.org | Cholesterol in LDL [Moles/volume] in Serum or Plasma |
| 22749-6 | http://loinc.org | Amylase.pancreatic [Enzymatic activity/volume] in Urine |
| 2276-4 | http://loinc.org | Ferritin [Mass/volume] in Serum or Plasma |
| 229-5 | http://loinc.org | Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2306-9 | http://loinc.org | Galactose [Presence] in Blood |
| 23159-7 | http://loinc.org | Leishmania sp DNA [Identifier] in Specimen by NAA with probe detection |
| 23198-5 | http://loinc.org | Leptospira sp Ab [Titer] in Serum by Agglutination |
| 2324-2 | http://loinc.org | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
| 2333-3 | http://loinc.org | Gastrin [Mass/volume] in Serum or Plasma |
| 2335-8 | http://loinc.org | Hemoglobin.gastrointestinal [Presence] in Stool |
| 233-7 | http://loinc.org | Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2338-2 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma |
| 2356-4 | http://loinc.org | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
| 23627-3 | http://loinc.org | Clofazimine [Susceptibility] |
| 23628-1 | http://loinc.org | Sparfloxacin [Susceptibility] |
| 23629-9 | http://loinc.org | Para aminosalicylate [Susceptibility] |
| 23636-4 | http://loinc.org | Cefdinir [Susceptibility] |
| 23637-2 | http://loinc.org | Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23638-0 | http://loinc.org | Grepafloxacin [Susceptibility] |
| 23639-8 | http://loinc.org | Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23640-6 | http://loinc.org | Quinupristin+Dalfopristin [Susceptibility] |
| 23641-4 | http://loinc.org | Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23642-2 | http://loinc.org | Trovafloxacin [Susceptibility] |
| 23643-0 | http://loinc.org | Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 23658-8 | http://loinc.org | Other Antibiotic [Susceptibility] |
| 23659-6 | http://loinc.org | Apramycin [Susceptibility] |
| 23709-9 | http://loinc.org | Ceftiofur [Susceptibility] |
| 23712-3 | http://loinc.org | Enrofloxacin [Susceptibility] |
| 23713-1 | http://loinc.org | Ethylene glycol [Presence] in Serum or Plasma |
| 23740-4 | http://loinc.org | Florfenicol [Susceptibility] |
| 23826-1 | http://loinc.org | Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection |
| 23831-1 | http://loinc.org | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum |
| 2387-9 | http://loinc.org | Glycerol [Mass/volume] in Serum or Plasma |
| 23883-2 | http://loinc.org | Inhibin A [Mass/volume] in Serum or Plasma |
| 23905-3 | http://loinc.org | Mycophenolate [Mass/volume] in Serum or Plasma |
| 23971-5 | http://loinc.org | Epstein Barr virus early IgG Ab [Titer] in Serum |
| 23991-3 | http://loinc.org | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 23992-1 | http://loinc.org | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 2399-4 | http://loinc.org | Glycosaminoglycans [Mass/volume] in Urine |
| 24-0 | http://loinc.org | Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 241-0 | http://loinc.org | Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24108-3 | http://loinc.org | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
| 24109-1 | http://loinc.org | Progesterone [Moles/volume] in Saliva (oral fluid) |
| 24110-9 | http://loinc.org | Treponema pallidum Ab [Presence] in Serum by Immunoassay |
| 24111-7 | http://loinc.org | Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection |
| 24117-4 | http://loinc.org | Ross River virus IgG Ab [Presence] in Serum by Immunoassay |
| 24118-2 | http://loinc.org | Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay |
| 24120-8 | http://loinc.org | Ross River virus IgM Ab [Presence] in Serum by Immunoassay |
| 24121-6 | http://loinc.org | Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay |
| 24124-0 | http://loinc.org | Casts [Presence] in Urine sediment by Light microscopy |
| 24125-7 | http://loinc.org | Androgen free Index in Serum or Plasma |
| 24312-1 | http://loinc.org | Treponema pallidum Ab [Presence] in Serum by Agglutination |
| 24377-4 | http://loinc.org | Platelet aggregation ADP induced [Presence] in Platelet rich plasma |
| 24378-2 | http://loinc.org | Platelet aggregation EPINEPHrine induced [Presence] in Platelet rich plasma |
| 24379-0 | http://loinc.org | Platelet aggregation collagen induced [Presence] in Platelet rich plasma |
| 24380-8 | http://loinc.org | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma |
| 24383-2 | http://loinc.org | Intrinsic factor Ab [Presence] in Serum by Immunoassay |
| 24390-7 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 24391-5 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 24393-1 | http://loinc.org | Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight |
| 24419-4 | http://loinc.org | Pathology report gross observation |
| 24467-3 | http://loinc.org | CD3+CD4+ (T4 helper) cells [#/volume] in Blood |
| 24471-5 | http://loinc.org | Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood |
| 24472-3 | http://loinc.org | Platelet function (closure time) collagen+ADP induced [Time] in Blood |
| 245-1 | http://loinc.org | Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 24518-3 | http://loinc.org | Calcium/Creatinine [Molar ratio] in Urine |
| 24521-7 | http://loinc.org | EPINEPHrine [Moles/volume] in Urine |
| 24522-5 | http://loinc.org | EPINEPHrine/Creatinine [Molar ratio] in Urine |
| 24523-3 | http://loinc.org | Norepinephrine/Creatinine [Molar ratio] in Urine |
| 24524-1 | http://loinc.org | DOPamine/Creatinine [Molar ratio] in Urine |
| 2458-8 | http://loinc.org | IgA [Mass/volume] in Serum or Plasma |
| 2460-4 | http://loinc.org | IgD [Mass/volume] in Serum |
| 2464-6 | http://loinc.org | IgG [Mass/volume] in Cerebral spinal fluid |
| 2465-3 | http://loinc.org | IgG [Mass/volume] in Serum or Plasma |
| 2466-1 | http://loinc.org | IgG subclass 1 [Mass/volume] in Serum |
| 2467-9 | http://loinc.org | IgG subclass 2 [Mass/volume] in Serum |
| 2468-7 | http://loinc.org | IgG subclass 3 [Mass/volume] in Serum |
| 2469-5 | http://loinc.org | IgG subclass 4 [Mass/volume] in Serum |
| 2470-3 | http://loinc.org | IgG/Albumin [Mass Ratio] in Cerebral spinal fluid |
| 2472-9 | http://loinc.org | IgM [Mass/volume] in Serum or Plasma |
| 2483-6 | http://loinc.org | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
| 2484-4 | http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
| 249-3 | http://loinc.org | Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2495-0 | http://loinc.org | Iodine [Mass/volume] in Urine |
| 25095-1 | http://loinc.org | Deoxypyridinoline/Creatinine [Molar ratio] in Urine |
| 25142-1 | http://loinc.org | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak |
| 25143-9 | http://loinc.org | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough |
| 25145-4 | http://loinc.org | Bacteria [Presence] in Urine sediment by Light microscopy |
| 2514-8 | http://loinc.org | Ketones [Presence] in Urine by Test strip |
| 25168-6 | http://loinc.org | Perhexiline [Mass/volume] in Serum or Plasma |
| 25170-2 | http://loinc.org | Mercury [Moles/volume] in Blood |
| 2520-5 | http://loinc.org | Lactate [Moles/volume] in Cerebral spinal fluid |
| 2524-7 | http://loinc.org | Lactate [Moles/volume] in Serum or Plasma |
| 25302-1 | http://loinc.org | Alanine aminotransferase [Enzymatic activity/volume] in Body fluid |
| 253-5 | http://loinc.org | 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25358-3 | http://loinc.org | C peptide [Moles/time] in 24 hour Urine |
| 25360-9 | http://loinc.org | Cadmium [Moles/volume] in Urine |
| 25361-7 | http://loinc.org | Caffeine [Moles/volume] in Serum or Plasma |
| 25374-0 | http://loinc.org | Chromium [Moles/volume] in Serum or Plasma |
| 25375-7 | http://loinc.org | Chymotrypsin [Enzymatic activity/mass] in Stool |
| 25378-1 | http://loinc.org | Cobalt [Moles/volume] in Serum or Plasma |
| 25386-4 | http://loinc.org | Creatinine [Moles/volume] in Body fluid |
| 25393-0 | http://loinc.org | Desethylamiodarone [Moles/volume] in Serum or Plasma |
| 25411-0 | http://loinc.org | Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25428-4 | http://loinc.org | Glucose [Presence] in Urine by Test strip |
| 25447-4 | http://loinc.org | Insulin Free [Moles/volume] in Serum or Plasma |
| 25451-6 | http://loinc.org | Isoniazid [Moles/volume] in Serum or Plasma |
| 25452-4 | http://loinc.org | Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25458-1 | http://loinc.org | lamoTRIgine [Moles/volume] in Serum or Plasma |
| 25466-4 | http://loinc.org | Manganese [Moles/volume] in Blood |
| 25471-4 | http://loinc.org | Mercury [Moles/time] in 24 hour Urine |
| 25474-8 | http://loinc.org | Metanephrines [Moles/volume] in Serum or Plasma |
| 25489-6 | http://loinc.org | Normetanephrine [Moles/volume] in Serum or Plasma |
| 25501-8 | http://loinc.org | Phosphate [Moles/volume] in Body fluid |
| 2550-2 | http://loinc.org | Lactate/Pyruvate [Molar ratio] in Blood |
| 25514-1 | http://loinc.org | Rubella virus IgG Ab [Presence] in Serum |
| 25521-6 | http://loinc.org | Selenium [Moles/volume] in Serum or Plasma |
| 25524-0 | http://loinc.org | Serotonin [Moles/volume] in Blood |
| 25541-4 | http://loinc.org | Topiramate [Moles/volume] in Serum or Plasma |
| 25542-2 | http://loinc.org | Toxoplasma gondii IgM Ab [Presence] in Serum |
| 25548-9 | http://loinc.org | Urate [Moles/volume] in Body fluid |
| 25549-7 | http://loinc.org | Urea [Moles/volume] in Body fluid |
| 25595-0 | http://loinc.org | Econazole [Susceptibility] |
| 25596-8 | http://loinc.org | Fosfomycin [Susceptibility] |
| 25597-6 | http://loinc.org | Josamycine [Susceptibility] |
| 25607-3 | http://loinc.org | Miconazole [Susceptibility] |
| 25608-1 | http://loinc.org | Nitroxoline [Susceptibility] |
| 25637-0 | http://loinc.org | Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25638-8 | http://loinc.org | Eosinophil cationic protein (ECP) [Mass/volume] in Serum |
| 25653-7 | http://loinc.org | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 256-8 | http://loinc.org | Foscarnet [Susceptibility] |
| 25702-2 | http://loinc.org | Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25721-2 | http://loinc.org | Mianserin [Moles/volume] in Serum or Plasma |
| 25722-0 | http://loinc.org | Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25723-8 | http://loinc.org | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2572-6 | http://loinc.org | Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma |
| 258-4 | http://loinc.org | Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 25867-3 | http://loinc.org | Echinococcus sp Ab [Titer] in Serum |
| 2589-0 | http://loinc.org | Lysozyme [Mass/volume] in Serum or Plasma |
| 25907-7 | http://loinc.org | Elastase.pancreatic [Mass/mass] in Stool |
| 25909-3 | http://loinc.org | EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine |
| 25931-7 | http://loinc.org | Homovanillate/Creatinine [Molar ratio] in 24 hour Urine |
| 2596-5 | http://loinc.org | Magnesium [Moles/volume] in Body fluid |
| 2597-3 | http://loinc.org | Magnesium [Moles/volume] in Red Blood Cells |
| 2598-1 | http://loinc.org | Magnesium [Moles/volume] in Urine |
| 2599-9 | http://loinc.org | Magnesium [Moles/time] in 24 hour Urine |
| 26004-2 | http://loinc.org | Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine |
| 26009-1 | http://loinc.org | Treponema pallidum Ab [Titer] in Serum by Hemagglutination |
| 2601-3 | http://loinc.org | Magnesium [Moles/volume] in Serum or Plasma |
| 26023-2 | http://loinc.org | Extractable nuclear Ab identified in Serum |
| 26043-0 | http://loinc.org | HLA-B27 [Presence] by NAA with probe detection |
| 2606-2 | http://loinc.org | Melanin [Presence] in Urine |
| 2614-6 | http://loinc.org | Methemoglobin/Hemoglobin.total in Blood |
| 262-6 | http://loinc.org | Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2639-3 | http://loinc.org | Myoglobin [Mass/volume] in Serum or Plasma |
| 2640-1 | http://loinc.org | Myoglobin [Presence] in Urine |
| 26444-0 | http://loinc.org | Basophils [#/volume] in Blood |
| 26446-5 | http://loinc.org | Blasts/100 leukocytes in Blood |
| 26449-9 | http://loinc.org | Eosinophils [#/volume] in Blood |
| 26450-7 | http://loinc.org | Eosinophils/100 leukocytes in Blood |
| 26453-1 | http://loinc.org | Erythrocytes [#/volume] in Blood |
| 26454-9 | http://loinc.org | Erythrocytes [#/volume] in Cerebral spinal fluid |
| 26455-6 | http://loinc.org | Erythrocytes [#/volume] in Body fluid |
| 26464-8 | http://loinc.org | Leukocytes [#/volume] in Blood |
| 26465-5 | http://loinc.org | Leukocytes [#/volume] in Cerebral spinal fluid |
| 26466-3 | http://loinc.org | Leukocytes [#/volume] in Body fluid |
| 26474-7 | http://loinc.org | Lymphocytes [#/volume] in Blood |
| 26475-4 | http://loinc.org | Lymphocytes [#/volume] in Cerebral spinal fluid |
| 26476-2 | http://loinc.org | Lymphocytes [#/volume] in Body fluid |
| 26477-0 | http://loinc.org | Variant lymphocytes [#/volume] in Blood |
| 26478-8 | http://loinc.org | Lymphocytes/100 leukocytes in Blood |
| 26484-6 | http://loinc.org | Monocytes [#/volume] in Blood |
| 26485-3 | http://loinc.org | Monocytes/100 leukocytes in Blood |
| 26489-5 | http://loinc.org | Mononuclear cells [#/volume] in Cerebral spinal fluid |
| 26490-3 | http://loinc.org | Mononuclear cells [#/volume] in Body fluid |
| 26499-4 | http://loinc.org | Neutrophils [#/volume] in Blood |
| 26500-9 | http://loinc.org | Neutrophils [#/volume] in Cerebral spinal fluid |
| 26507-4 | http://loinc.org | Band form neutrophils [#/volume] in Blood |
| 26508-2 | http://loinc.org | Band form neutrophils/100 leukocytes in Blood |
| 26511-6 | http://loinc.org | Neutrophils/100 leukocytes in Blood |
| 26515-7 | http://loinc.org | Platelets [#/volume] in Blood |
| 26523-1 | http://loinc.org | Promyelocytes [#/volume] in Blood |
| 265-9 | http://loinc.org | Ganciclovir [Susceptibility] |
| 26621-3 | http://loinc.org | Legionella sp Ag [Presence] in Specimen |
| 26705-4 | http://loinc.org | Epstein Barr virus nuclear IgM Ab [Titer] in Serum |
| 267-5 | http://loinc.org | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2676-5 | http://loinc.org | Organic acids [Presence] in Urine |
| 26784-9 | http://loinc.org | diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
| 26833-4 | http://loinc.org | Hippurate [Presence] in Urine |
| 2685-6 | http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma |
| 26885-4 | http://loinc.org | Ova and parasites identified in Specimen by Concentration |
| 2692-2 | http://loinc.org | Osmolality of Serum or Plasma |
| 2695-5 | http://loinc.org | Osmolality of Urine |
| 26960-5 | http://loinc.org | Trypsin [Presence] in Stool |
| 26969-6 | http://loinc.org | Parietal cell Ab [Presence] in Serum by Immunofluorescence |
| 27071-0 | http://loinc.org | CD45 (Lymphs) cells [#/volume] in Blood |
| 27081-9 | http://loinc.org | Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
| 27109-8 | http://loinc.org | PARoxetine [Presence] in Urine |
| 271-7 | http://loinc.org | Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 27198-1 | http://loinc.org | Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct |
| 27200-5 | http://loinc.org | Nuclear Ab [Units/volume] in Serum |
| 2721-9 | http://loinc.org | Pancreatic polypeptide [Mass/volume] in Serum or Plasma |
| 27252-6 | http://loinc.org | Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma |
| 27265-8 | http://loinc.org | Giardia sp Ag [Presence] in Stool |
| 2731-8 | http://loinc.org | Parathyrin.intact [Mass/volume] in Serum or Plasma |
| 27320-1 | http://loinc.org | Parietal cell Ab [Titer] in Serum |
| 27403-5 | http://loinc.org | Gamma glutamyl transferase [Enzymatic activity/volume] in Urine |
| 2742-5 | http://loinc.org | Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
| 2748-2 | http://loinc.org | pH of Body fluid |
| 2752-4 | http://loinc.org | pH of Semen |
| 275-8 | http://loinc.org | Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2758-1 | http://loinc.org | Phenol [Mass/volume] in Urine |
| 27811-9 | http://loinc.org | Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
| 27812-7 | http://loinc.org | Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27815-0 | http://loinc.org | Coagulation factor XIII activity actual/normal in Platelet poor plasma by Chromogenic method |
| 27816-8 | http://loinc.org | von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27818-4 | http://loinc.org | Protein C actual/normal in Platelet poor plasma by Chromogenic method |
| 27819-2 | http://loinc.org | Protein C actual/normal in Platelet poor plasma by Coagulation assay |
| 27820-0 | http://loinc.org | Protein C Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27821-8 | http://loinc.org | Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay |
| 27822-6 | http://loinc.org | Protein S actual/normal in Platelet poor plasma by Coagulation assay |
| 279-0 | http://loinc.org | Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 27977-8 | http://loinc.org | Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine |
| 27978-6 | http://loinc.org | Metanephrines/Creatinine [Molar ratio] in 24 hour Urine |
| 2809-2 | http://loinc.org | Porphobilinogen [Presence] in Urine |
| 28-1 | http://loinc.org | Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2811-8 | http://loinc.org | Porphobilinogen [Moles/volume] in Urine |
| 2812-6 | http://loinc.org | Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells |
| 2821-7 | http://loinc.org | Potassium [Moles/volume] in Body fluid |
| 2823-3 | http://loinc.org | Potassium [Moles/volume] in Serum or Plasma |
| 2828-2 | http://loinc.org | Potassium [Moles/volume] in Urine |
| 2829-0 | http://loinc.org | Potassium [Moles/time] in 24 hour Urine |
| 28539-5 | http://loinc.org | MCH [Entitic mass] |
| 28540-3 | http://loinc.org | MCHC [Mass/volume] |
| 28542-9 | http://loinc.org | Platelet mean volume [Entitic volume] in Blood |
| 2857-1 | http://loinc.org | Prostate specific Ag [Mass/volume] in Serum or Plasma |
| 287-3 | http://loinc.org | Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2880-3 | http://loinc.org | Protein [Mass/volume] in Cerebral spinal fluid |
| 2881-1 | http://loinc.org | Protein [Mass/volume] in Body fluid |
| 2885-2 | http://loinc.org | Protein [Mass/volume] in Serum or Plasma |
| 2888-6 | http://loinc.org | Protein [Mass/volume] in Urine |
| 2889-4 | http://loinc.org | Protein [Mass/time] in 24 hour Urine |
| 2890-2 | http://loinc.org | Protein/Creatinine [Mass Ratio] in Urine |
| 2903-3 | http://loinc.org | Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood |
| 291-5 | http://loinc.org | Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2915-7 | http://loinc.org | Renin [Enzymatic activity/volume] in Plasma |
| 29247-4 | http://loinc.org | Sirolimus [Mass/volume] in Blood |
| 29254-0 | http://loinc.org | Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 29257-3 | http://loinc.org | Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection |
| 29258-1 | http://loinc.org | Linezolid [Susceptibility] |
| 29265-6 | http://loinc.org | Calcium [Moles/volume] corrected for albumin in Serum or Plasma |
| 29300-1 | http://loinc.org | Procedure type |
| 2947-0 | http://loinc.org | Sodium [Moles/volume] in Blood |
| 2950-4 | http://loinc.org | Sodium [Moles/volume] in Body fluid |
| 2951-2 | http://loinc.org | Sodium [Moles/volume] in Serum or Plasma |
| 29520-4 | http://loinc.org | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine |
| 29541-0 | http://loinc.org | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 2954-6 | http://loinc.org | Sodium [Moles/volume] in Sweat |
| 2955-3 | http://loinc.org | Sodium [Moles/volume] in Urine |
| 29558-4 | http://loinc.org | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
| 295-6 | http://loinc.org | Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 2956-1 | http://loinc.org | Sodium [Moles/time] in 24 hour Urine |
| 29577-4 | http://loinc.org | Fungal susceptibility panel |
| 29591-5 | http://loinc.org | Enterovirus RNA [Presence] in Specimen by NAA with probe detection |
| 2963-7 | http://loinc.org | Somatotropin [Mass/volume] in Serum or Plasma |
| 29652-5 | http://loinc.org | Dothiepin [Mass/volume] in Serum or Plasma |
| 29653-3 | http://loinc.org | Dothiepin [Moles/volume] in Serum or Plasma |
| 29659-0 | http://loinc.org | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay |
| 29660-8 | http://loinc.org | Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
| 29662-4 | http://loinc.org | Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay |
| 29747-3 | http://loinc.org | Tocopherols [Moles/volume] in Serum or Plasma |
| 29764-8 | http://loinc.org | Iron [Moles/volume] in Body fluid |
| 29765-5 | http://loinc.org | Cholesterol [Moles/volume] in Body fluid |
| 29766-3 | http://loinc.org | Triglyceride [Moles/volume] in Body fluid |
| 29771-3 | http://loinc.org | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay |
| 29877-8 | http://loinc.org | Methylmalonate [Presence] in Urine |
| 29891-9 | http://loinc.org | Helicobacter pylori [Presence] in Stomach by urea breath test |
| 29904-0 | http://loinc.org | Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection |
| 29908-1 | http://loinc.org | Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection |
| 29909-9 | http://loinc.org | Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection |
| 29910-7 | http://loinc.org | Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection |
| 29953-7 | http://loinc.org | Nuclear Ab [Titer] in Serum |
| 29954-5 | http://loinc.org | Extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 299-8 | http://loinc.org | Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 29990-9 | http://loinc.org | Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy |
| 30000-4 | http://loinc.org | Microalbumin/Creatinine [Ratio] in Urine |
| 3002-3 | http://loinc.org | Thiocyanate [Mass/volume] in Serum or Plasma |
| 3004-9 | http://loinc.org | Thiocyanate [Mass/volume] in Urine |
| 3013-0 | http://loinc.org | Thyroglobulin [Mass/volume] in Serum or Plasma |
| 30131-7 | http://loinc.org | Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma |
| 3016-3 | http://loinc.org | Thyrotropin [Units/volume] in Serum or Plasma |
| 30173-9 | http://loinc.org | Cortisol Free [Moles/volume] in Urine |
| 30180-4 | http://loinc.org | Basophils/100 leukocytes in Blood |
| 30206-7 | http://loinc.org | Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma |
| 30246-3 | http://loinc.org | Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
| 30248-9 | http://loinc.org | Transferrin receptor.soluble [Mass/volume] in Serum or Plasma |
| 30298-4 | http://loinc.org | lamiVUDine [Susceptibility] |
| 30299-2 | http://loinc.org | Amprenavir [Susceptibility] |
| 30300-8 | http://loinc.org | Didanosine [Susceptibility] |
| 30301-6 | http://loinc.org | Zalcitabine [Susceptibility] |
| 30302-4 | http://loinc.org | Stavudine [Susceptibility] |
| 30303-2 | http://loinc.org | Abacavir [Susceptibility] |
| 30304-0 | http://loinc.org | Adefovir [Susceptibility] |
| 30305-7 | http://loinc.org | Delavirdine [Susceptibility] |
| 30306-5 | http://loinc.org | Efavirenz [Susceptibility] |
| 30307-3 | http://loinc.org | Indinavir [Susceptibility] |
| 30308-1 | http://loinc.org | Ritonavir [Susceptibility] |
| 30309-9 | http://loinc.org | Nelfinavir [Susceptibility] |
| 30310-7 | http://loinc.org | Saquinavir [Susceptibility] |
| 30311-5 | http://loinc.org | Nevirapine [Susceptibility] |
| 30313-1 | http://loinc.org | Hemoglobin [Mass/volume] in Arterial blood |
| 30316-4 | http://loinc.org | Alpha subunit free [Mass/volume] in Serum or Plasma |
| 30325-5 | http://loinc.org | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma |
| 30339-6 | http://loinc.org | Epstein Barr virus capsid IgG Ab [Presence] in Serum |
| 30340-4 | http://loinc.org | Epstein Barr virus capsid IgM Ab [Presence] in Serum |
| 30341-2 | http://loinc.org | Erythrocyte sedimentation rate |
| 3034-6 | http://loinc.org | Transferrin [Mass/volume] in Serum or Plasma |
| 30376-8 | http://loinc.org | Blasts [#/volume] in Blood |
| 303-8 | http://loinc.org | Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 30385-9 | http://loinc.org | Erythrocyte distribution width [Ratio] |
| 30391-7 | http://loinc.org | Erythrocytes [#/volume] in Urine |
| 30392-5 | http://loinc.org | Nucleated erythrocytes [#/volume] in Blood |
| 30397-4 | http://loinc.org | Hairy cells [#/volume] in Blood |
| 3040-3 | http://loinc.org | Lipase [Enzymatic activity/volume] in Serum or Plasma |
| 30405-5 | http://loinc.org | Leukocytes [#/volume] in Urine |
| 3041-1 | http://loinc.org | Trichloroacetate [Mass/volume] in Urine |
| 30412-1 | http://loinc.org | Abnormal lymphocytes [#/volume] in Blood |
| 30422-0 | http://loinc.org | Lymphoma cells [#/volume] in Blood |
| 30428-7 | http://loinc.org | MCV [Entitic volume] |
| 30433-7 | http://loinc.org | Metamyelocytes [#/volume] in Blood |
| 30446-9 | http://loinc.org | Myelocytes [#/volume] in Blood |
| 30449-3 | http://loinc.org | Neutrophils.hypersegmented [#/volume] in Blood |
| 30450-1 | http://loinc.org | Neutrophils.hypersegmented/100 leukocytes in Blood |
| 30458-4 | http://loinc.org | Plasma cells [#/volume] in Blood |
| 30464-2 | http://loinc.org | Prolymphocytes [#/volume] in Blood |
| 30480-8 | http://loinc.org | Orotate [Presence] in Urine |
| 30522-7 | http://loinc.org | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |